pmid,nct_id,Title,ArticleType,Substance,MeSH,PubDate,Journal,pub_source,ctg_links,Abstract
32251729,NCT04326790,The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design.,Clinical Trial Protocol|Journal Article,Antirheumatic Agents|Troponin|Colchicine|NA,"Antirheumatic Agents|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Colchicine|Coronavirus Infections|Heart Diseases|Humans|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Symptom Assessment|Troponin|NA",2020-07-24,Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,Abstract,https://clinicaltrials.gov/ct2/show/NCT04326790,2
32293449,NCT04292964,Prognostic value of NT-proBNP in patients with severe COVID-19.,Journal Article|Observational Study,"Peptide Fragments|pro-brain natriuretic peptide (1-76)|Natriuretic Peptide, Brain|NA","Adult|Aged|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Female|Hospital Mortality|Humans|Male|Middle Aged|Mortality|Natriuretic Peptide, Brain|Pandemics|Peptide Fragments|Pneumonia, Viral|Predictive Value of Tests|Prognosis|Reference Values|Retrospective Studies|Risk Factors|SARS-CoV-2|NA",2020-04-22,Respiratory research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04292964,2
32304640,NCT04315948,Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.,Journal Article,Hydroxychloroquine|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Drug Repositioning|Evidence-Based Medicine|Health Services Needs and Demand|Humans|Hydroxychloroquine|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-06-29,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04315948,3
32330277,NCT04323527,Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.,"Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Anti-Bacterial Agents|Antiviral Agents|Oseltamivir|chloroquine diphosphate|Azithromycin|Chloroquine|NA,"Adult|Aged|Anti-Bacterial Agents|Antiviral Agents|Azithromycin|Betacoronavirus|Brazil|COVID-19|Chloroquine|Coronavirus Infections|Disease Outbreaks|Dose-Response Relationship, Drug|Double-Blind Method|Female|Humans|Male|Middle Aged|Oseltamivir|Pandemics|Pneumonia, Viral|SARS-CoV-2|Tertiary Care Centers|NA",2020-04-29,JAMA network open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04323527,1
32330305,NCT04279782,"SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens.","Journal Article|Research Support, Non-U.S. Gov't","RNA, Viral|NA","Adult|Anal Canal|Body Fluids|COVID-19|Female|Humans|Male|Middle Aged|Oropharynx|RNA, Viral|Real-Time Polymerase Chain Reaction|SARS-CoV-2|NA",2020-12-23,Journal of medical virology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04279782,1
32353223,NCT04318366,"Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy.",Journal Article, , ,2020-05-05,Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
32356926,NCT04355936,Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19.,Journal Article,"Angiotensin II Type 1 Receptor Blockers|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|ACE2 protein, human|Angiotensin-Converting Enzyme 2|Telmisartan|NA","Angiotensin II Type 1 Receptor Blockers|Angiotensin-Converting Enzyme 2|COVID-19|Clinical Trials, Phase II as Topic|Humans|Lung|Pandemics|Protein Binding|SARS-CoV-2|Spike Glycoprotein, Coronavirus|Telmisartan|Virus Internalization|NA",2020-12-04,Drug development research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04355936,1
32383125,NCT04308668,Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.,Clinical Trial Protocol|Journal Article|Multicenter Study|Randomized Controlled Trial,Hydroxychloroquine|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Double-Blind Method|Humans|Hydroxychloroquine|Pandemics|Pneumonia, Viral|Post-Exposure Prophylaxis|SARS-CoV-2|Severity of Illness Index|NA",2020-08-24,Canadian journal of anaesthesia = Journal canadien d'anesthesie,Abstract,https://clinicaltrials.gov/ct2/show/NCT04308668,4
32386744,NCT04321278,Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?,Editorial,Antimalarials|NA,"Antimalarials|Betacoronavirus|COVID-19|Coronavirus Infections|Global Health|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|Treatment Outcome|NA",2020-07-24,Medicina clinica,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321278,2
32391667,NCT04261517,[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].,Journal Article|Randomized Controlled Trial,"RNA, Viral|Hydroxychloroquine|NA","Betacoronavirus|COVID-19|China|Coronavirus Infections|Humans|Hydroxychloroquine|Pandemics|Pilot Projects|Pneumonia, Viral|RNA, Viral|SARS-CoV-2|Treatment Outcome|NA",2020-05-12,Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,Abstract,https://clinicaltrials.gov/ct2/show/NCT04261517,1
32401715,NCT04276688,"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.","Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Drug Combinations|lopinavir-ritonavir drug combination|Interferon beta-1b|Lopinavir|Ribavirin|Ritonavir|NA,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Combinations|Drug Therapy, Combination|Female|Hong Kong|Hospitalization|Humans|Interferon beta-1b|Lopinavir|Male|Middle Aged|Pandemics|Pneumonia, Viral|Ribavirin|Ritonavir|SARS-CoV-2|NA",2020-06-02,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04276688,2
32407672,NCT04372589,Coagulation abnormalities and thrombosis in patients with COVID-19.,Journal Article,"Anticoagulants|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|fibrin fragment D|NA","Anticoagulants|Betacoronavirus|Blood Coagulation|COVID-19|Coronavirus Infections|Disseminated Intravascular Coagulation|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|Humans|Pandemics|Platelet Count|Pneumonia, Viral|Prothrombin Time|SARS-CoV-2|Thrombosis|NA",2020-06-09,The Lancet. Haematology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04372589,3
32407672,NCT04345848,Coagulation abnormalities and thrombosis in patients with COVID-19.,Journal Article,"Anticoagulants|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|fibrin fragment D|NA","Anticoagulants|Betacoronavirus|Blood Coagulation|COVID-19|Coronavirus Infections|Disseminated Intravascular Coagulation|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|Humans|Pandemics|Platelet Count|Pneumonia, Viral|Prothrombin Time|SARS-CoV-2|Thrombosis|NA",2020-06-09,The Lancet. Haematology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04345848,2
32407672,NCT04367831,Coagulation abnormalities and thrombosis in patients with COVID-19.,Journal Article,"Anticoagulants|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|fibrin fragment D|NA","Anticoagulants|Betacoronavirus|Blood Coagulation|COVID-19|Coronavirus Infections|Disseminated Intravascular Coagulation|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|Humans|Pandemics|Platelet Count|Pneumonia, Viral|Prothrombin Time|SARS-CoV-2|Thrombosis|NA",2020-06-09,The Lancet. Haematology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04367831,2
32407672,NCT04366960,Coagulation abnormalities and thrombosis in patients with COVID-19.,Journal Article,"Anticoagulants|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|fibrin fragment D|NA","Anticoagulants|Betacoronavirus|Blood Coagulation|COVID-19|Coronavirus Infections|Disseminated Intravascular Coagulation|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|Humans|Pandemics|Platelet Count|Pneumonia, Viral|Prothrombin Time|SARS-CoV-2|Thrombosis|NA",2020-06-09,The Lancet. Haematology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04366960,2
32423584,NCT04257656,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.",Journal Article|Multicenter Study|Randomized Controlled Trial,Antiviral Agents|remdesivir|Adenosine Monophosphate|Alanine|NA,"Adenosine Monophosphate|Aged|Alanine|Antiviral Agents|Betacoronavirus|COVID-19|China|Coronavirus Infections|Double-Blind Method|Female|Humans|Infusions, Intravenous|Male|Middle Aged|Negative Results|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-05-29,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04257656,2
32425051,NCT04329832,"Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial.","Clinical Trial Protocol|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Anti-Infective Agents|Hydroxychloroquine|Azithromycin|NA,"Adult|Anti-Infective Agents|Azithromycin|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Monitoring|Female|Humans|Hydroxychloroquine|Male|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Treatment Outcome|Utah|NA",2020-08-13,Annals of the American Thoracic Society,Abstract,https://clinicaltrials.gov/ct2/show/NCT04329832,2
32427279,NCT04374071,Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19.,Journal Article,Adrenal Cortex Hormones|Methylprednisolone|NA,Adrenal Cortex Hormones|COVID-19|Female|Hospitalization|Humans|Male|Methylprednisolone|Middle Aged|Multicenter Studies as Topic|NA,2020-12-14,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Abstract,https://clinicaltrials.gov/ct2/show/NCT04374071,1
32445440,NCT04280705,Remdesivir for the Treatment of Covid-19 - Final Report.,"Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Antiviral Agents|remdesivir|Adenosine Monophosphate|Alanine|NA,"Adenosine Monophosphate|Administration, Intravenous|Adult|Aged|Alanine|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Double-Blind Method|Extracorporeal Membrane Oxygenation|Female|Humans|Kaplan-Meier Estimate|Male|Middle Aged|Oxygen Inhalation Therapy|Pandemics|Pneumonia, Viral|Respiration, Artificial|SARS-CoV-2|Time Factors|Young Adult|NA",2020-12-01,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04280705,3
32448345,NCT04257656,"Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.",Clinical Trial Protocol|Journal Article,Antiviral Agents|remdesivir|Adenosine Monophosphate|Alanine|NA,"Adenosine Monophosphate|Alanine|Antiviral Agents|Betacoronavirus|COVID-19|China|Clinical Trials, Phase III as Topic|Coronavirus Infections|Double-Blind Method|Equivalence Trials as Topic|Female|Humans|Infusions, Intravenous|Male|Multicenter Studies as Topic|Pandemics|Patient Safety|Pneumonia, Viral|Risk Assessment|Risk Factors|SARS-CoV-2|Severity of Illness Index|Time Factors|Treatment Outcome|NA",2020-05-27,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04257656,2
32450106,NCT04313127,"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.","Clinical Trial, Phase I|Journal Article","Ad5-nCoV vaccine|Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Vaccines, Synthetic|Viral Vaccines|NA","Adenoviridae|Adolescent|Adult|Antibodies, Neutralizing|Antibodies, Viral|Betacoronavirus|COVID-19|COVID-19 Vaccines|China|Coronavirus Infections|Enzyme-Linked Immunosorbent Assay|Female|Humans|Immunity, Cellular|Immunity, Humoral|Injections, Intramuscular|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|T-Lymphocytes|Vaccines, Synthetic|Viral Vaccines|Young Adult|NA",2020-06-17,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04313127,1
32459919,NCT04292899,Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.,"Clinical Trial, Phase III|Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|remdesivir|Adenosine Monophosphate|Alanine|NA,"Adenosine Monophosphate|Adult|Aged|Alanine|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Administration Schedule|Female|Hospitalization|Humans|Male|Middle Aged|Oxygen Inhalation Therapy|Pandemics|Pneumonia, Viral|SARS-CoV-2|Treatment Outcome|NA",2020-12-01,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04292899,1
32468508,NCT04321421,Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol.,Clinical Trial Protocol|Journal Article|Multicenter Study, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Immunization, Passive|Pandemics|Plasma|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-28,Internal and emergency medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321421,4
32472191,NCT04324736,Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.,"Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't","Glycated Hemoglobin A|hemoglobin A1c protein, human|NA","Aged|Aged, 80 and over|COVID-19|Coronavirus Infections|Diabetes Mellitus, Type 2|Female|Glycated Hemoglobin A|Humans|Hypertension|Inpatients|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prognosis|Respiration, Artificial|Risk Factors|NA",2020-07-27,Diabetologia,Abstract,https://clinicaltrials.gov/ct2/show/NCT04324736,3
32473681,NCT04354701,Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.,"Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Antiviral Agents|Hydroxychloroquine|Azithromycin|NA,"Aged|Antiviral Agents|Azithromycin|Betacoronavirus|COVID-19|Cause of Death|Comorbidity|Coronavirus Infections|Databases, Factual|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Neoplasms|Pandemics|Pneumonia, Viral|Prognosis|Risk Factors|SARS-CoV-2|NA",2020-07-02,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04354701,2
32492293,NCT04308668,A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Hydroxychloroquine|NA,"Adult|Betacoronavirus|COVID-19|Canada|Coronavirus Infections|Double-Blind Method|Female|Humans|Hydroxychloroquine|Inhalation Exposure|Male|Middle Aged|Occupational Exposure|Pandemics|Pneumonia, Viral|Post-Exposure Prophylaxis|SARS-CoV-2|Treatment Failure|United States|NA",2020-08-12,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04308668,4
32492354,NCT04332991,Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural",Antimalarials|Hydroxychloroquine|NA,"Adult|Antimalarials|Betacoronavirus|COVID-19|Coronavirus Infections|Dose-Response Relationship, Drug|Hospitalization|Humans|Hydroxychloroquine|Pandemics|Pneumonia, Viral|SARS-CoV-2|Single-Blind Method|Treatment Outcome|NA",2020-09-21,Annals of the American Thoracic Society,Abstract,https://clinicaltrials.gov/ct2/show/NCT04332991,2
32493441,NCT04330638,Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,"Anti-Inflammatory Agents|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|IL6 protein, human|IL6R protein, human|Interleukin 1 Receptor Antagonist Protein|Interleukin-1|Interleukin-6|Receptors, Interleukin-6|tocilizumab|siltuximab|NA","Anti-Inflammatory Agents|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Belgium|Betacoronavirus|COVID-19|Clinical Trials, Phase III as Topic|Coronavirus Infections|Drug Therapy, Combination|Host-Pathogen Interactions|Humans|Interleukin 1 Receptor Antagonist Protein|Interleukin-1|Interleukin-6|Multicenter Studies as Topic|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|Receptors, Interleukin-6|SARS-CoV-2|Severity of Illness Index|Time Factors|Treatment Outcome|NA",2020-06-10,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04330638,1
32493468,NCT04343768,"Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.",Clinical Trial Protocol|Letter,Antiviral Agents|Drug Combinations|lopinavir-ritonavir drug combination|Interferon beta-1b|Lopinavir|Hydroxychloroquine|Ritonavir|Interferon beta-1a|NA,"Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Combinations|Drug Therapy, Combination|Host-Pathogen Interactions|Humans|Hydroxychloroquine|Interferon beta-1a|Interferon beta-1b|Iran|Lopinavir|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Ritonavir|SARS-CoV-2|Severity of Illness Index|Time Factors|Treatment Outcome|NA",2020-06-10,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343768,2
32493478,NCT04328961,Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Antiviral Agents|Hydroxychloroquine|Ascorbic Acid|NA,"Adolescent|Adult|Aged|Aged, 80 and over|Antiviral Agents|Ascorbic Acid|Betacoronavirus|COVID-19|Contact Tracing|Coronavirus Infections|Drug Administration Schedule|Female|Humans|Hydroxychloroquine|Incidence|Male|Middle Aged|Multicenter Studies as Topic|Occupational Exposure|Occupational Health|Pandemics|Pneumonia, Viral|Post-Exposure Prophylaxis|Randomized Controlled Trials as Topic|Risk Assessment|Risk Factors|SARS-CoV-2|Time Factors|Treatment Outcome|United States|Virus Shedding|Young Adult|NA",2020-06-10,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04328961,2
32496206,NCT04331171,Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application.,Journal Article, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Disease Outbreaks|France|Humans|Middle Aged|Olfaction Disorders|Pandemics|Pneumonia, Viral|SARS-CoV-2|Self-Assessment|Surveys and Questionnaires|Young Adult|NA",2020-06-17,Journal of medical Internet research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331171,3
32501454,NCT04318366,"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.",Journal Article, , ,2020-09-28,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
32503602,NCT04328441,Two Randomized Controlled Trials of Bacillus Calmette-GuÃ©rin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.,Clinical Trial Protocol|Letter,BCG Vaccine|NA,"Absenteeism|Adult|Aged|Aged, 80 and over|BCG Vaccine|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Health Personnel|Hospitalization|Humans|Male|Middle Aged|Multicenter Studies as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Vaccination|NA",2020-06-30,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04328441,1
32503620,NCT04360980,Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.,Clinical Trial Protocol|Letter,Drug Combinations|lopinavir-ritonavir drug combination|Lopinavir|Ritonavir|Colchicine|NA,"Betacoronavirus|COVID-19|Colchicine|Coronavirus Infections|Double-Blind Method|Drug Combinations|Hospitalization|Humans|Lopinavir|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|Ritonavir|SARS-CoV-2|NA",2020-06-30,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04360980,1
32503657,NCT04333589,"The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Letter,"Amides|Antiviral Agents|Pyrazines|RNA, Viral|favipiravir|NA","Adolescent|Adult|Aged|Aged, 80 and over|Amides|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Male|Middle Aged|Multicenter Studies as Topic|Pandemics|Pneumonia, Viral|Pyrazines|RNA, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Treatment Outcome|Young Adult|NA",2020-06-30,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04333589,1
32503662,NCT04316377,Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Hydroxychloroquine|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Female|Hospitalization|Humans|Hydroxychloroquine|Male|Norway|Pandemics|Pneumonia, Viral|Pragmatic Clinical Trials as Topic|Research Design|SARS-CoV-2|Viral Load|NA",2020-06-30,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04316377,2
32503663,NCT04326920,Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Recombinant Proteins|sargramostim|Granulocyte-Macrophage Colony-Stimulating Factor|Oxygen|NA,"Acute Disease|Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Clinical Trials, Phase IV as Topic|Coronavirus Infections|Female|Granulocyte-Macrophage Colony-Stimulating Factor|Humans|Male|Middle Aged|Oxygen|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|Recombinant Proteins|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Young Adult|NA",2020-06-30,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04326920,2
32511534,NCT04306393,Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2).,Preprint, , ,2020-09-28,medRxiv : the preprint server for health sciences,Abstract,https://clinicaltrials.gov/ct2/show/NCT04306393,2
32512291,NCT04335786,"Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.","Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't",Angiotensin II Type 1 Receptor Blockers|Placebos|Valsartan|NA,"Adult|Angiotensin II Type 1 Receptor Blockers|Betacoronavirus|COVID-19|Coronary Care Units|Coronavirus Infections|Double-Blind Method|Drug Administration Schedule|Humans|Inpatients|Multicenter Studies as Topic|Netherlands|Pandemics|Placebos|Pneumonia, Viral|Randomized Controlled Trials as Topic|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|Time Factors|Valsartan|NA",2020-08-26,American heart journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04335786,1
32513231,NCT04341493,Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Thiazoles|Hydroxychloroquine|nitazoxanide|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Drug Therapy, Combination|Humans|Hydroxychloroquine|Pandemics|Pneumonia, Viral|Prognosis|Randomized Controlled Trials as Topic|Respiration, Artificial|Risk Factors|SARS-CoV-2|Single-Blind Method|Thiazoles|NA",2020-06-30,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04341493,1
32513299,NCT04334265,"Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Letter,"Antiviral Agents|Drugs, Chinese Herbal|anluohuaxian|NA","Adolescent|Adult|Aged|Aged, 80 and over|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drugs, Chinese Herbal|Female|Humans|Lung|Male|Middle Aged|Multicenter Studies as Topic|Outcome Assessment, Health Care|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|SARS-CoV-2|Walking|Young Adult|NA",2020-06-30,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04334265,1
32513308,NCT04359810,Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.,Clinical Trial Protocol|Letter,"Antibodies, Viral|NA","Adult|Antibodies, Viral|Betacoronavirus|COVID-19|Clinical Trials, Phase II as Topic|Coronavirus Infections|Humans|Immunization, Passive|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|SARS-CoV-2|NA",2020-06-30,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04359810,3
32518419,NCT04338958,The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.,"Journal Article|Research Support, Non-U.S. Gov't","Anti-Inflammatory Agents|Cytokines|INCB018424|Protein Kinase Inhibitors|Pyrazoles|JAK1 protein, human|JAK2 protein, human|Janus Kinase 1|Janus Kinase 2|NA","Adult|Aged|Aged, 80 and over|Anti-Inflammatory Agents|Betacoronavirus|COVID-19|Clinical Trials as Topic|Coronavirus Infections|Cytokine Release Syndrome|Cytokines|Drug Administration Schedule|Female|Gene Expression Regulation|Humans|Immunity, Innate|Inflammation|Janus Kinase 1|Janus Kinase 2|Male|Middle Aged|Pandemics|Patient Safety|Pneumonia, Viral|Protein Kinase Inhibitors|Pyrazoles|Retrospective Studies|SARS-CoV-2|Severe Acute Respiratory Syndrome|T-Lymphocytes|Treatment Outcome|NA",2020-07-14,Leukemia,Abstract,https://clinicaltrials.gov/ct2/show/NCT04338958,1
32520406,NCT04368338,The association of lung ultrasound images with COVID-19 infection in an emergency room cohort.,Journal Article|Observational Study, ,"Adult|Aged|Area Under Curve|COVID-19|Cohort Studies|Coronavirus Infections|Emergency Medical Services|Emergency Service, Hospital|Female|Humans|Lung|Male|Middle Aged|Organ Dysfunction Scores|Pandemics|Pleura|Pneumonia, Viral|Polymerase Chain Reaction|Predictive Value of Tests|ROC Curve|Sensitivity and Specificity|Triage|Ultrasonography|NA",2020-11-19,Anaesthesia,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368338,1
32522282,NCT04322396,Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Antiviral Agents|Hydroxychloroquine|Azithromycin|NA,"Antiviral Agents|Azithromycin|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Care|Denmark|Double-Blind Method|Drug Administration Schedule|Hospital Mortality|Host-Pathogen Interactions|Humans|Hydroxychloroquine|Inpatients|Length of Stay|Multicenter Studies as Topic|Noninvasive Ventilation|Pandemics|Patient Admission|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Severity of Illness Index|Time Factors|Treatment Outcome|NA",2020-06-17,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04322396,2
32527993,NCT04352517,[Influence of physical activity during outbreak on psychological states in adults in the Covid-19 pandemic: a study protocol.],Journal Article|Multicenter Study|Observational Study, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Clinical Protocols|Coronavirus Infections|Cross-Sectional Studies|Disease Outbreaks|Exercise|Female|Health Behavior|Health Status|Health Surveys|Humans|Latin America|Male|Mental Health|Middle Aged|Pandemics|Pneumonia, Viral|Portugal|Quarantine|SARS-CoV-2|Spain|NA",2020-06-17,Revista espanola de salud publica,Abstract,https://clinicaltrials.gov/ct2/show/NCT04352517,1
32532356,NCT04336254,Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).,"Clinical Trial Protocol|Clinical Trial, Phase I|Clinical Trial, Phase II|Letter", ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Coronavirus Infections|Dental Pulp|Female|Humans|Male|Middle Aged|Outcome Assessment, Health Care|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Stem Cell Transplantation|Transplantation, Homologous|Young Adult|NA",2020-06-22,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04336254,1
32554923,NCT04369469,The complement system in COVID-19: friend and foe?,"Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review", ,"Betacoronavirus|Blood Coagulation|COVID-19|Complement Activation|Coronavirus Infections|Endothelial Cells|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-17,JCI insight,Abstract,https://clinicaltrials.gov/ct2/show/NCT04369469,3
32555385,NCT04354259,IBD in the time of corona - vigilance for immune-mediated diseases.,Journal Article|Review, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Immunity, Mucosal|Inflammatory Bowel Diseases|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-08,Nature reviews. Gastroenterology &amp; hepatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04354259,3
32555385,NCT04276688,IBD in the time of corona - vigilance for immune-mediated diseases.,Journal Article|Review, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Immunity, Mucosal|Inflammatory Bowel Diseases|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-08,Nature reviews. Gastroenterology &amp; hepatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04276688,2
32556328,NCT04343781,National French Survey of Coronavirus Disease (COVID-19) Symptoms in People Aged 70 and Over.,Journal Article, ,"Aged|Aged, 80 and over|COVID-19|Coronavirus|Coronavirus Infections|France|Humans|SARS-CoV-2|NA",2021-02-24,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343781,1
32559419,NCT04326920,Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities.,"Journal Article|Research Support, Non-U.S. Gov't|Review",Immunologic Factors|Granulocyte-Macrophage Colony-Stimulating Factor|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Disease Progression|Granulocyte-Macrophage Colony-Stimulating Factor|Humans|Immunologic Factors|Immunomodulation|Pandemics|Pneumonia, Viral|Respiratory Distress Syndrome|SARS-CoV-2|NA",2020-08-31,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04326920,2
32560746,NCT04355364,Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter|Multicenter Study,Aerosols|Recombinant Proteins|Deoxyribonuclease I|dornase alfa|NA,"Adult|Aerosols|Betacoronavirus|COVID-19|Coronavirus Infections|Deoxyribonuclease I|Humans|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|Recombinant Proteins|Respiratory Distress Syndrome|SARS-CoV-2|Trachea|NA",2020-07-07,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04355364,1
32564693,NCT04331574,Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.,"Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't",Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|NA,"Adolescent|Adult|Age Distribution|Age Factors|Aged|Aged, 80 and over|Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|Betacoronavirus|COVID-19|Coronavirus Infections|Cross-Sectional Studies|Female|Humans|Hypertension|Italy|Male|Middle Aged|Multimorbidity|Pandemics|Pneumonia, Viral|Prognosis|Renin-Angiotensin System|SARS-CoV-2|Societies, Medical|Survival Rate|Young Adult|NA",2020-07-20,"Hypertension (Dallas, Tex. : 1979)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04331574,3
32569585,NCT04365959,Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study.,"Clinical Trial|Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Care|Feasibility Studies|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prone Position|Prospective Studies|Pulmonary Gas Exchange|Respiratory Distress Syndrome|Respiratory Mechanics|SARS-CoV-2|Young Adult|NA",2020-08-31,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04365959,1
32579195,NCT04326790,Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.,Journal Article|Randomized Controlled Trial,Fibrin Fibrinogen Degradation Products|Troponin|Tubulin Modulators|fibrin fragment D|C-Reactive Protein|Colchicine|NA,"Aged|Aged, 80 and over|Betacoronavirus|C-Reactive Protein|COVID-19|Cause of Death|Colchicine|Coronavirus Infections|Diarrhea|Disease Progression|Female|Fibrin Fibrinogen Degradation Products|Greece|Hospitalization|Humans|Inflammation|Kaplan-Meier Estimate|Male|Middle Aged|Mortality|Pandemics|Pneumonia, Viral|Respiration, Artificial|SARS-CoV-2|Time Factors|Treatment Outcome|Troponin|Tubulin Modulators|NA",2020-07-02,JAMA network open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04326790,2
32586395,NCT04368156,"A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCoreÂ®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial&quot;.",Clinical Trial Protocol|Letter, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Intensive Care Units|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|Respiration, Artificial|SARS-CoV-2|Vagus Nerve Stimulation|NA",2020-07-07,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368156,1
32586399,NCT04348513,Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.,"Clinical Trial Protocol|Clinical Trial, Phase II|Letter|Multicenter Study",Triiodothyronine|NA,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Illness|Double-Blind Method|Extracorporeal Membrane Oxygenation|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|Respiration, Artificial|SARS-CoV-2|Triiodothyronine|Young Adult|NA",2020-07-07,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04348513,1
32589496,NCT04338672,The Impact of the Coronavirus Disease 2019 Outbreak on the Attendance of Patients with Surgical Complaints at a Tertiary Hospital Emergency Department.,Journal Article|Observational Study, ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Coronavirus Infections|Emergency Service, Hospital|Female|Health Personnel|Hospitalization|Humans|Intestinal Diseases|Israel|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Sex Factors|Surgery Department, Hospital|Tachycardia|Tertiary Care Centers|Young Adult|NA",2020-09-28,Journal of laparoendoscopic &amp; advanced surgical techniques. Part A,Abstract,https://clinicaltrials.gov/ct2/show/NCT04338672,1
32602006,NCT04334291,Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.,"Journal Article|Research Support, Non-U.S. Gov't","Peptidyl-Dipeptidase A|ACE2 protein, human|Angiotensin-Converting Enzyme 2|NA","Acute Kidney Injury|Aged|Aged, 80 and over|Angiotensin-Converting Enzyme 2|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Glomerular Filtration Rate|Humans|Male|Middle Aged|Pandemics|Peptidyl-Dipeptidase A|Pneumonia, Viral|Registries|Risk Assessment|SARS-CoV-2|NA",2020-08-10,Journal of nephrology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04334291,6
32602562,NCT04327531,Evaluating the effects of the COVID-19 pandemic on the physical and mental well-being of obstetricians and gynecologists in Turkey.,Journal Article, ,"Adaptation, Psychological|Adult|Anxiety|Attitude of Health Personnel|COVID-19|Female|Gynecology|Humans|Male|Mental Health|Middle Aged|Obstetrics|Pandemics|Practice Patterns, Physicians'|Prospective Studies|Surveys and Questionnaires|Turkey|NA",2020-12-21,International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,Abstract,https://clinicaltrials.gov/ct2/show/NCT04327531,1
32602677,NCT04339608,Prevalence of Flu-like Symptoms and COVID-19 in Healthcare Workers from India.,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Health Personnel|Humans|India|Pandemics|Pneumonia, Viral|Prevalence|SARS-CoV-2|NA",2020-07-06,The Journal of the Association of Physicians of India,Abstract,https://clinicaltrials.gov/ct2/show/NCT04339608,1
32613089,NCT04380818,Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial.,Journal Article, , ,2020-09-28,Clinical and translational radiation oncology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04380818,1
32616063,NCT04410562,Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.,Clinical Trial Protocol|Letter,Antiviral Agents|Hydroxychloroquine|NA,"Antiviral Agents|Betacoronavirus|COVID-19|Chemoprevention|Coronavirus Infections|Double-Blind Method|Drug Administration Schedule|Female|Host-Pathogen Interactions|Humans|Hydroxychloroquine|Multicenter Studies as Topic|Pandemics|Pneumonia, Viral|Pregnancy|Pregnancy Complications, Infectious|Protective Factors|Randomized Controlled Trials as Topic|Risk Assessment|Risk Factors|SARS-CoV-2|Severity of Illness Index|Spain|Time Factors|Treatment Outcome|Virus Shedding|NA",2020-07-10,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04410562,1
32618282,NCT04307693,Testing COVID-19 therapies to prevent progression of mild disease.,Journal Article|Comment, ,"Betacoronavirus|COVID-19|Humans|Pandemics|Pneumonia, Viral|NA",2020-12-04,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04307693,1
32627860,NCT04368676,Psychological interventions to foster resilience in healthcare professionals.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Adult|Allied Health Personnel|Cognitive Behavioral Therapy|Female|Health Personnel|Humans|Male|Middle Aged|Mindfulness|Occupational Diseases|Randomized Controlled Trials as Topic|Resilience, Psychological|Stress, Psychological|NA",2020-09-25,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368676,2
32633094,NCT04331106,The Orthostatic Hypotension Questionnaire in Swedish tested in patients with parkinsonism.,"Journal Article|Research Support, Non-U.S. Gov't", , ,2021-02-22,Brain and behavior,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331106,1
32641154,NCT04390464,Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.,"Clinical Trial Protocol|Clinical Trial, Phase IV|Letter","Antibodies, Monoclonal, Humanized|Azetidines|Immunologic Factors|Sulfonamides|ravulizumab|baricitinib|NA","Antibodies, Monoclonal, Humanized|Azetidines|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Repositioning|Humans|Immunologic Factors|Intensive Care Units|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Sulfonamides|NA",2020-07-14,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04390464,1
32641163,NCT04339816,Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.,Clinical Trial Protocol|Journal Article|Multicenter Study,Hydroxychloroquine|Azithromycin|NA,"Azithromycin|Betacoronavirus|COVID-19|Coronavirus Infections|Double-Blind Method|Drug Therapy, Combination|Humans|Hydroxychloroquine|Intensive Care Units|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|SARS-CoV-2|NA",2020-07-14,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04339816,1
32641343,NCT04264533,Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial.,"Clinical Trial Protocol|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Vitamins|Ascorbic Acid|NA,"Administration, Intravenous|Ascorbic Acid|Betacoronavirus|COVID-19|China|Coronavirus Infections|Cytokine Release Syndrome|Hospital Mortality|Humans|Intensive Care Units|Pandemics|Pneumonia, Viral|Respiration, Artificial|SARS-CoV-2|Severity of Illness Index|Treatment Outcome|Vitamins|NA",2020-07-17,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04264533,1
32645153,NCT04321265,Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients.,Journal Article|Multicenter Study,Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|NA,"Aged|Aged, 80 and over|Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|COVID-19|Critical Illness|Female|Humans|Intensive Care Units|Male|Prospective Studies|SARS-CoV-2|NA",2021-01-26,European heart journal. Cardiovascular pharmacotherapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321265,2
32648959,NCT04321421,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Betacoronavirus|COVID-19|Cause of Death|Coronavirus Infections|Early Termination of Clinical Trials|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Respiration, Artificial|SARS-CoV-2|Selection Bias|Severity of Illness Index|Treatment Outcome|NA",2020-07-22,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321421,4
32650305,NCT04471701,Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.,Journal Article, ,"Adolescent|Adult|Aged|Aged, 80 and over|Area Under Curve|Betacoronavirus|COVID-19|Coronavirus|Coronavirus Infections|Cross-Sectional Studies|Female|Health Status|Health Surveys|Humans|Italy|Male|Middle Aged|Odds Ratio|Pandemics|Pneumonia, Viral|Population Surveillance|Prevalence|ROC Curve|SARS-CoV-2|Self Report|Severe Acute Respiratory Syndrome|Young Adult|NA",2020-10-02,JMIR public health and surveillance,Abstract,https://clinicaltrials.gov/ct2/show/NCT04471701,3
32658300,NCT04312009,[COVID-19 and kidney disease].,Journal Article, ,"Acute Kidney Injury|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-07-20,Lakartidningen,Abstract,https://clinicaltrials.gov/ct2/show/NCT04312009,1
32658300,NCT04311177,[COVID-19 and kidney disease].,Journal Article, ,"Acute Kidney Injury|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-07-20,Lakartidningen,Abstract,https://clinicaltrials.gov/ct2/show/NCT04311177,1
32658300,NCT04335123,[COVID-19 and kidney disease].,Journal Article, ,"Acute Kidney Injury|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-07-20,Lakartidningen,Abstract,https://clinicaltrials.gov/ct2/show/NCT04335123,1
32660611,NCT04369469,"A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Letter,"Antibodies, Monoclonal, Humanized|Antiviral Agents|Complement Inactivating Agents|ravulizumab|NA","Administration, Intravenous|Antibodies, Monoclonal, Humanized|Antiviral Agents|Betacoronavirus|COVID-19|Clinical Trials, Phase III as Topic|Complement Inactivating Agents|Coronavirus Infections|Female|Host-Pathogen Interactions|Humans|Male|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Time Factors|Treatment Outcome|NA",2020-07-15,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04369469,3
32663912,NCT04283461,An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.,"Clinical Trial, Phase I|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|RNA, Messenger|Spike Glycoprotein, Coronavirus|Viral Vaccines|spike protein, SARS-CoV-2|mRNA-1273 vaccine|NA","Adult|Antibodies, Neutralizing|Antibodies, Viral|Antibody Formation|Betacoronavirus|COVID-19|COVID-19 Vaccines|Coronavirus Infections|Female|Humans|Immunization, Secondary|Male|Pandemics|Pneumonia, Viral|RNA, Messenger|SARS-CoV-2|Spike Glycoprotein, Coronavirus|T-Lymphocytes|Viral Vaccines|Young Adult|NA",2020-11-16,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04283461,2
32665041,NCT04368676,Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial.,"Clinical Trial Protocol|Clinical Trial, Phase I|Clinical Trial, Phase II|Letter", ,"Betacoronavirus|COVID-19|Coronavirus Infections|Education, Distance|Feasibility Studies|Humans|Long-Term Care|Mind-Body Therapies|Outcome Assessment, Health Care|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Respiration|SARS-CoV-2|Yoga|NA",2020-08-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368676,2
32671131,NCT04252274,Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19.,Journal Article, , ,2020-09-28,Open forum infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04252274,1
32672790,NCT04394195,Excess Soluble fms-like Tyrosine Kinase 1 Correlates With Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients.,Journal Article,Vascular Endothelial Growth Factor A|Vascular Endothelial Growth Factor Receptor-1|NA,COVID-19|Critical Illness|Humans|SARS-CoV-2|Vascular Endothelial Growth Factor A|Vascular Endothelial Growth Factor Receptor-1|NA,2021-05-20,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Abstract,https://clinicaltrials.gov/ct2/show/NCT04394195,1
32673060,NCT04308668,Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.,Journal Article|Multicenter Study|Randomized Controlled Trial,Antimalarials|Hydroxychloroquine|NA,"Adult|Antimalarials|Betacoronavirus|COVID-19|Coronavirus Infections|Double-Blind Method|Female|Follow-Up Studies|Humans|Hydroxychloroquine|Male|Middle Aged|Outpatients|Pandemics|Pneumonia, Viral|Retrospective Studies|Risk Factors|SARS-CoV-2|Time Factors|NA",2020-10-27,Annals of internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04308668,4
32675217,NCT04318366,Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19.,Journal Article|Observational Study, ,"Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Correlation of Data|Echocardiography|Female|Hospitalization|Humans|Hypertension, Pulmonary|Italy|Male|Middle Aged|Outcome Assessment, Health Care|Pandemics|Pneumonia, Viral|Prevalence|SARS-CoV-2|Severity of Illness Index|Ventricular Dysfunction, Right|NA",2020-08-25,Heart (British Cardiac Society),Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
32676976,NCT04251871,Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial.,Journal Article|Randomized Controlled Trial,"Drugs, Chinese Herbal|Interferon-alpha|Lopinavir|NA","Administration, Inhalation|Adult|COVID-19|China|Coronavirus Infections|Dose-Response Relationship, Drug|Drug Administration Schedule|Drugs, Chinese Herbal|Female|Follow-Up Studies|Humans|Integrative Medicine|Interferon-alpha|Lopinavir|Male|Middle Aged|Pandemics|Pneumonia, Viral|Risk Assessment|Severe Acute Respiratory Syndrome|Severity of Illness Index|Survival Rate|NA",2020-09-08,Chinese journal of integrative medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04251871,2
32677025,NCT04370067,"Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Communicable Disease Control|Coronavirus Infections|Cross-Sectional Studies|Female|Health Policy|Humans|Hungary|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prevalence|SARS-CoV-2|Social Isolation|Surveys and Questionnaires|Young Adult|NA",2020-08-17,GeroScience,Abstract,https://clinicaltrials.gov/ct2/show/NCT04370067,1
32678530,NCT04381936,Dexamethasone in Hospitalized Patients with Covid-19.,Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial,Anti-Infective Agents|Glucocorticoids|Dexamethasone|NA,"Administration, Oral|Aged|Aged, 80 and over|Anti-Infective Agents|COVID-19|Dexamethasone|Drug Therapy, Combination|Female|Glucocorticoids|Hospitalization|Humans|Injections, Intravenous|Kaplan-Meier Estimate|Length of Stay|Male|Odds Ratio|Oxygen Inhalation Therapy|Respiration, Artificial|United Kingdom|NA",2021-03-01,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04381936,4
32680942,NCT04368390,Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study.,Journal Article|Multicenter Study, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|Brain|Brain Ischemia|COVID-19|Confusion|Consciousness Disorders|Coronavirus Infections|Encephalitis|Female|France|Headache|Humans|Magnetic Resonance Imaging|Male|Meningitis|Meningoencephalitis|Middle Aged|Pandemics|Pneumonia, Viral|Psychomotor Agitation|Pyramidal Tracts|Respiratory Distress Syndrome|Retrospective Studies|SARS-CoV-2|Stroke|Young Adult|NA",2020-10-08,Neurology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368390,1
32690074,NCT04361474,Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter|Multicenter Study,Budesonide|NA,"Betacoronavirus|Budesonide|COVID-19|Coronavirus Infections|Humans|Olfaction Disorders|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|NA",2020-08-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04361474,1
32699166,NCT04279899,A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol.,Journal Article|Multicenter Study|Observational Study, ,"Betacoronavirus|COVID-19|Child Development|China|Coronavirus Infections|Female|Hospitals, Maternity|Hospitals, Pediatric|Humans|Infant|Infant, Newborn|Neurodevelopmental Disorders|Pandemics|Pneumonia, Viral|Pregnancy|Pregnancy Complications, Infectious|Premature Birth|Prospective Studies|SARS-CoV-2|Severity of Illness Index|NA",2020-07-30,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04279899,1
32702087,NCT04403607,The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study.,Journal Article|Multicenter Study|Observational Study, ,COVID-19|Convalescence|Electrocardiography|Heart|Heart Diseases|Host-Pathogen Interactions|Humans|Kidney|Kidney Diseases|Longitudinal Studies|Lung|Multimodal Imaging|Predictive Value of Tests|Prospective Studies|Research Design|SARS-CoV-2|Scotland|Time Factors|NA,2020-12-09,Cardiovascular research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04403607,1
32702298,NCT04324606,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.","Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Analgesics, Non-Narcotic|Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Immunoglobulin G|Spike Glycoprotein, Coronavirus|Viral Vaccines|spike protein, SARS-CoV-2|Acetaminophen|NA","Acetaminophen|Adenoviruses, Simian|Adult|Analgesics, Non-Narcotic|Antibodies, Neutralizing|Antibodies, Viral|Betacoronavirus|COVID-19|COVID-19 Vaccines|Coronavirus Infections|Female|Genetic Vectors|Humans|Immunization, Secondary|Immunoglobulin G|Male|Pandemics|Pneumonia, Viral|SARS-CoV-2|Single-Blind Method|Spike Glycoprotein, Coronavirus|T-Lymphocytes|United Kingdom|Viral Vaccines|NA",2020-08-24,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04324606,4
32702299,NCT04341389,"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.","Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Ad5-nCoV vaccine|Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Spike Glycoprotein, Coronavirus|Viral Vaccines|spike protein, SARS-CoV-2|NA","Adenoviridae|Adolescent|Adult|Age Factors|Aged|Aged, 80 and over|Antibodies, Neutralizing|Antibodies, Viral|Betacoronavirus|COVID-19|COVID-19 Vaccines|China|Coronavirus Infections|Double-Blind Method|Female|Genetic Vectors|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|Spike Glycoprotein, Coronavirus|T-Lymphocytes|Viral Vaccines|Young Adult|NA",2020-08-24,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04341389,1
32706953,NCT04322123,Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Hydroxychloroquine|Azithromycin|NA,"Adult|Aged|Aged, 80 and over|Antiviral Agents|Azithromycin|Betacoronavirus|Brazil|COVID-19|Coronavirus Infections|Drug Therapy, Combination|Female|Hospitalization|Humans|Hydroxychloroquine|Male|Middle Aged|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Treatment Failure|NA",2020-12-01,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04322123,1
32712702,NCT04441489,COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome.,Clinical Trial|Journal Article,Radiopharmaceuticals|Fluorodeoxyglucose F18|NA,"Aged|Aged, 80 and over|COVID-19|Female|Fluorodeoxyglucose F18|Heart|Humans|Inflammation|Lung|Lymph Nodes|Male|Middle Aged|Positron Emission Tomography Computed Tomography|Radiopharmaceuticals|Treatment Outcome|NA",2021-02-02,European journal of nuclear medicine and molecular imaging,Abstract,https://clinicaltrials.gov/ct2/show/NCT04441489,1
32720012,NCT04323644,Acute abdomen in patients with SARS-CoV-2 infection or co-infection.,Journal Article, ,"Abdomen, Acute|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Cohort Studies|Coinfection|Coronavirus Infections|Female|Hospitalization|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Postoperative Complications|SARS-CoV-2|Survival Rate|Treatment Outcome|NA",2020-09-09,Langenbeck's archives of surgery,Abstract,https://clinicaltrials.gov/ct2/show/NCT04323644,1
32727613,NCT04331834,"Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.",Clinical Trial Protocol|Letter|Multicenter Study,Hydroxychloroquine|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Double-Blind Method|Health Personnel|Humans|Hydroxychloroquine|Pandemics|Pneumonia, Viral|Pre-Exposure Prophylaxis|Randomized Controlled Trials as Topic|SARS-CoV-2|NA",2020-08-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331834,1
32728965,NCT04368975,"Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.","Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't", ,"Adult|Analysis of Variance|COVID-19|Correlation of Data|Female|Humans|Male|Middle Aged|Proportional Hazards Models|Prospective Studies|Respiration, Artificial|Respiratory Distress Syndrome|Severity of Illness Index|Spain|Statistics, Nonparametric|NA",2020-12-23,Intensive care medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368975,1
32736592,NCT04393246,muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial.,"Clinical Trial Protocol|Clinical Trial, Phase II|Clinical Trial, Phase III|Letter",Benzhydryl Compounds|Glucosides|Immunologic Factors|Phenylpropionates|Pyridazines|dapagliflozin|ambrisentan|NA,"Benzhydryl Compounds|Betacoronavirus|COVID-19|Coronavirus Infections|Glucosides|Humans|Immunologic Factors|Intensive Care Units|Pandemics|Phenylpropionates|Pneumonia, Viral|Pyridazines|Randomized Controlled Trials as Topic|Respiration, Artificial|SARS-CoV-2|Standard of Care|NA",2020-08-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04393246,1
32736597,NCT04363827,PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.,Clinical Trial Protocol|Comparative Study|Journal Article|Observational Study,Hydroxychloroquine|NA,"Betacoronavirus|COVID-19|Cluster Analysis|Coronavirus Infections|Female|Humans|Hydroxychloroquine|Male|Pandemics|Patient Reported Outcome Measures|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Telemedicine|NA",2020-08-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04363827,1
32738255,NCT04433910,An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection.,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Viral|Spike Glycoprotein, Coronavirus|NA","Animals|Antibodies, Viral|Betacoronavirus|COVID-19|Chlorocebus aethiops|Coronavirus Infections|Enzyme-Linked Immunosorbent Assay|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|Severe Acute Respiratory Syndrome|Spike Glycoprotein, Coronavirus|Vero Cells|Viral Plaque Assay|NA",2020-09-07,Antiviral research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04433910,1
32738928,NCT04416399,Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?,"Journal Article|Research Support, Non-U.S. Gov't",Adrenal Cortex Hormones|NA,"Administration, Inhalation|Adrenal Cortex Hormones|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-16,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04416399,2
32738928,NCT04377711,Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?,"Journal Article|Research Support, Non-U.S. Gov't",Adrenal Cortex Hormones|NA,"Administration, Inhalation|Adrenal Cortex Hormones|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-16,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04377711,1
32738928,NCT04355637,Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?,"Journal Article|Research Support, Non-U.S. Gov't",Adrenal Cortex Hormones|NA,"Administration, Inhalation|Adrenal Cortex Hormones|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-16,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04355637,1
32738928,NCT04331470,Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?,"Journal Article|Research Support, Non-U.S. Gov't",Adrenal Cortex Hormones|NA,"Administration, Inhalation|Adrenal Cortex Hormones|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-16,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331470,1
32738928,NCT04330586,Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?,"Journal Article|Research Support, Non-U.S. Gov't",Adrenal Cortex Hormones|NA,"Administration, Inhalation|Adrenal Cortex Hormones|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-16,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04330586,1
32745512,NCT04331509,Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.,"Journal Article|Observational Study|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't", ,"Adult|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Female|Health Personnel|Humans|Infectious Disease Transmission, Patient-to-Professional|Male|Middle Aged|Mobile Applications|Pandemics|Personal Protective Equipment|Pneumonia, Viral|Prospective Studies|Risk Assessment|Self Report|United Kingdom|United States|Young Adult|NA",2020-09-09,The Lancet. Public health,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331509,1
32758438,NCT04346186,Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.,"Journal Article|Observational Study|Research Support, Non-U.S. Gov't","Antibodies, Viral|Immunoglobulin G|Immunoglobulin M|NA","Adult|Antibodies, Viral|Blood Donors|COVID-19|Cohort Studies|Denmark|Female|Health Personnel|Humans|Immunoglobulin G|Immunoglobulin M|Male|Middle Aged|Occupational Health|Point-of-Care Testing|SARS-CoV-2|Seroconversion|Seroepidemiologic Studies|NA",2020-12-11,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04346186,1
32758441,NCT04296643,Use of facemasks during the COVID-19 pandemic.,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Disease Transmission, Infectious|Humans|Masks|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-10-13,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04296643,1
32770466,NCT04392245,Deadlock of proctologic practice in Italy during COVID-19 pandemic: a national report from ProctoLock2020.,Journal Article, ,"Ambulatory Surgical Procedures|COVID-19|Colorectal Surgery|Elective Surgical Procedures|Emergency Service, Hospital|Female|Health Care Surveys|Health Services Accessibility|Hospital Administration|Humans|Infection Control|Infectious Disease Transmission, Patient-to-Professional|Italy|Male|Middle Aged|Pandemics|NA",2020-12-07,Updates in surgery,Abstract,https://clinicaltrials.gov/ct2/show/NCT04392245,1
32771032,NCT04338698,"Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.",Clinical Trial Protocol|Letter|Multicenter Study|Observational Study|Randomized Controlled Trial,Oseltamivir|Hydroxychloroquine|Azithromycin|NA,"Azithromycin|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Humans|Hydroxychloroquine|Oseltamivir|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Research Design|SARS-CoV-2|NA",2020-08-17,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04338698,1
32771034,NCT04401202,"Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial.","Clinical Trial Protocol|Clinical Trial, Phase II|Letter", ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Coronavirus Infections|Dietary Supplements|Humans|Middle Aged|Nigella sativa|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|SARS-CoV-2|Standard of Care|Young Adult|NA",2020-08-17,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04401202,1
32776309,NCT04401540,A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society.,Clinical Trial|Journal Article|Multicenter Study, ,"Adult|COVID-19|COVID-19 Nucleic Acid Testing|Cesarean Section|Female|Humans|Infant, Low Birth Weight|Infant, Newborn|Infant, Premature|Infectious Disease Transmission, Vertical|Intensive Care, Neonatal|Male|Pregnancy|Pregnancy Complications, Infectious|Pregnancy Outcome|Premature Birth|Prognosis|Prospective Studies|Turkey|NA",2021-03-01,European journal of pediatrics,Abstract,https://clinicaltrials.gov/ct2/show/NCT04401540,1
32779705,NCT04434131,Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.,Clinical Trial|Journal Article,"Antibodies, Neutralizing|Antibodies, Viral|Immunoglobulin G|RNA, Viral|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|NA","Adult|Aged|Aged, 80 and over|Antibodies, Neutralizing|Antibodies, Viral|Betacoronavirus|Blood Donors|COVID-19|Cohort Studies|Coronavirus Infections|Female|Humans|Immunization, Passive|Immunoglobulin G|Male|Middle Aged|New Mexico|Pandemics|Pneumonia, Viral|RNA, Viral|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Spike Glycoprotein, Coronavirus|Treatment Outcome|NA",2020-11-02,The Journal of infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04434131,3
32781244,NCT04316949,Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study).,Journal Article|Multicenter Study, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Child|Child, Preschool|Coronavirus Infections|Female|Hospitalization|Humans|Italy|Logistic Models|Male|Middle Aged|Multivariate Analysis|Pandemics|Pneumonia, Viral|Prognosis|Reproducibility of Results|Respiratory Insufficiency|Retrospective Studies|Risk Assessment|Risk Factors|SARS-CoV-2|Sensitivity and Specificity|Young Adult|NA",2020-11-20,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04316949,1
32785213,NCT04368728,PhaseÂ I/II study of COVID-19 RNA vaccine BNT162b1 in adults.,"Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Immunoglobulin G|Spike Glycoprotein, Coronavirus|Viral Vaccines|spike protein, SARS-CoV-2|NA","Adult|Antibodies, Neutralizing|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Coronavirus Infections|Female|Humans|Immunization, Passive|Immunoglobulin G|Male|Middle Aged|Pandemics|Pneumonia, Viral|Spike Glycoprotein, Coronavirus|Time Factors|Viral Vaccines|Young Adult|NA",2020-10-29,Nature,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368728,5
32785710,NCT04343729,"Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial.","Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Methylprednisolone|NA,Adolescent|Adult|Brazil|COVID-19|Double-Blind Method|Humans|Methylprednisolone|Middle Aged|SARS-CoV-2|Treatment Outcome|NA,2021-05-10,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343729,1
32788120,NCT04394000,Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study.,Journal Article,"Anticoagulants|Biomarkers|Heparin, Low-Molecular-Weight|Factor Xa|NA","Aged|Anticoagulants|Biomarkers|COVID-19|Clinical Protocols|Critical Illness|Databases, Factual|Drug Monitoring|Factor Xa|Female|Heparin, Low-Molecular-Weight|Humans|Intensive Care Units|Longitudinal Studies|Male|Middle Aged|Retrospective Studies|Risk Factors|Treatment Outcome|Venous Thromboembolism|NA",2020-12-10,Thrombosis research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04394000,1
32788708,NCT04344600,The type I interferon response in COVID-19: implications for treatment.,"Journal Article|Research Support, Non-U.S. Gov't","Azetidines|IL6 protein, human|Interferon Regulatory Factors|Interferon-alpha|Interleukin-1|Interleukin-6|Sulfonamides|Tumor Necrosis Factor-alpha|interferon-lambda, human|Interferon-beta|Interferons|JAK1 protein, human|Janus Kinase 1|baricitinib|NA","Azetidines|Betacoronavirus|COVID-19|Coronavirus Infections|Gene Expression Regulation|Humans|Immunity, Cellular|Immunity, Humoral|Interferon Regulatory Factors|Interferon-alpha|Interferon-beta|Interferons|Interleukin-1|Interleukin-6|Janus Kinase 1|Lung|Pandemics|Pneumonia, Viral|SARS-CoV-2|Severity of Illness Index|Sulfonamides|Tumor Necrosis Factor-alpha|NA",2020-10-06,Nature reviews. Immunology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04344600,1
32788708,NCT04385095,The type I interferon response in COVID-19: implications for treatment.,"Journal Article|Research Support, Non-U.S. Gov't","Azetidines|IL6 protein, human|Interferon Regulatory Factors|Interferon-alpha|Interleukin-1|Interleukin-6|Sulfonamides|Tumor Necrosis Factor-alpha|interferon-lambda, human|Interferon-beta|Interferons|JAK1 protein, human|Janus Kinase 1|baricitinib|NA","Azetidines|Betacoronavirus|COVID-19|Coronavirus Infections|Gene Expression Regulation|Humans|Immunity, Cellular|Immunity, Humoral|Interferon Regulatory Factors|Interferon-alpha|Interferon-beta|Interferons|Interleukin-1|Interleukin-6|Janus Kinase 1|Lung|Pandemics|Pneumonia, Viral|SARS-CoV-2|Severity of Illness Index|Sulfonamides|Tumor Necrosis Factor-alpha|NA",2020-10-06,Nature reviews. Immunology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04385095,2
32788708,NCT04343976,The type I interferon response in COVID-19: implications for treatment.,"Journal Article|Research Support, Non-U.S. Gov't","Azetidines|IL6 protein, human|Interferon Regulatory Factors|Interferon-alpha|Interleukin-1|Interleukin-6|Sulfonamides|Tumor Necrosis Factor-alpha|interferon-lambda, human|Interferon-beta|Interferons|JAK1 protein, human|Janus Kinase 1|baricitinib|NA","Azetidines|Betacoronavirus|COVID-19|Coronavirus Infections|Gene Expression Regulation|Humans|Immunity, Cellular|Immunity, Humoral|Interferon Regulatory Factors|Interferon-alpha|Interferon-beta|Interferons|Interleukin-1|Interleukin-6|Janus Kinase 1|Lung|Pandemics|Pneumonia, Viral|SARS-CoV-2|Severity of Illness Index|Sulfonamides|Tumor Necrosis Factor-alpha|NA",2020-10-06,Nature reviews. Immunology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343976,1
32788708,NCT04354259,The type I interferon response in COVID-19: implications for treatment.,"Journal Article|Research Support, Non-U.S. Gov't","Azetidines|IL6 protein, human|Interferon Regulatory Factors|Interferon-alpha|Interleukin-1|Interleukin-6|Sulfonamides|Tumor Necrosis Factor-alpha|interferon-lambda, human|Interferon-beta|Interferons|JAK1 protein, human|Janus Kinase 1|baricitinib|NA","Azetidines|Betacoronavirus|COVID-19|Coronavirus Infections|Gene Expression Regulation|Humans|Immunity, Cellular|Immunity, Humoral|Interferon Regulatory Factors|Interferon-alpha|Interferon-beta|Interferons|Interleukin-1|Interleukin-6|Janus Kinase 1|Lung|Pandemics|Pneumonia, Viral|SARS-CoV-2|Severity of Illness Index|Sulfonamides|Tumor Necrosis Factor-alpha|NA",2020-10-06,Nature reviews. Immunology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04354259,3
32790733,NCT04347993,Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.,Journal Article|Multicenter Study|Observational Study,"Antibodies, Monoclonal, Humanized|Antimalarials|IL6 protein, human|Interleukin-6|Hydroxychloroquine|Azithromycin|tocilizumab|NA","Adolescent|Adult|Aged|Aged, 80 and over|Antibodies, Monoclonal, Humanized|Antimalarials|Azithromycin|Betacoronavirus|COVID-19|Child|Child, Preschool|Coronavirus Infections|Drug Therapy, Combination|Female|Follow-Up Studies|Hospitalization|Humans|Hydroxychloroquine|Infant|Infant, Newborn|Intensive Care Units|Interleukin-6|Kaplan-Meier Estimate|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Treatment Outcome|Young Adult|NA",2020-08-28,PloS one,Abstract,https://clinicaltrials.gov/ct2/show/NCT04347993,2
32795330,NCT04345614,Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Calcium Release Activated Calcium Channels|NA,"Aged|COVID-19|Calcium Release Activated Calcium Channels|Coronavirus Infections|Critical Care|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Severity of Illness Index|Standard of Care|Treatment Outcome|NA",2020-08-20,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04345614,1
32798473,NCT04352556,"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.",Journal Article|Multicenter Study|Observational Study, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Female|Follow-Up Studies|Hematologic Neoplasms|Humans|Inpatients|Italy|Leukemia|Lymphoma, Non-Hodgkin|Male|Middle Aged|Myeloproliferative Disorders|Neoplasms, Plasma Cell|Pandemics|Pneumonia, Viral|Retrospective Studies|Risk Factors|SARS-CoV-2|Young Adult|NA",2020-10-02,The Lancet. Haematology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04352556,1
32799933,NCT04325061,Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.,Clinical Trial Protocol|Journal Article|Multicenter Study,Dexamethasone|NA,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Dexamethasone|Humans|Outcome Assessment, Health Care|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Respiratory Distress Syndrome|SARS-CoV-2|Sample Size|NA",2020-08-25,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04325061,1
32800064,NCT04375410,COVID-19 reopening causes high risk of irritant contact dermatitis in children.,Journal Article|Multicenter Study|Observational Study,"Anti-Infective Agents, Local|NA","Anti-Infective Agents, Local|Betacoronavirus|COVID-19|Child|Child, Preschool|Coronavirus Infections|Denmark|Dermatitis, Irritant|Female|Humans|Incidence|Infant|Infant, Newborn|Male|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-27,Danish medical journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04375410,1
32807209,NCT04381962,A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial.,"Clinical Trial Protocol|Clinical Trial, Phase II|Clinical Trial, Phase III|Comparative Study|Journal Article|Multicenter Study",Anti-Bacterial Agents|Azithromycin|NA,"Anti-Bacterial Agents|Azithromycin|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|Prospective Studies|Randomized Controlled Trials as Topic|Research Design|SARS-CoV-2|Severity of Illness Index|NA",2020-08-25,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04381962,1
32809969,NCT04438629,Baricitinib restrains the immune dysregulation in patients with severe COVID-19.,Clinical Trial|Journal Article|Multicenter Study|Observational Study,Azetidines|Cytokines|Purines|Pyrazoles|Sulfonamides|baricitinib|NA,"Aged|Aged, 80 and over|Azetidines|B-Lymphocytes|COVID-19|Cytokines|Female|Humans|Longitudinal Studies|Male|Middle Aged|Off-Label Use|Purines|Pyrazoles|SARS-CoV-2|Severity of Illness Index|Sulfonamides|T-Lymphocytes|NA",2020-12-14,The Journal of clinical investigation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04438629,1
32815416,NCT04372589,"Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.","Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Anticoagulants|Antiviral Agents|Heparin|NA,"Adolescent|Adult|Anticoagulants|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Dose-Response Relationship, Drug|Female|Heparin|Humans|Male|Pandemics|Pneumonia, Viral|SARS-CoV-2|Thrombosis|Treatment Outcome|Young Adult|NA",2020-10-15,"Clinical trials (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04372589,3
32817460,NCT04412057,Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal|IL6 protein, human|Interleukin-6|TNFSF14 protein, human|Tumor Necrosis Factor Ligand Superfamily Member 14|NA","Adult|Age Factors|Aged|Antibodies, Monoclonal|Betacoronavirus|COVID-19|Clinical Trials as Topic|Coronavirus Infections|Cytokine Release Syndrome|Hospitalization|Humans|Interleukin-6|Middle Aged|Pandemics|Pneumonia, Viral|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|Tumor Necrosis Factor Ligand Superfamily Member 14|NA",2020-09-04,mSphere,Abstract,https://clinicaltrials.gov/ct2/show/NCT04412057,1
32821939,NCT04292730,Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.,"Clinical Trial, Phase III|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|remdesivir|Adenosine Monophosphate|Alanine|NA,"Adenosine Monophosphate|Administration, Intravenous|Aged|Alanine|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Administration Schedule|Female|Hospitalization|Humans|Male|Middle Aged|Odds Ratio|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Treatment Outcome|NA",2020-09-29,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04292730,1
32828741,NCT04370288,"Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial.",Case Reports|Journal Article,Ascorbic Acid|Methylene Blue|Acetylcysteine|NA,"Acetylcysteine|Ascorbic Acid|COVID-19|Clinical Trials, Phase I as Topic|Compassionate Use Trials|Coronavirus Infections|Critical Illness|Female|Humans|Hypoxia|Male|Methylene Blue|Middle Aged|Pandemics|Pneumonia, Viral|NA",2020-10-13,European journal of pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04370288,2
32829467,NCT04262921,Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.,"Case Reports|Journal Article|Research Support, Non-U.S. Gov't", ,"Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Cytokine Release Syndrome|Fatal Outcome|France|Humans|Longitudinal Studies|Lymphocyte Activation|Male|Multiple Organ Failure|Pandemics|Pneumonia, Viral|Prospective Studies|Respiratory Distress Syndrome|SARS-CoV-2|Severity of Illness Index|T-Lymphocytes, Cytotoxic|Th1 Cells|Th2 Cells|NA",2020-10-27,Journal of clinical immunology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04262921,3
32829745,NCT04337541,Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19.,Journal Article|Randomized Controlled Trial, ,"Adult|Aged|COVID-19|Communicable Disease Control|Coronavirus Infections|Denmark|Female|Humans|Incidence|Infectious Disease Transmission, Vertical|Male|Masks|Middle Aged|Pandemics|Pneumonia, Viral|Primary Prevention|Public Health|Risk Assessment|World Health Organization|NA",2020-08-31,Danish medical journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04337541,2
32838109,NCT04357730,STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial.,Journal Article, , ,2021-04-28,Research and practice in thrombosis and haemostasis,Abstract,https://clinicaltrials.gov/ct2/show/NCT04357730,1
32838323,NCT04347993,Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.,Journal Article, , ,2020-09-28,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04347993,2
32838353,NCT04252885,Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.,Journal Article, , ,2021-01-10,"Med (New York, N.Y.)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04252885,1
32843098,NCT04395105,High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter|Multicenter Study|Randomized Controlled Trial,Glucocorticoids|Dexamethasone|NA,"Argentina|Betacoronavirus|COVID-19|Coronavirus Infections|Cross Infection|Delirium|Dexamethasone|Glucocorticoids|Humans|Mortality|Organ Dysfunction Scores|Pandemics|Patient Positioning|Pneumonia, Viral|Prone Position|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|Virus Shedding|NA",2020-09-03,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04395105,1
32847626,NCT04420741,The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.,Clinical Trial Protocol|Letter|Multicenter Study|Randomized Controlled Trial,"THBD protein, human|Thrombomodulin|Vasodilator Agents|Iloprost|NA","Betacoronavirus|COVID-19|Coronavirus Infections|Denmark|Endothelium, Vascular|Humans|Iloprost|Infusions, Intravenous|Intensive Care Units|Pandemics|Pneumonia, Viral|Respiration, Artificial|SARS-CoV-2|Thrombomodulin|Vasodilator Agents|NA",2020-09-03,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04420741,1
32847826,NCT04324736,Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study.,Letter|Comment, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Diabetes Mellitus, Type 1|Humans|Inpatients|Pandemics|Pneumonia, Viral|Prognosis|SARS-CoV-2|NA",2020-10-23,Diabetes care,Abstract,https://clinicaltrials.gov/ct2/show/NCT04324736,3
32864604,NCT04378595,High Level of Food Insecurity among Families with Children Seeking Routine Care at Federally Qualified Health Centers during the Coronavirus Disease 2019 Pandemic.,Journal Article, , ,2020-09-28,The journal of pediatrics: X,Abstract,https://clinicaltrials.gov/ct2/show/NCT04378595,1
32876113,NCT04378582,"Characteristics and outcomes of patients with COVID-19 admitted to the ICU in a university hospital in SÃ£o Paulo, Brazil - study protocol.",Journal Article, ,"Betacoronavirus|Brazil|COVID-19|Cohort Studies|Coronavirus Infections|Hospital Mortality|Hospitals, University|Humans|Intensive Care Units|Observational Studies as Topic|Pandemics|Pneumonia, Viral|Research Design|SARS-CoV-2|NA",2020-09-10,"Clinics (Sao Paulo, Brazil)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04378582,1
32876695,NCT04327401,Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Anti-Inflammatory Agents|Dexamethasone|NA,"Administration, Intravenous|Aged|Anti-Inflammatory Agents|Betacoronavirus|Brazil|COVID-19|Catheter-Related Infections|Coronavirus Infections|Dexamethasone|Early Termination of Clinical Trials|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|NA",2020-11-04,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04327401,1
32877349,NCT04305574,The Relation Between Official WhatsApp-Distributed COVID-19 News Exposure and Psychological Symptoms: Cross-Sectional Survey Study.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Anxiety|COVID-19|Coronavirus Infections|Cross-Sectional Studies|Depression|Disease Outbreaks|Female|Health Surveys|Humans|Male|Mental Health|Mobile Applications|Pandemics|Pneumonia, Viral|Public Health|NA",2020-10-05,Journal of medical Internet research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04305574,1
32877576,NCT04368988,Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.,"Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Adjuvants, Immunologic|Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Immunoglobulin G|Matrix-M|Saponins|Spike Glycoprotein, Coronavirus|Vaccines, Synthetic|spike glycoprotein, SARS-CoV|NA","Adjuvants, Immunologic|Adolescent|Adult|Antibodies, Neutralizing|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Enzyme-Linked Immunosorbent Assay|Female|Humans|Immunization Schedule|Immunogenicity, Vaccine|Immunoglobulin G|Male|Middle Aged|Nanoparticles|Pandemics|Saponins|Spike Glycoprotein, Coronavirus|Th1 Cells|Vaccines, Synthetic|Young Adult|NA",2020-12-17,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368988,3
32888112,NCT04338841,Outpatient management or hospitalization of patients with proven or suspected SARS-CoV-2 infection: the HOME-CoV rule.,Journal Article, ,"Aged|Ambulatory Care|COVID-19|Coronavirus Infections|Delphi Technique|Hospitalization|Humans|Male|Middle Aged|Outpatients|Pandemics|Pneumonia, Viral|Risk Factors|Surveys and Questionnaires|NA",2020-11-24,Internal and emergency medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04338841,2
32895056,NCT04445935,"Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Equivalence Trial|Letter,"Anticoagulants|Antithrombins|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|Hirudins|Peptide Fragments|Recombinant Proteins|fibrin fragment D|Heparin|bivalirudin|NA","Anticoagulants|Antithrombins|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Illness|Fibrin Fibrinogen Degradation Products|Heparin|Heparin, Low-Molecular-Weight|Hirudins|Humans|Pandemics|Partial Thromboplastin Time|Peptide Fragments|Pneumonia, Viral|Qatar|Recombinant Proteins|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|NA",2020-09-10,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04445935,1
32896291,NCT04437875,"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.","Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't","Ad5-nCoV vaccine|Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Immunoglobulin G|Viral Vaccines|NA","Adenoviridae|Adult|Antibodies, Neutralizing|Antibodies, Viral|Betacoronavirus|COVID-19|COVID-19 Vaccines|Coronavirus Infections|Female|Humans|Immunity, Cellular|Immunity, Humoral|Immunization, Secondary|Immunoglobulin G|Injections, Intramuscular|Male|Pandemics|Pneumonia, Viral|Russia|SARS-CoV-2|Viral Vaccines|Young Adult|NA",2020-10-05,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04437875,1
32896291,NCT04436471,"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.","Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't","Ad5-nCoV vaccine|Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Immunoglobulin G|Viral Vaccines|NA","Adenoviridae|Adult|Antibodies, Neutralizing|Antibodies, Viral|Betacoronavirus|COVID-19|COVID-19 Vaccines|Coronavirus Infections|Female|Humans|Immunity, Cellular|Immunity, Humoral|Immunization, Secondary|Immunoglobulin G|Injections, Intramuscular|Male|Pandemics|Pneumonia, Viral|Russia|SARS-CoV-2|Viral Vaccines|Young Adult|NA",2020-10-05,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04436471,1
32896292,NCT04321278,Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Hydroxychloroquine|Azithromycin|NA,"Aged|Antiviral Agents|Azithromycin|Betacoronavirus|Brazil|COVID-19|Coronavirus Infections|Drug Therapy, Combination|Female|Humans|Hydroxychloroquine|Length of Stay|Male|Middle Aged|Pandemics|Pneumonia, Viral|Respiratory Therapy|SARS-CoV-2|Standard of Care|Treatment Outcome|NA",2020-10-14,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04321278,2
32896832,NCT04333849,Communication Technology Preferences of Hospitalized and Institutionalized Frail Older Adults During COVID-19 Confinement: Cross-Sectional Survey Study.,Clinical Trial|Journal Article, ,"Aged|Aged, 80 and over|COVID-19|Consumer Behavior|Coronavirus Infections|Cross-Sectional Studies|Female|Frail Elderly|Hospitalization|Humans|Loneliness|Male|Nursing Homes|Pandemics|Pneumonia, Viral|Social Isolation|Telephone|Videoconferencing|NA",2020-09-28,JMIR mHealth and uHealth,Abstract,https://clinicaltrials.gov/ct2/show/NCT04333849,1
32900326,NCT04318366,"Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy.",Journal Article, ,"Age Factors|Aged|Betacoronavirus|COVID-19|Cause of Death|Coronavirus Infections|Female|Humans|Hypertension|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Respiration, Artificial|Respiratory Distress Syndrome|Risk Factors|SARS-CoV-2|NA",2020-09-10,Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
32903199,NCT04347681,Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study.,Journal Article, , ,2020-10-23,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04347681,2
32907635,NCT04400799,Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.,Clinical Trial Protocol|Letter,Anticoagulants|Enoxaparin|NA,"Anticoagulants|Betacoronavirus|Blood Coagulation|COVID-19|Coronavirus Infections|Enoxaparin|Equivalence Trials as Topic|Host-Pathogen Interactions|Humans|Multicenter Studies as Topic|Pandemics|Pneumonia, Viral|SARS-CoV-2|Thrombosis|Time Factors|Treatment Outcome|NA",2020-09-16,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04400799,1
32907638,NCT04357808,Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,"Anti-Inflammatory Agents|Antibodies, Monoclonal, Humanized|sarilumab|NA","Adult|Aged|Anti-Inflammatory Agents|Antibodies, Monoclonal, Humanized|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Administration Schedule|Female|Host-Pathogen Interactions|Humans|Male|Middle Aged|Pandemics|Patient Admission|Pneumonia, Viral|Proof of Concept Study|Randomized Controlled Trials as Topic|SARS-CoV-2|Spain|Time Factors|Treatment Outcome|Young Adult|NA",2020-09-16,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04357808,1
32915072,NCT04396197,Rehabilitation Levels in Patients with COVID-19 Admitted to Intensive Care Requiring Invasive Ventilation. An Observational Study.,Journal Article|Observational Study, ,"COVID-19|Critical Care|Female|Follow-Up Studies|Humans|Length of Stay|Male|Middle Aged|Pandemics|Prospective Studies|Respiration, Artificial|SARS-CoV-2|Treatment Outcome|United Kingdom|NA",2021-01-13,Annals of the American Thoracic Society,Abstract,https://clinicaltrials.gov/ct2/show/NCT04396197,1
32917259,NCT04399317,Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Feasibility Studies|Host-Pathogen Interactions|Humans|Lung|Pandemics|Pneumonia, Viral|Prospective Studies|Qatar|Randomized Controlled Trials as Topic|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|Time Factors|Treatment Outcome|NA",2020-09-16,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04399317,1
32934758,NCT04327206,Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.,"Journal Article|Research Support, Non-U.S. Gov't|Review",BCG Vaccine|Cytokines|NA,"BCG Vaccine|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coinfection|Coronavirus Infections|Cytokines|Diagnostic Errors|Disease Outbreaks|Humans|Influenza, Human|Middle East Respiratory Syndrome Coronavirus|Pandemics|Pneumonia, Viral|SARS Virus|SARS-CoV-2|Severe Acute Respiratory Syndrome|Severity of Illness Index|Tuberculosis|NA",2020-09-24,Canadian respiratory journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04327206,1
32936948,NCT04352959,Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anti-Infective Agents|Mouthwashes|Nasal Sprays|NA,"Anti-Infective Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Health Personnel|Humans|Infectious Disease Transmission, Patient-to-Professional|Mouth|Mouthwashes|Nasal Sprays|Nose|Occupational Diseases|Pandemics|Pneumonia, Viral|SARS-CoV-2|Therapeutic Irrigation|NA",2020-09-30,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04352959,2
32936949,NCT04364802,Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anti-Infective Agents|Mouthwashes|Nasal Sprays|NA,"Anti-Infective Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Health Personnel|Humans|Infectious Disease Transmission, Patient-to-Professional|Mouth|Mouthwashes|Nasal Sprays|Nose|Occupational Diseases|Pandemics|Pneumonia, Viral|SARS-CoV-2|Therapeutic Irrigation|NA",2020-09-30,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04364802,1
32943115,NCT04373291,Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.,Clinical Trial Protocol|Letter,BCG Vaccine|NA,"Absenteeism|BCG Vaccine|Betacoronavirus|COVID-19|Coronavirus Infections|Denmark|Female|Health Personnel|Humans|Male|Multicenter Studies as Topic|Occupational Health|Pandemics|Patient Admission|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Sick Leave|Single-Blind Method|Time Factors|Treatment Outcome|Vaccination|NA",2020-09-23,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04373291,1
32944767,NCT04367129,"Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement.",Journal Article|Multicenter Study,Biomarkers|NA,"Aged|Aged, 80 and over|Arrhythmias, Cardiac|Biomarkers|COVID-19|Critical Illness|Cross-Sectional Studies|Electrocardiography|Female|Hospitalization|Humans|Italy|Male|Middle Aged|Pandemics|Respiration, Artificial|Retrospective Studies|SARS-CoV-2|NA",2021-01-07,"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",Abstract,https://clinicaltrials.gov/ct2/show/NCT04367129,1
32945968,NCT04318366,Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients.,Journal Article, ,"Age Factors|Aged|Artificial Intelligence|COVID-19|Comorbidity|Coronary Artery Disease|Deep Learning|Emergency Service, Hospital|Female|Hospitalization|Humans|Intensive Care Units|Italy|Male|Middle Aged|Mortality|Neurodegenerative Diseases|Prognosis|Proportional Hazards Models|Pulmonary Disease, Chronic Obstructive|Radiography|Radiography, Thoracic|Retrospective Studies|SARS-CoV-2|Severity of Illness Index|Sex Factors|Tomography, X-Ray Computed|NA",2021-02-22,European radiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
32950749,NCT04439084,Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study.,Journal Article, , ,2021-04-24,Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,Abstract,https://clinicaltrials.gov/ct2/show/NCT04439084,1
32951151,NCT04343261,Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective PhaseÂ II Clinical Trial.,Journal Article, , ,2021-04-28,Infectious diseases and therapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343261,4
32958495,NCT04315948,"Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.","Adaptive Clinical Trial|Clinical Trial Protocol|Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Drug Combinations|lopinavir-ritonavir drug combination|Lopinavir|remdesivir|Adenosine Monophosphate|Hydroxychloroquine|Ritonavir|Alanine|Interferon beta-1a|NA,"Adenosine Monophosphate|Adult|Alanine|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Combinations|Drug Therapy, Combination|Early Warning Score|Extracorporeal Membrane Oxygenation|Hospital Mortality|Hospitalization|Humans|Hydroxychloroquine|Interferon beta-1a|Length of Stay|Lopinavir|Oxygen Inhalation Therapy|Pandemics|Pneumonia, Viral|Respiration, Artificial|Ritonavir|SARS-CoV-2|Standard of Care|Treatment Outcome|NA",2020-10-05,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04315948,3
32969710,NCT04280705,Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System.,"Introductory Journal Article|Research Support, Non-U.S. Gov't",Troponin T|NA,"Autopsy|COVID-19|Cardiovascular Diseases|Cardiovascular System|Humans|Magnetic Resonance Imaging, Cine|SARS-CoV-2|Troponin T|NA",2021-04-13,Circulation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04280705,3
32972320,NCT04335162,High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019.,Journal Article,"Antibodies, Antiphospholipid|Biomarkers|PROS1 protein, human|Protein S|NA","Aged|Antibodies, Antiphospholipid|Antiphospholipid Syndrome|Biomarkers|COVID-19|Coronavirus Infections|Female|France|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prevalence|Prognosis|Protein S|Protein S Deficiency|Risk Factors|Severity of Illness Index|Thrombosis|NA",2020-11-18,Journal of the American Heart Association,Abstract,https://clinicaltrials.gov/ct2/show/NCT04335162,1
32983830,NCT04343261,Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective PhaseÂ II Clinical Trial.,Journal Article, , ,2020-11-23,Infectious diseases and therapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343261,4
32989425,NCT04334291,"Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design.",Journal Article, , ,2020-10-07,Contemporary clinical trials communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04334291,6
32991329,NCT04318366,COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain.,Clinical Trial|Journal Article|Multicenter Study,"Antibodies, Viral|Antigens, Viral|Epitopes|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|NA","Aged|Antibodies, Viral|Antigens, Viral|COVID-19|Epitopes|Female|Follow-Up Studies|Humans|Male|Middle Aged|Protein Domains|SARS-CoV-2|Spike Glycoprotein, Coronavirus|NA",2020-12-14,The Journal of clinical investigation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
32991794,NCT04283461,Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.,"Clinical Trial, Phase I|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|mRNA-1273 vaccine|NA","Aged|Antibodies, Neutralizing|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Dose-Response Relationship, Drug|Female|Humans|Male|Middle Aged|Neutralization Tests|SARS-CoV-2|Spike Glycoprotein, Coronavirus|T-Lymphocytes|NA",2020-12-23,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04283461,2
32993779,NCT04321928,Personalised health education against health damage of COVID-19 epidemic in the elderly Hungarian population (PROACTIVE-19): protocol of an adaptive randomised controlled clinical trial.,Clinical Trial Protocol|Journal Article, ,"Adaptive Clinical Trials as Topic|Age Factors|Aged|Aged, 80 and over|Alcohol Drinking|Betacoronavirus|COVID-19|Coronavirus Infections|Exercise|Feeding Behavior|Female|Health Education|Health Knowledge, Attitudes, Practice|Health Status|Host-Pathogen Interactions|Humans|Hungary|Male|Mental Health|Middle Aged|Pandemics|Pneumonia, Viral|Pragmatic Clinical Trials as Topic|Protective Factors|Risk Assessment|Risk Factors|Risk Reduction Behavior|SARS-CoV-2|Smoking|NA",2020-10-13,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321928,1
32999432,NCT04394416,Imatinib is not a potent anti-SARS-CoV-2 drug.,"Letter|Research Support, N.I.H., Extramural",Antiviral Agents|Protein Kinase Inhibitors|Pyrazoles|asciminib|Niacinamide|Imatinib Mesylate|NA,"Antiviral Agents|Betacoronavirus|COVID-19|Caco-2 Cells|Coronavirus Infections|Drug Repositioning|Humans|Imatinib Mesylate|Inhibitory Concentration 50|Niacinamide|Pandemics|Pneumonia, Viral|Protein Kinase Inhibitors|Pyrazoles|Randomized Controlled Trials as Topic|SARS-CoV-2|Virus Internalization|Virus Replication|NA",2020-11-05,Leukemia,Abstract,https://clinicaltrials.gov/ct2/show/NCT04394416,2
33001138,NCT04329923,Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.,Journal Article|Multicenter Study|Randomized Controlled Trial,Hydroxychloroquine|NA,"Adult|COVID-19|Cross Infection|Double-Blind Method|Female|Hospitals, Urban|Humans|Hydroxychloroquine|Incidence|Male|Pennsylvania|Personnel, Hospital|Pre-Exposure Prophylaxis|SARS-CoV-2|NA",2021-02-05,JAMA internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04329923,1
33001967,NCT04377815,"Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.","Journal Article|Observational Study|Research Support, Non-U.S. Gov't","Antibodies, Viral|Immunoglobulin G|Immunoglobulin M|NA","Adult|Antibodies, Viral|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Female|Humans|Immunoglobulin G|Immunoglobulin M|London|Male|Middle Aged|Olfaction Disorders|Pandemics|Pneumonia, Viral|Point-of-Care Testing|SARS-CoV-2|Seroconversion|Seroepidemiologic Studies|Taste Disorders|Text Messaging|NA",2020-10-07,PLoS medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04377815,2
33006086,NCT04352764,Creating a safe workplace by universal testing of SARS-CoV-2 infection in asymptomatic patients and healthcare workers in the electrophysiology units: a multi-center experience.,Journal Article, , ,2020-10-04,Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing,Abstract,https://clinicaltrials.gov/ct2/show/NCT04352764,1
33015643,NCT04333420,"Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial.",Journal Article, , ,2020-11-27,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04333420,1
33021869,NCT04384926,"Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.","Comparative Study|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't", ,"Aged|Aged, 80 and over|COVID-19|Cohort Studies|Critical Care|Elective Surgical Procedures|Epidemics|Female|Humans|International Cooperation|Logistic Models|Male|Middle Aged|Neoplasms|Outcome Assessment, Health Care|Postoperative Complications|SARS-CoV-2|NA",2021-01-25,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04384926,1
33022004,NCT04331574,Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension.,"Clinical Trial|Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Cross-Sectional Studies|Female|Heart Failure|Humans|Hypertension|Intensive Care Units|Italy|Male|Middle Aged|Obesity|Pandemics|Patient Admission|Pneumonia, Viral|Renal Insufficiency, Chronic|Risk Factors|SARS-CoV-2|Severity of Illness Index|Sex Factors|Young Adult|NA",2020-10-27,PloS one,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331574,3
33026892,NCT04358029,"Malignant Arrhythmias in Patients With COVID-19: Incidence, Mechanisms, and Outcomes.",Comparative Study|Journal Article, ,"Action Potentials|Adult|Aged|Aged, 80 and over|Arrhythmias, Cardiac|COVID-19|Female|Heart Conduction System|Heart Rate|Hospital Mortality|Hospitalization|Humans|Incidence|Male|Middle Aged|New York City|Prognosis|Registries|Risk Assessment|Risk Factors|Time Factors|Young Adult|NA",2020-12-04,Circulation. Arrhythmia and electrophysiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04358029,1
33027186,NCT04323839,Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People.,"Journal Article|Observational Study|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't", ,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Pandemics|Pneumonia, Viral|Pregnancy|Pregnancy Complications, Infectious|Prospective Studies|Risk Factors|SARS-CoV-2|Symptom Assessment|United States|Young Adult|NA",2020-12-01,Obstetrics and gynecology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04323839,1
33031652,NCT04381936,Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.,Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial,Antiviral Agents|Hydroxychloroquine|NA,"Aged|Aged, 80 and over|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Hospitalization|Humans|Hydroxychloroquine|Male|Middle Aged|Pandemics|Pneumonia, Viral|Respiration, Artificial|SARS-CoV-2|Treatment Failure|NA",2020-12-01,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04381936,4
33031955,NCT04317092,TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol.,Clinical Trial Protocol|Journal Article,"Antibodies, Monoclonal, Humanized|Immunologic Factors|Receptors, Interleukin-6|tocilizumab|NA","Administration, Intravenous|Adult|Antibodies, Monoclonal, Humanized|COVID-19|Clinical Trials, Phase II as Topic|Cytokine Release Syndrome|Drug Administration Schedule|Drug Monitoring|Female|Humans|Immunologic Factors|Male|Multicenter Studies as Topic|Pneumonia, Viral|Receptors, Interleukin-6|Treatment Outcome|NA",2020-12-11,Contemporary clinical trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04317092,3
33040020,NCT04307459,Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study.,Journal Article|Multicenter Study|Observational Study,Oxygen|NA,"Aged|Betacoronavirus|Blood Gas Analysis|COVID-19|Coronavirus Infections|Female|Hospital Mortality|Hospitalization|Hospitals|Humans|Hypoxia|Intensive Care Units|Italy|Lung|Male|Middle Aged|Oxygen|Pandemics|Partial Pressure|Pneumonia, Viral|Prospective Studies|Respiratory Distress Syndrome|Respiratory Insufficiency|Risk Factors|SARS-CoV-2|Severe Acute Respiratory Syndrome|Severity of Illness Index|NA",2020-10-29,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04307459,1
33043164,NCT04317092,"A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan.",Journal Article, , ,2021-04-28,Contemporary clinical trials communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04317092,3
33044747,NCT04342182,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Coronavirus Infections|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Treatment Outcome|NA",2020-10-21,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04342182,2
33044747,NCT04321421,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Coronavirus Infections|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Treatment Outcome|NA",2020-10-21,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321421,4
33044747,NCT04357106,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Coronavirus Infections|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Treatment Outcome|NA",2020-10-21,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04357106,2
33044747,NCT04441424,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Coronavirus Infections|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Treatment Outcome|NA",2020-10-21,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04441424,2
33044747,NCT04343261,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Coronavirus Infections|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Treatment Outcome|NA",2020-10-21,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343261,4
33044747,NCT04434131,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Coronavirus Infections|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Treatment Outcome|NA",2020-10-21,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04434131,3
33044747,NCT04340050,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Coronavirus Infections|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Treatment Outcome|NA",2020-10-21,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04340050,2
33046998,NCT04507282,Elevated eosinophil count is related with lower anti-factor Xa activity in COVID-19 patients.,Journal Article, , ,2020-10-16,Journal of hematopathology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04507282,1
33050459,NCT04555096,May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?,Journal Article, , ,2020-11-03,"Antioxidants (Basel, Switzerland)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04555096,1
33050924,NCT04356495,Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).,"Clinical Trial, Phase III|Letter|Randomized Controlled Trial",Amides|Antihypertensive Agents|Antimalarials|Antiviral Agents|Protein Kinase Inhibitors|Pyrazines|Hydroxychloroquine|Imatinib Mesylate|favipiravir|Telmisartan|NA,"Aged|Aged, 80 and over|Amides|Antihypertensive Agents|Antimalarials|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Tolerance|Feasibility Studies|France|Hospitalization|Humans|Hydroxychloroquine|Imatinib Mesylate|Luxembourg|Outpatients|Pandemics|Pneumonia, Viral|Protein Kinase Inhibitors|Pyrazines|Risk Reduction Behavior|SARS-CoV-2|Telmisartan|Therapies, Investigational|Treatment Outcome|NA",2020-11-03,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04356495,1
33050947,NCT04445467,An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial.,"Clinical Trial, Phase II|Letter|Multicenter Study|Randomized Controlled Trial",Amides|Antiviral Agents|Biomarkers|Placebos|Pyrazines|favipiravir|NA,"Amides|Antiviral Agents|Australia|Betacoronavirus|Biomarkers|COVID-19|Clinical Protocols|Coronavirus Infections|Female|Hospitalization|Humans|Male|Pandemics|Placebos|Pneumonia, Viral|Pyrazines|SARS-CoV-2|Safety|Treatment Outcome|NA",2020-11-03,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04445467,1
33053279,NCT04368728,Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.,"Clinical Trial, Phase I|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Viral|COVID-19 Vaccines|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|BNT162 vaccine|NA","Adolescent|Adult|Aged|Aged, 80 and over|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Female|Humans|Injections, Intramuscular|Male|Middle Aged|Neutralization Tests|SARS-CoV-2|Single-Blind Method|Spike Glycoprotein, Coronavirus|Young Adult|NA",2020-12-23,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368728,5
33058695,NCT04314232,Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.,Journal Article,"Biomarkers|GDF15 protein, human|Growth Differentiation Factor 15|Peptide Fragments|Troponin T|pro-brain natriuretic peptide (1-76)|Natriuretic Peptide, Brain|C-Reactive Protein|NA","Adult|Aged|Area Under Curve|Biomarkers|C-Reactive Protein|COVID-19|Female|Growth Differentiation Factor 15|Hospitalization|Humans|Intensive Care Units|Male|Middle Aged|Natriuretic Peptide, Brain|Peptide Fragments|Prognosis|Prospective Studies|ROC Curve|SARS-CoV-2|Treatment Outcome|Troponin T|NA",2020-12-09,Circulation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04314232,2
33063141,NCT04448717,"Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study.",Journal Article, ,"Adolescent|Bayes Theorem|COVID-19|Child|Child, Preschool|Humans|Longitudinal Studies|Pandemics|Prospective Studies|Risk Factors|SARS-CoV-2|Saliva|Schools|Seroepidemiologic Studies|Switzerland|NA",2020-12-16,International journal of public health,Abstract,https://clinicaltrials.gov/ct2/show/NCT04448717,3
33066761,NCT04343963,"A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.",Clinical Trial Protocol|Journal Article,Cholinesterase Inhibitors|Pyridostigmine Bromide|NA,"Adult|Betacoronavirus|COVID-19|Cholinesterase Inhibitors|Coronavirus Infections|Humans|Inflammation|Lung|Pandemics|Pneumonia, Viral|Pyridostigmine Bromide|Respiration, Artificial|SARS-CoV-2|NA",2020-10-26,BMC infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343963,1
33066801,NCT04262921,SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Aged|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Illness|Female|France|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prospective Studies|Respiration, Artificial|Respiratory Distress Syndrome|Respiratory System|SARS-CoV-2|Switzerland|Viral Load|Virus Shedding|NA",2020-10-21,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04262921,3
33068425,NCT04328467,Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.,"Journal Article|Research Support, Non-U.S. Gov't|Research Support, N.I.H., Extramural", , ,2021-06-02,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Abstract,https://clinicaltrials.gov/ct2/show/NCT04328467,2
33071007,NCT04423770,Estimating COVID-19 prevalence and infection control practices among US dentists.,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Dentists|Humans|Infection Control|Pandemics|Pneumonia, Viral|Prevalence|SARS-CoV-2|NA",2020-11-09,Journal of the American Dental Association (1939),Abstract,https://clinicaltrials.gov/ct2/show/NCT04423770,1
33072814,NCT04323592,Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia.,Journal Article, , ,2021-04-28,Open forum infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04323592,1
33078076,NCT04411459,Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs.,Journal Article, , ,2021-04-28,Journal of intensive care,Abstract,https://clinicaltrials.gov/ct2/show/NCT04411459,2
33080005,NCT04346355,Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|Receptors, Interleukin-6|C-Reactive Protein|tocilizumab|NA","Aged|Antibodies, Monoclonal, Humanized|Blood Gas Analysis|C-Reactive Protein|COVID-19|Disease Progression|Early Termination of Clinical Trials|Female|Fever|Hospital Mortality|Hospitalization|Humans|Intensive Care Units|Italy|Male|Medical Futility|Middle Aged|Receptors, Interleukin-6|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|NA",2021-01-15,JAMA internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04346355,1
33080017,NCT04331808,Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Adrenal Cortex Hormones|Anti-Bacterial Agents|Antibodies, Monoclonal, Humanized|Anticoagulants|Antiviral Agents|Receptors, Interleukin-6|Vasoconstrictor Agents|tocilizumab|NA","Adrenal Cortex Hormones|Aged|Anti-Bacterial Agents|Antibodies, Monoclonal, Humanized|Anticoagulants|Antiviral Agents|COVID-19|Disease Progression|Female|Hospital Mortality|Hospitalization|Humans|Intubation, Intratracheal|Male|Middle Aged|Mortality|Noninvasive Ventilation|Oxygen Inhalation Therapy|Receptors, Interleukin-6|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Severity of Illness Index|Vasoconstrictor Agents|NA",2021-01-15,JAMA internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331808,1
33081817,NCT04322396,Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.,Journal Article|Multicenter Study|Randomized Controlled Trial,Anti-Bacterial Agents|Antimalarials|Placebos|Hydroxychloroquine|Azithromycin|NA,"Aged|Anti-Bacterial Agents|Antibiotic Prophylaxis|Antimalarials|Azithromycin|Betacoronavirus|COVID-19|Case-Control Studies|Coronavirus Infections|Denmark|Double-Blind Method|Drug Therapy, Combination|Female|Hospital Mortality|Hospitalization|Humans|Hydroxychloroquine|Intensive Care Units|Intention to Treat Analysis|Male|Noninvasive Ventilation|Pandemics|Placebos|Pneumonia, Viral|Risk Reduction Behavior|SARS-CoV-2|NA",2020-11-03,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04322396,2
33082342,NCT04316377,A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Hydroxychloroquine|NA,"Aged|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|Treatment Outcome|Viral Load|NA",2020-11-02,Nature communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04316377,2
33083026,NCT04436276,Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.,Journal Article, , ,2020-10-22,NPJ vaccines,Abstract,https://clinicaltrials.gov/ct2/show/NCT04436276,3
33085857,NCT04356937,Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|IL6R protein, human|Receptors, Interleukin-6|tocilizumab|NA","Adult|Aged|Aged, 80 and over|Antibodies, Monoclonal, Humanized|Boston|COVID-19|Disease Progression|Double-Blind Method|Female|Humans|Intubation|Male|Middle Aged|Receptors, Interleukin-6|Respiratory Therapy|Treatment Failure|Young Adult|NA",2020-12-17,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04356937,1
33087116,NCT04416100,Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study.,Journal Article|Multicenter Study|Observational Study,Interleukin-6|C-Reactive Protein|Ferritins|Iron|NA,"Adult|Aged|Anemia|C-Reactive Protein|COVID-19|Cohort Studies|Coronavirus Infections|Female|Ferritins|Follow-Up Studies|Homeostasis|Humans|Inflammation|Interleukin-6|Iron|Lung Diseases|Male|Middle Aged|Monocytes|Pandemics|Pneumonia, Viral|Prospective Studies|Tomography, X-Ray Computed|NA",2020-10-29,Respiratory research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04416100,2
33087150,NCT04317092,Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.,"Clinical Trial, Phase II|Journal Article|Multicenter Study","Antibodies, Monoclonal, Humanized|tocilizumab|NA","Adult|Aged|Aged, 80 and over|Antibodies, Monoclonal, Humanized|Betacoronavirus|COVID-19|Cohort Studies|Coronavirus Infections|Female|Humans|Italy|Male|Middle Aged|Mortality|Off-Label Use|Pandemics|Pneumonia, Viral|SARS-CoV-2|Treatment Outcome|Validation Studies as Topic|NA",2020-10-30,Journal of translational medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04317092,3
33089824,NCT04282135,Rapid non-invasive detection of Influenza-A-infection by multicapillary column coupled ion mobility spectrometry.,Evaluation Study|Journal Article, ,"Aged|Betacoronavirus|Breath Tests|COVID-19|Coronavirus Infections|Discriminant Analysis|Female|Humans|Influenza A virus|Influenza, Human|Ion Mobility Spectrometry|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prospective Studies|SARS-CoV-2|Sensitivity and Specificity|NA",2020-10-29,Journal of breath research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04282135,1
33092632,NCT04374526,&quot;Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial&quot;.,"Clinical Trial, Phase II|Clinical Trial, Phase III|Comparative Study|Letter|Randomized Controlled Trial", ,"Aged|Aged, 80 and over|Betacoronavirus|Blood Transfusion|COVID-19|Comorbidity|Coronavirus Infections|Disease Progression|Female|Humans|Immunization, Passive|Informed Consent|Italy|Male|Mortality|Pandemics|Pneumonia|Pneumonia, Viral|SARS-CoV-2|Tomography, X-Ray Computed|Viral Load|NA",2020-11-03,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04374526,1
33093033,NCT04290780,"Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV-2 transmission: NOSO-COR Project.",Journal Article|Multicenter Study|Observational Study, ,"Adolescent|Adult|Betacoronavirus|COVID-19|Child|Coronavirus Infections|Cross Infection|Female|France|Hospitals|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prospective Studies|Risk Factors|SARS-CoV-2|Young Adult|NA",2020-11-05,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04290780,1
33106167,NCT04403477,"Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.","Clinical Trial, Phase II|Letter|Multicenter Study|Randomized Controlled Trial", ,"Bangladesh|Betacoronavirus|Blood Transfusion|COVID-19|Coronavirus Infections|Dose-Response Relationship, Immunologic|Female|Hospital Mortality|Humans|Immunization, Passive|Male|Pandemics|Patient Discharge|Pneumonia, Viral|SARS-CoV-2|Safety|Severity of Illness Index|Time Factors|Treatment Outcome|Ventilators, Mechanical|NA",2020-11-02,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04403477,1
33108622,NCT04389840,"Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19.","Clinical Trial, Phase II|Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial",Anti-Inflammatory Agents|Heparin|NA,"Acute Lung Injury|Adult|Aged|Aged, 80 and over|Anti-Inflammatory Agents|COVID-19|Double-Blind Method|Female|Heparin|Humans|Male|Middle Aged|Respiratory Insufficiency|SARS-CoV-2|Treatment Outcome|NA",2021-02-22,Advances in therapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04389840,1
33110590,NCT04344197,"Screening policies, preventive measures and in-hospital infection of COVID-19 in global surgical practices.",Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Cross Infection|Cross-Sectional Studies|Hospitals|Humans|Infection Control|Mass Screening|Pandemics|Pneumonia, Viral|Policy|Practice Patterns, Physicians'|SARS-CoV-2|Surgical Procedures, Operative|Surveys and Questionnaires|NA",2020-11-04,Journal of global health,Abstract,https://clinicaltrials.gov/ct2/show/NCT04344197,1
33110944,NCT04328493,A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam.,Journal Article, , ,2020-10-29,Wellcome open research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04328493,1
33111650,NCT04440098,"Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19.","Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't", ,Adolescent|Adult|Age Factors|Alcoholism|Anxiety|COVID-19|Cross-Sectional Studies|Depression|Female|Health Status|Humans|Loneliness|Male|Mental Health|Pandemics|Psychiatric Status Rating Scales|Sex Factors|Substance-Related Disorders|Surveys and Questionnaires|United States|Young Adult|NA,2021-03-11,Journal of psychoactive drugs,Abstract,https://clinicaltrials.gov/ct2/show/NCT04440098,1
33113295,NCT04427501,SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.,"Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|Immunologic Factors|RNA, Viral|bamlanivimab|NA","Adolescent|Adult|Aged|Aged, 80 and over|Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|COVID-19|Dose-Response Relationship, Drug|Double-Blind Method|Female|Hospitalization|Humans|Immunologic Factors|Male|Middle Aged|Outpatients|RNA, Viral|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Severity of Illness Index|Viral Load|Young Adult|NA",2021-02-03,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04427501,2
33115543,NCT04394416,Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Protein Kinase Inhibitors|Imatinib Mesylate|NA,"Administration, Oral|Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Care|Dose-Response Relationship, Drug|Double-Blind Method|Drug Monitoring|Female|Humans|Imatinib Mesylate|Male|Pandemics|Pneumonia, Viral|Protein Kinase Inhibitors|Randomized Controlled Trials as Topic|SARS-CoV-2|Treatment Outcome|NA",2020-11-05,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04394416,2
33125416,NCT04407156,Acute kidney injury associated with COVID-19: A retrospective cohort study.,Journal Article, ,"Acute Kidney Injury|Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Ethnic Groups|Female|Hospital Mortality|Hospitalization|Humans|Incidence|Intensive Care Units|Male|Middle Aged|Pandemics|Pneumonia, Viral|Renal Insufficiency, Chronic|Respiration, Artificial|Retrospective Studies|Risk Factors|SARS-CoV-2|United Kingdom|Young Adult|NA",2020-11-11,PLoS medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04407156,1
33129363,NCT04392973,A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Amides|Antiviral Agents|Pyrazines|Hydroxychloroquine|favipiravir|NA,"Amides|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Therapy, Combination|Female|Host-Pathogen Interactions|Humans|Hydroxychloroquine|Inpatients|Male|Multicenter Studies as Topic|Pandemics|Pneumonia, Viral|Pyrazines|Randomized Controlled Trials as Topic|SARS-CoV-2|Saudi Arabia|Time Factors|Treatment Outcome|NA",2020-11-04,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04392973,1
33138848,NCT04352959,Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Antiviral Agents|Mouthwashes|beta-Cyclodextrins|betadex|NA,"Adult|Antiviral Agents|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Drug Monitoring|Female|Humans|Male|Mouthwashes|Nasal Cavity|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Saliva|Treatment Outcome|Viral Load|beta-Cyclodextrins|NA",2020-11-09,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04352959,2
33138867,NCT04521309,Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,"Immunoglobulins, Intravenous|Immunologic Factors|NA","Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Illness|Female|Humans|Immunization, Passive|Immunoglobulins, Intravenous|Immunologic Factors|Male|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|SARS-CoV-2|Severity of Illness Index|Treatment Outcome|NA",2020-11-09,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04521309,2
33138974,NCT04336345,Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study.,Journal Article|Multicenter Study|Observational Study, ,COVID-19|Critical Illness|Humans|Intensive Care Units|Male|Mexico|Middle Aged|SARS-CoV-2|NA,2020-12-21,Heart &amp; lung : the journal of critical care,Abstract,https://clinicaltrials.gov/ct2/show/NCT04336345,1
33139139,NCT04368988,NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.,"Journal Article|Research Support, Non-U.S. Gov't","Adjuvants, Immunologic|Antibodies, Neutralizing|COVID-19 Vaccines|Immune Sera|Spike Glycoprotein, Coronavirus|Vaccines, Synthetic|recombinant SARS-CoV-2 vaccine NVX-cov2373|spike protein, SARS-CoV-2|ACE2 protein, human|Angiotensin-Converting Enzyme 2|NA","Adjuvants, Immunologic|Adolescent|Adult|Aged|Angiotensin-Converting Enzyme 2|Animals|Antibodies, Neutralizing|COVID-19|COVID-19 Vaccines|Chlorocebus aethiops|Female|Humans|Immune Sera|Macaca fascicularis|Male|Middle Aged|SARS-CoV-2|Spike Glycoprotein, Coronavirus|Vaccines, Synthetic|Vero Cells|Viral Load|Young Adult|NA",2020-12-11,Vaccine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368988,3
33147165,NCT04331171,Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study.,Journal Article|Observational Study, ,"COVID-19|Coronavirus Infections|Emergency Service, Hospital|France|Hospitalization|Humans|Pandemics|Pneumonia, Viral|Self Care|Software|Surveys and Questionnaires|Telephone|Triage|NA",2020-12-01,Journal of medical Internet research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331171,3
33148977,NCT04401579,COVID-19 and Solid Organ Transplantation: A Review Article.,Journal Article|Review, ,"COVID-19|Humans|Immune Tolerance|Kidney Failure, Chronic|Organ Transplantation|SARS-CoV-2|NA",2021-01-06,Transplantation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04401579,2
33148977,NCT04492475,COVID-19 and Solid Organ Transplantation: A Review Article.,Journal Article|Review, ,"COVID-19|Humans|Immune Tolerance|Kidney Failure, Chronic|Organ Transplantation|SARS-CoV-2|NA",2021-01-06,Transplantation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04492475,1
33150375,NCT04349202,COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking.,Journal Article, , ,2020-11-17,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Abstract,https://clinicaltrials.gov/ct2/show/NCT04349202,1
33153145,NCT04557605,Wearing of Cloth or Disposable Surgical Face Masks has no Effect on Vigorous Exercise Performance in Healthy Individuals.,Journal Article|Randomized Controlled Trial, ,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Exercise|Exercise Test|Female|Humans|Male|Masks|Oximetry|Oxygen Consumption|Pandemics|Pneumonia, Viral|SARS-CoV-2|Young Adult|NA",2020-11-23,International journal of environmental research and public health,Abstract,https://clinicaltrials.gov/ct2/show/NCT04557605,1
33153629,NCT04351152,GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study.,"Journal Article|Multicenter Study|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|Granulocyte-Macrophage Colony-Stimulating Factor|lenzilumab|NA","Aged|Antibodies, Monoclonal, Humanized|COVID-19|Dose-Response Relationship, Drug|Female|Granulocyte-Macrophage Colony-Stimulating Factor|Humans|Infusions, Intravenous|Male|Middle Aged|Pandemics|SARS-CoV-2|Treatment Outcome|NA",2020-12-08,Mayo Clinic proceedings,Abstract,https://clinicaltrials.gov/ct2/show/NCT04351152,3
33157937,NCT04428099,Effectiveness of a healthy lifestyle promotion program as adjunctive teletherapy for treatment-resistant major depression during COVID 19 pandemic: A randomized clinical trial protocol.,Clinical Trial Protocol|Journal Article, ,"COVID-19|Cognitive Behavioral Therapy|Coronavirus Infections|Depressive Disorder, Treatment-Resistant|Health Promotion|Healthy Lifestyle|Humans|Mindfulness|Pandemics|Pneumonia, Viral|Pragmatic Clinical Trials as Topic|Quality of Life|Surveys and Questionnaires|Telemedicine|NA",2020-11-18,Medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04428099,1
33160700,NCT04318366,"COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study.",Journal Article|Observational Study, ,Adult|Aged|Ambulatory Care|Anthropometry|COVID-19|Cohort Studies|Female|Hospitalization|Humans|Italy|Male|Malnutrition|Middle Aged|Nutritional Status|Prospective Studies|SARS-CoV-2|Weight Loss|NA,2021-05-12,"Clinical nutrition (Edinburgh, Scotland)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
33165503,NCT04412538,"Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.",Journal Article, , ,2020-12-10,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Abstract,https://clinicaltrials.gov/ct2/show/NCT04412538,2
33165621,NCT04332991,Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural",Hydroxychloroquine|NA,Adult|Aged|COVID-19|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Treatment Failure|NA,2020-12-11,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04332991,2
33165755,NCT04334291,"Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry.",Journal Article, , ,2020-11-13,Internal and emergency medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04334291,6
33166179,NCT04329832,"Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with COVID-19 (HAHPS): Results of a Randomized, Active Comparator Trial.",Journal Article, , ,2021-04-07,Annals of the American Thoracic Society,Abstract,https://clinicaltrials.gov/ct2/show/NCT04329832,2
33169671,NCT04346342,"Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study.","Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't", ,"Aged|COVID-19|Cohort Studies|Female|Humans|Male|Middle Aged|Netherlands|Respiration, Artificial|Retrospective Studies|Treatment Outcome|NA",2021-02-25,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04346342,2
33175694,NCT04557241,COVID-19 Misinformation Prophylaxis: Protocol for a Randomized Trial of a Brief Informational Intervention.,Journal Article, , ,2020-12-12,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04557241,1
33175877,NCT04486404,"Availability of personal protective equipment and diagnostic and treatment facilities for healthcare workers involved in COVID-19 care: A cross-sectional study in Brazil, Colombia, and Ecuador.","Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|Brazil|COVID-19|Colombia|Coronavirus Infections|Cross-Sectional Studies|Ecuador|Health Facilities|Health Personnel|Humans|Pandemics|Personal Protective Equipment|Pneumonia, Viral|SARS-CoV-2|Surveys and Questionnaires|NA",2020-11-18,PloS one,Abstract,https://clinicaltrials.gov/ct2/show/NCT04486404,1
33175911,NCT04366882,The clinical value of minimal invasive autopsy in COVID-19 patients.,"Journal Article|Research Support, Non-U.S. Gov't","RNA, Viral|NA","Aged|Autopsy|Belgium|Betacoronavirus|COVID-19|Cause of Death|Coronavirus Infections|Female|Humans|Male|Pandemics|Pneumonia, Viral|Prospective Studies|RNA, Viral|SARS-CoV-2|Tomography, X-Ray Computed|NA",2020-11-18,PloS one,Abstract,https://clinicaltrials.gov/ct2/show/NCT04366882,1
33176886,NCT04487990,Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.,Clinical Trial Protocol|Letter,Anticoagulants|Fibrin Fibrinogen Degradation Products|Hemoglobins|fibrin fragment D|Heparin|NA,"Acute Kidney Injury|Adult|Anticoagulants|Blood Coagulation|COVID-19|Coronavirus Infections|Drug Monitoring|Female|Fibrin Fibrinogen Degradation Products|Hemoglobins|Hemorrhage|Heparin|Humans|Male|Outcome Assessment, Health Care|Pandemics|Pneumonia, Viral|Randomized Controlled Trials as Topic|Renal Dialysis|Risk Adjustment|Thrombocytopenia|Thrombosis|NA",2020-11-23,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04487990,1
33177145,NCT04391140,Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial.,"Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|Cannula|Coronavirus Infections|Equivalence Trials as Topic|Humans|Hypoxia|Meta-Analysis as Topic|Oxygen Inhalation Therapy|Pandemics|Patient Positioning|Pneumonia, Viral|Prone Position|Randomized Controlled Trials as Topic|SARS-CoV-2|Wakefulness|NA",2020-11-19,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04391140,1
33177145,NCT04395144,Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial.,"Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|Cannula|Coronavirus Infections|Equivalence Trials as Topic|Humans|Hypoxia|Meta-Analysis as Topic|Oxygen Inhalation Therapy|Pandemics|Patient Positioning|Pneumonia, Viral|Prone Position|Randomized Controlled Trials as Topic|SARS-CoV-2|Wakefulness|NA",2020-11-19,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04395144,1
33177145,NCT04347941,Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial.,"Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|Cannula|Coronavirus Infections|Equivalence Trials as Topic|Humans|Hypoxia|Meta-Analysis as Topic|Oxygen Inhalation Therapy|Pandemics|Patient Positioning|Pneumonia, Viral|Prone Position|Randomized Controlled Trials as Topic|SARS-CoV-2|Wakefulness|NA",2020-11-19,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04347941,1
33177145,NCT04358939,Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial.,"Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|Cannula|Coronavirus Infections|Equivalence Trials as Topic|Humans|Hypoxia|Meta-Analysis as Topic|Oxygen Inhalation Therapy|Pandemics|Patient Positioning|Pneumonia, Viral|Prone Position|Randomized Controlled Trials as Topic|SARS-CoV-2|Wakefulness|NA",2020-11-19,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04358939,1
33178207,NCT04386395,A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.,Clinical Trial|Journal Article,"Biomarkers|CD14 protein, human|FCGR3B protein, human|GPI-Linked Proteins|HLA-DR Antigens|Lipopolysaccharide Receptors|Receptors, IgG|NA","Aged|Biomarkers|CD4-Positive T-Lymphocytes|CD8-Positive T-Lymphocytes|COVID-19|Female|GPI-Linked Proteins|HLA-DR Antigens|Humans|Immunity, Cellular|Lipopolysaccharide Receptors|Longitudinal Studies|Male|Middle Aged|Monocytes|Prospective Studies|Receptors, IgG|SARS-CoV-2|Severity of Illness Index|NA",2020-12-07,Frontiers in immunology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04386395,1
33178783,NCT04346342,PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands.,Journal Article, , ,2020-11-13,Annals of translational medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04346342,2
33180097,NCT04342663,Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.,"Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Fluvoxamine|NA,Adult|COVID-19|Clinical Deterioration|Double-Blind Method|Female|Fluvoxamine|Humans|Illinois|Male|Middle Aged|Missouri|Outpatients|Treatment Outcome|NA,2020-12-18,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04342663,2
33183506,NCT04412655,Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI.,Journal Article|Multicenter Study, ,"Aged|COVID-19|Coronavirus Infections|Europe|Female|Humans|Male|Middle Aged|Pandemics|Percutaneous Coronary Intervention|Pneumonia, Viral|Registries|Retrospective Studies|ST Elevation Myocardial Infarction|NA",2020-11-19,Journal of the American College of Cardiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04412655,2
33184083,NCT04364022,Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial.,"Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't",Antiviral Agents|Drug Combinations|lopinavir-ritonavir drug combination|Lopinavir|Ritonavir|NA,"Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Combinations|Humans|Lopinavir|Pandemics|Pneumonia, Viral|Post-Exposure Prophylaxis|Randomized Controlled Trials as Topic|Ritonavir|SARS-CoV-2|Switzerland|NA",2020-11-19,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04364022,1
33184088,NCT04435041,What items should be included in an early warning score for remote assessment of suspected COVID-19? qualitative and Delphi study.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|Checklist|Confusion|Coronavirus Infections|Delphi Technique|Disease Progression|Dyspnea|Early Warning Score|Fever|Heart Rate|Humans|Hypoxia|Myalgia|Pandemics|Pneumonia, Viral|Qualitative Research|Risk Assessment|Risk Factors|SARS-CoV-2|Telemedicine|Time Factors|United Kingdom|NA",2020-11-19,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04435041,2
33184146,NCT04459247,"Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).",Journal Article, , ,2020-11-13,Postgraduate medical journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04459247,2
33186055,NCT04435184,Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome.,"Comparative Study|Journal Article|Research Support, N.I.H., Extramural",Troponin|NA,"Aged|COVID-19|Disease-Free Survival|Female|Heart Injuries|Humans|Male|Middle Aged|Myocardium|Prevalence|Registries|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|Severity of Illness Index|Survival Rate|Troponin|NA",2021-02-15,Circulation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04435184,1
33189161,NCT04385095,"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.","Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Interferon beta-1a|NA,"Administration, Inhalation|Adult|Aged|Antiviral Agents|COVID-19|Double-Blind Method|Female|Humans|Interferon beta-1a|Male|Middle Aged|Nebulizers and Vaporizers|Treatment Outcome|NA",2021-02-25,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04385095,2
33190086,NCT04374149,Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.,"Clinical Trial|Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|COVID-19|Critical Illness|Cytokine Release Syndrome|Female|Humans|Male|Middle Aged|Oxygen Inhalation Therapy|Pilot Projects|Plasma Exchange|Prospective Studies|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Severity of Illness Index|NA",2021-01-11,Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04374149,1
33192504,NCT04487964,Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of <i>Glycyrrhiza glabra</i> L. (Licorice).,Journal Article, , ,2020-11-17,Frontiers in pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04487964,1
33196449,NCT04468893,A Self-Administered Multicomponent Web-Based Mental Health Intervention for the Mexican Population During the COVID-19 Pandemic: Protocol for a Randomized Controlled Trial.,Journal Article, , ,2020-12-07,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04468893,1
33203440,NCT04455360,CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter, ,"Adult|Anxiety|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Illness|Depression|Eye Movement Desensitization Reprocessing|Feasibility Studies|Female|Home Care Services, Hospital-Based|Humans|Internet-Based Intervention|Male|Pandemics|Pneumonia, Viral|Psychological Techniques|Quality of Life|Randomized Controlled Trials as Topic|SARS-CoV-2|Stress Disorders, Post-Traumatic|NA",2020-11-23,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04455360,1
33204764,NCT04328467,Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.,Journal Article, , ,2021-04-28,Open forum infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04328467,2
33205991,NCT04337541,Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't", ,"Adult|COVID-19|COVID-19 Nucleic Acid Testing|COVID-19 Serological Testing|Denmark|Disease Transmission, Infectious|Humans|Masks|Middle Aged|Pandemics|Physical Distancing|SARS-CoV-2|NA",2021-03-23,Annals of internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04337541,2
33212440,NCT04341922,Brief Online Cognitive Behavioural Intervention for Dysfunctional Worry Related to the COVID-19 Pandemic: A Randomised Controlled Trial.,Journal Article|Randomized Controlled Trial, ,"Adult|Aged|Aged, 80 and over|Anxiety|COVID-19|Cognitive Behavioral Therapy|Female|Humans|Internet-Based Intervention|Male|Middle Aged|Patient Health Questionnaire|SARS-CoV-2|Sweden|Treatment Outcome|Young Adult|NA",2021-05-04,Psychotherapy and psychosomatics,Abstract,https://clinicaltrials.gov/ct2/show/NCT04341922,1
33213529,NCT04382755,Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.,"Clinical Trial, Phase II|Letter|Multicenter Study|Randomized Controlled Trial",Anti-Bacterial Agents|Complement C5|Ceftriaxone|Oxygen|NA,"Acute Disease|Adult|Anti-Bacterial Agents|Belgium|Betacoronavirus|COVID-19|Case-Control Studies|Ceftriaxone|Complement C5|Coronavirus Infections|Cytokine Release Syndrome|Drug Therapy, Combination|Humans|Hypoxia|Infusions, Intravenous|Injections, Subcutaneous|Oxygen|Pandemics|Pneumonia, Viral|Prospective Studies|Respiratory Insufficiency|SARS-CoV-2|Safety|Treatment Outcome|NA",2020-11-26,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04382755,1
33217362,NCT04352608,"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.","Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Immunoglobulin G|Immunoglobulin M|Vaccines, Inactivated|NA","Adolescent|Adult|Antibodies, Neutralizing|Antibodies, Viral|COVID-19|COVID-19 Vaccines|China|Female|Healthy Volunteers|Humans|Immunization Schedule|Immunogenicity, Vaccine|Immunoglobulin G|Immunoglobulin M|Male|Middle Aged|SARS-CoV-2|Seroconversion|Vaccination|Vaccines, Inactivated|Young Adult|NA",2021-02-15,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04352608,1
33220855,NCT04400838,"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.","Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",COVID-19 Vaccines|Immunoglobulin G|ChAdOx1 COVID-19 vaccine|NA,"Adolescent|Adult|Age Factors|Aged|Aged, 80 and over|COVID-19|COVID-19 Vaccines|Female|Humans|Immunization, Secondary|Immunogenicity, Vaccine|Immunoglobulin G|Male|Middle Aged|SARS-CoV-2|Single-Blind Method|Young Adult|NA",2020-12-31,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04400838,5
33222617,NCT04406090,European Multicenter Study of ET-COVID-19.,Journal Article|Multicenter Study, ,"Aged|Aged, 80 and over|COVID-19|Cohort Studies|Endovascular Procedures|Europe|Female|Humans|Ischemic Stroke|Male|Middle Aged|Registries|Risk Factors|SARS-CoV-2|Thrombectomy|Treatment Outcome|NA",2021-01-07,Stroke,Abstract,https://clinicaltrials.gov/ct2/show/NCT04406090,1
33225952,NCT04412304,Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.,Journal Article,Anticoagulants|Tinzaparin|Dalteparin|NA,APACHE|Aged|Anticoagulants|COVID-19|Critical Illness|Dalteparin|Female|Humans|Intensive Care Units|Male|Middle Aged|Retrospective Studies|SARS-CoV-2|Sweden|Thrombosis|Tinzaparin|NA,2020-12-11,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04412304,1
33225960,NCT04449380,Interferon Î²-1a (IFNÎ²-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.,"Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial",Antiviral Agents|Oxygen|Interferon beta-1a|NA,"Adult|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Data Management|Female|Humans|Injections, Subcutaneous|Interferon beta-1a|Italy|Length of Stay|Male|Mortality|Oxygen|Pandemics|Pneumonia, Viral|SARS-CoV-2|Treatment Outcome|Viral Load|NA",2020-11-26,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04449380,1
33225989,NCT04495816,Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction.,Letter|Randomized Controlled Trial,"Fatty Acids, Omega-3|Placebos|NA","Betacoronavirus|COVID-19|Case-Control Studies|Coronavirus Infections|Dietary Supplements|Double-Blind Method|Fatty Acids, Omega-3|Humans|New York|Olfaction Disorders|Pandemics|Placebos|Pneumonia, Viral|SARS-CoV-2|Smell|NA",2020-11-26,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04495816,1
33225990,NCT04477655,"Prone positioning in non-intubated patients with COVID-19 associated acute respiratory failure, the PRO-CARF trial: A structured summary of a study protocol for a randomised controlled trial.",Letter|Randomized Controlled Trial,Oxygen|NA,"Acute Disease|Adult|Betacoronavirus|COVID-19|Cannula|Case-Control Studies|Coronavirus Infections|Female|Hospitalization|Humans|Intubation, Intratracheal|Male|Mexico|Oxygen|Pandemics|Patient Positioning|Pneumonia, Viral|Prone Position|Respiratory Insufficiency|SARS-CoV-2|NA",2020-11-26,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04477655,1
33225995,NCT04438070,Comparison of four COVID-19 screening strategies to facilitate early case identification within the homeless shelter population: A structured summary of a study protocol for a randomised controlled trial.,Comparative Study|Letter|Randomized Controlled Trial, ,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Early Diagnosis|Female|Homeless Persons|Humans|Male|Mass Screening|Ontario|Pandemics|Patient Compliance|Pneumonia, Viral|Program Evaluation|Prospective Studies|SARS-CoV-2|Specimen Handling|Time Factors|NA",2020-11-26,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04438070,1
33231487,NCT04357535,"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.",Journal Article|Multicenter Study,Angiotensin II Type 1 Receptor Blockers|Angiotensin-Converting Enzyme Inhibitors|C-Reactive Protein|NA,"Adult|Age Factors|Aged|Aged, 80 and over|Angiotensin II Type 1 Receptor Blockers|Angiotensin-Converting Enzyme Inhibitors|C-Reactive Protein|COVID-19|Cardiovascular Diseases|Female|Hematologic Tests|Hospital Mortality|Humans|Hypertension|Intensive Care Units|Logistic Models|Male|Middle Aged|Obesity|Prospective Studies|Respiration, Artificial|SARS-CoV-2|Severity of Illness Index|NA",2021-04-14,Journal of cardiovascular pharmacology and therapeutics,Abstract,https://clinicaltrials.gov/ct2/show/NCT04357535,1
33232588,NCT04383535,A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Immunoglobulin G|NA","Aged|Aged, 80 and over|Antibodies, Neutralizing|Blood Component Transfusion|COVID-19|Disease Progression|Double-Blind Method|Female|Hospitalization|Humans|Immunization, Passive|Immunoglobulin G|Kaplan-Meier Estimate|Male|Middle Aged|Pneumonia, Viral|SARS-CoV-2|Severity of Illness Index|NA",2021-02-23,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04383535,2
33234158,NCT04529525,Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.,Letter|Randomized Controlled Trial,Antiparasitic Agents|Placebos|Ivermectin|NA,Adult|Antiparasitic Agents|Argentina|COVID-19|Case-Control Studies|Double-Blind Method|Female|Hospitalization|Humans|Ivermectin|Male|Pandemics|Placebos|Prospective Studies|SARS-CoV-2|Time Factors|NA,2020-12-07,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04529525,1
33234651,NCT04341142,"Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study.",Clinical Study|Journal Article|Multicenter Study,"Antibodies, Viral|NA","Antibodies, Viral|COVID-19|Female|Humans|Male|Mass Screening|Pandemics|Prospective Studies|SARS-CoV-2|Serologic Tests|NA",2020-12-10,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04341142,1
33234656,NCT04380987,"Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study.","Journal Article|Research Support, Non-U.S. Gov't", ,Adult|COVID-19|COVID-19 Testing|Family Characteristics|Female|Follow-Up Studies|Humans|Incidence|Intensive Care Units|Luxembourg|Male|Pandemics|Prospective Studies|Risk Factors|SARS-CoV-2|Severity of Illness Index|Time Factors|NA,2020-12-10,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04380987,1
33237291,NCT04344119,"Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.","Journal Article|Research Support, Non-U.S. Gov't",Interferon-alpha|NA,Adolescent|Adult|Aged|COVID-19|Chilblains|Child|Female|Humans|Interferon-alpha|Male|Middle Aged|Prospective Studies|Young Adult|NA,2021-03-11,JAMA dermatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04344119,1
33239100,NCT04430608,Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.,Letter|Randomized Controlled Trial, ,"Adult|Blood Glucose Self-Monitoring|COVID-19|Denmark|Diabetes Mellitus, Type 2|Female|Glycemic Control|Health Personnel|Hospitalization|Humans|Infectious Disease Transmission, Patient-to-Professional|Male|Quarantine|Remote Consultation|SARS-CoV-2|NA",2020-12-07,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04430608,1
33240091,NCT04280705,Challenges for Drug Repurposing in the COVID-19 Pandemic Era.,Journal Article|Review, , ,2020-11-27,Frontiers in pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04280705,3
33240091,NCT04321174,Challenges for Drug Repurposing in the COVID-19 Pandemic Era.,Journal Article|Review, , ,2020-11-27,Frontiers in pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321174,3
33240091,NCT04359329,Challenges for Drug Repurposing in the COVID-19 Pandemic Era.,Journal Article|Review, , ,2020-11-27,Frontiers in pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04359329,1
33240091,NCT04244591,Challenges for Drug Repurposing in the COVID-19 Pandemic Era.,Journal Article|Review, , ,2020-11-27,Frontiers in pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04244591,1
33240091,NCT04304313,Challenges for Drug Repurposing in the COVID-19 Pandemic Era.,Journal Article|Review, , ,2020-11-27,Frontiers in pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04304313,1
33240091,NCT04342663,Challenges for Drug Repurposing in the COVID-19 Pandemic Era.,Journal Article|Review, , ,2020-11-27,Frontiers in pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04342663,2
33240091,NCT04348695,Challenges for Drug Repurposing in the COVID-19 Pandemic Era.,Journal Article|Review, , ,2020-11-27,Frontiers in pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04348695,1
33246499,NCT04429854,"A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.","Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial","Antibodies, Viral|NA","Adult|Antibodies, Viral|Belgium|COVID-19|Combined Modality Therapy|Female|Global Burden of Disease|Hospitalization|Humans|Immunization, Passive|Male|Mortality|Respiration, Artificial|SARS-CoV-2|Safety|Standard of Care|Treatment Outcome|NA",2020-12-07,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04429854,1
33247380,NCT04447534,"Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial.",Journal Article, , ,2020-12-02,Biological trace element research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04447534,1
33249320,NCT04444661,Detraining effects after 18Â months of high intensity resistance training on osteosarcopenia in older men-Six-month follow-up of the randomized controlled Franconian Osteopenia and Sarcopenia Trial (FrOST).,Journal Article, , ,2021-05-07,Bone,Abstract,https://clinicaltrials.gov/ct2/show/NCT04444661,1
33251500,NCT04349592,Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19.,Journal Article, , ,2020-12-18,EClinicalMedicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04349592,1
33257488,NCT04386083,The Philippine <i>C</i>OVID-19 <i>O</i>utcomes: a <i>R</i>etrospective study <i>O</i>f <i>N</i>eurological manifestations and <i>A</i>ssociated symptoms (The Philippine <i>CORONA</i> study): a protocol study.,"Journal Article|Research Support, Non-U.S. Gov't", ,Adult|Aged|COVID-19|Case-Control Studies|Critical Care|Female|Hospitalization|Humans|Male|Middle Aged|Nervous System|Nervous System Diseases|Pandemics|Philippines|Research Design|Respiratory Insufficiency|Retrospective Studies|SARS-CoV-2|Severity of Illness Index|Young Adult|NA,2020-12-11,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04386083,1
33258996,NCT04361877,Altered nutrition behavior during COVID-19 pandemic lockdown in young adults.,Journal Article, , ,2020-12-07,European journal of nutrition,Abstract,https://clinicaltrials.gov/ct2/show/NCT04361877,2
33259326,NCT04445324,Online and Recovery-Oriented Support Groups Facilitated by Peer Support Workers in Times of COVID-19: Protocol for a Feasibility Pre-Post Study.,Journal Article, , ,2020-12-31,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04445324,1
33261718,NCT04405726,"Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.",Journal Article,"Antibodies, Viral|NA","Adult|Aged|Antibodies, Viral|COVID-19|COVID-19 Testing|Case-Control Studies|Family|Female|France|Humans|Immunity, Cellular|Male|Middle Aged|SARS-CoV-2|Seroconversion|Serologic Tests|T-Lymphocytes|NA",2021-01-05,Emerging infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04405726,1
33264556,NCT04315948,Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.,"Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Lopinavir|remdesivir|Adenosine Monophosphate|Hydroxychloroquine|Alanine|Interferon beta-1a|NA,"Adenosine Monophosphate|Aged|Alanine|Antiviral Agents|COVID-19|Drug Therapy, Combination|Female|Hospital Mortality|Hospitalization|Humans|Hydroxychloroquine|Intention to Treat Analysis|Interferon beta-1a|Kaplan-Meier Estimate|Length of Stay|Lopinavir|Male|Middle Aged|Respiration, Artificial|Treatment Failure|NA",2021-02-12,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04315948,3
33270471,NCT04343053,"Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure.",Journal Article, , ,2021-05-10,Platelets,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343053,3
33272319,NCT04395807,Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET).,Comparative Study|Journal Article|Randomized Controlled Trial, ,"Adult|COVID-19|Cannula|Continuous Positive Airway Pressure|Female|Head Protective Devices|Humans|Hypoxia|Male|Oxygen Inhalation Therapy|Positive-Pressure Respiration|Respiration, Artificial|SARS-CoV-2|Sweden|NA",2020-12-14,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04395807,1
33273742,NCT04405739,Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets.,"Journal Article|Research Support, N.I.H., Extramural",Antiviral Agents|Cytokines|Hydroxylamines|remdesivir|Adenosine Monophosphate|Cytidine|Alanine|molnupiravir|NA,"Adenosine Monophosphate|Alanine|Animals|Antiviral Agents|COVID-19|Chlorocebus aethiops|Cytidine|Cytokines|Disease Models, Animal|Disease Transmission, Infectious|Female|Ferrets|Hydroxylamines|Random Allocation|SARS-CoV-2|Vero Cells|NA",2021-01-13,Nature microbiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04405739,1
33273742,NCT04405570,Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets.,"Journal Article|Research Support, N.I.H., Extramural",Antiviral Agents|Cytokines|Hydroxylamines|remdesivir|Adenosine Monophosphate|Cytidine|Alanine|molnupiravir|NA,"Adenosine Monophosphate|Alanine|Animals|Antiviral Agents|COVID-19|Chlorocebus aethiops|Cytidine|Cytokines|Disease Models, Animal|Disease Transmission, Infectious|Female|Ferrets|Hydroxylamines|Random Allocation|SARS-CoV-2|Vero Cells|NA",2021-01-13,Nature microbiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04405570,1
33276318,NCT04645563,Use of WhatsApp for Polyclinic Consultation of Suspected Patients With COVID-19: Retrospective Case Control Study.,Journal Article, ,"Adult|Aged|Aged, 80 and over|COVID-19|Case-Control Studies|Emergency Service, Hospital|Female|Humans|Infectious Disease Transmission, Patient-to-Professional|Length of Stay|Male|Middle Aged|Mobile Applications|Pandemics|Remote Consultation|Retrospective Studies|SARS-CoV-2|Time Factors|NA",2021-01-08,JMIR mHealth and uHealth,Abstract,https://clinicaltrials.gov/ct2/show/NCT04645563,1
33284679,NCT04328961,Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Hydroxychloroquine|NA,"Adolescent|Adult|Aged|Aged, 80 and over|Antiviral Agents|COVID-19|COVID-19 Nucleic Acid Testing|Double-Blind Method|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Post-Exposure Prophylaxis|SARS-CoV-2|Time Factors|Treatment Outcome|United States|Young Adult|NA",2021-03-23,Annals of internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04328961,2
33287790,NCT04558476,A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol.,Clinical Trial Protocol|Journal Article,"Antibodies, Viral|NA","Adult|Antibodies, Viral|Belgium|COVID-19|Clinical Trials, Phase II as Topic|Humans|Immunization, Passive|Intensive Care Units|Multicenter Studies as Topic|Randomized Controlled Trials as Topic|Respiration, Artificial|Severe Acute Respiratory Syndrome|Time Factors|Treatment Outcome|NA",2020-12-21,BMC pulmonary medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04558476,1
33289973,NCT04304053,A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Anti-Infective Agents|Hydroxychloroquine|NA,"Adult|Anti-Infective Agents|COVID-19|Disease Transmission, Infectious|Double-Blind Method|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Patient Compliance|SARS-CoV-2|Treatment Failure|Viral Load|NA",2021-02-09,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04304053,2
33290245,NCT04476667,Using the Online Psychotherapy Tool to Address Mental Health Problems in the Context of the COVID-19 Pandemic: Protocol for an Electronically Delivered Cognitive Behavioral Therapy Program.,Journal Article, , ,2020-12-31,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04476667,1
33293316,NCT04510623,"Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection.","Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't",Angiotensin II Type 1 Receptor Blockers|NA,Angiotensin II Type 1 Receptor Blockers|COVID-19|Humans|Logistic Models|Multicenter Studies as Topic|Pandemics|Pragmatic Clinical Trials as Topic|Prospective Studies|SARS-CoV-2|Treatment Outcome|NA,2020-12-21,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04510623,1
33296868,NCT04502108,"Physical Activity, Nutritional Habits, and Sleep Behavior Among Health Profession Students and Employees of a Swiss University During and After COVID-19 Confinement: Protocol for a Longitudinal Observational Study.",Journal Article, , ,2021-01-01,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04502108,2
33298117,NCT04369378,Effectiveness of using a meditation app in reducing anxiety and improving well-being during the COVID-19 pandemic: A structured summary of a study protocol for a randomized controlled trial.,Letter|Randomized Controlled Trial, ,Adult|Anxiety|COVID-19|Case-Control Studies|Humans|Meditation|Mindfulness|Mobile Applications|SARS-CoV-2|Surveys and Questionnaires|NA,2020-12-21,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04369378,1
33301246,NCT04368728,Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.,"Clinical Trial, Phase II|Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","COVID-19 Vaccines|Vaccines, Synthetic|mRNA Vaccine|BNT162 vaccine|NA","Adolescent|Adult|Aged|COVID-19|COVID-19 Vaccines|Fatigue|Female|Headache|Humans|Immunization, Secondary|Male|Middle Aged|SARS-CoV-2|Single-Blind Method|Treatment Outcome|Vaccines, Synthetic|Young Adult|NA",2021-01-12,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368728,5
33302976,NCT04362059,Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.,Letter|Randomized Controlled Trial,Surface-Active Agents|NA,"Adult|COVID-19|Case-Control Studies|Feasibility Studies|Humans|Intensive Care Units|London|Mortality|Nebulizers and Vaporizers|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Safety|Surface-Active Agents|Treatment Outcome|Ventilation|NA",2020-12-21,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04362059,1
33303470,NCT04348929,Birth experience during COVID-19 confinement (CONFINE): protocol for a multicentre prospective study.,Comparative Study|Journal Article|Multicenter Study, ,"COVID-19|Depression, Postpartum|Female|France|Humans|Parturition|Physical Distancing|Postpartum Period|Pregnancy|Prospective Studies|Psychiatric Status Rating Scales|Research Design|Stress Disorders, Post-Traumatic|Surveys and Questionnaires|Time Factors|NA",2020-12-29,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04348929,1
33303539,NCT04416100,Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial.,"Journal Article|Research Support, Non-U.S. Gov't", , ,2021-05-03,The European respiratory journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04416100,2
33304914,NCT04351906,Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform to Enhance Lung-Protective Ventilation in Hypercapnic Patients With Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome.,Journal Article, , ,2020-12-12,Frontiers in medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04351906,1
33306283,NCT04401579,Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.,"Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Antiviral Agents|Azetidines|Janus Kinase Inhibitors|Purines|Pyrazoles|Sulfonamides|remdesivir|Adenosine Monophosphate|baricitinib|Alanine|NA,"Adenosine Monophosphate|Adult|Aged|Alanine|Antiviral Agents|Azetidines|COVID-19|Double-Blind Method|Drug Therapy, Combination|Female|Hospital Mortality|Hospitalization|Humans|Janus Kinase Inhibitors|Male|Middle Aged|Oxygen Inhalation Therapy|Purines|Pyrazoles|Respiration, Artificial|Sulfonamides|Treatment Outcome|NA",2021-03-08,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04401579,2
33306989,NCT04444674,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.","Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",COVID-19 Vaccines|ChAdOx1 COVID-19 vaccine|NA,Adolescent|Adult|Aged|Brazil|COVID-19|COVID-19 Vaccines|Double-Blind Method|Female|Humans|Male|Middle Aged|Single-Blind Method|South Africa|Treatment Outcome|United Kingdom|Young Adult|NA,2021-02-01,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04444674,3
33306989,NCT04324606,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.","Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",COVID-19 Vaccines|ChAdOx1 COVID-19 vaccine|NA,Adolescent|Adult|Aged|Brazil|COVID-19|COVID-19 Vaccines|Double-Blind Method|Female|Humans|Male|Middle Aged|Single-Blind Method|South Africa|Treatment Outcome|United Kingdom|Young Adult|NA,2021-02-01,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04324606,4
33306989,NCT04400838,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.","Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",COVID-19 Vaccines|ChAdOx1 COVID-19 vaccine|NA,Adolescent|Adult|Aged|Brazil|COVID-19|COVID-19 Vaccines|Double-Blind Method|Female|Humans|Male|Middle Aged|Single-Blind Method|South Africa|Treatment Outcome|United Kingdom|Young Adult|NA,2021-02-01,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04400838,5
33307107,NCT04315480,Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients.,"Clinical Trial, Phase II|Journal Article|Multicenter Study","Antibodies, Monoclonal, Humanized|Biomarkers|Circulating MicroRNA|MIRN146 microRNA, human|MicroRNAs|tocilizumab|NA","Adult|Aged|Antibodies, Monoclonal, Humanized|Biomarkers|COVID-19|Circulating MicroRNA|Female|Humans|Inflammation|Male|MicroRNAs|Middle Aged|Pandemics|SARS-CoV-2|NA",2021-01-12,Mechanisms of ageing and development,Abstract,https://clinicaltrials.gov/ct2/show/NCT04315480,1
33310665,NCT04444531,Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study.,Controlled Clinical Trial|Journal Article,Ozone|NA,"Aged|Aged, 80 and over|Blood Transfusion, Autologous|COVID-19|Female|Humans|Kaplan-Meier Estimate|Male|Middle Aged|Ozone|SARS-CoV-2|Treatment Outcome|NA",2021-01-22,International immunopharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04444531,1
33310814,NCT04369690,"Social, financial and psychological stress during an emerging pandemic: observations from a population survey in the acute phase of COVID-19.",Journal Article|Multicenter Study|Observational Study, ,"Adaptation, Psychological|Adult|Aged|COVID-19|Canada|Cross-Sectional Studies|Employment|Female|Humans|Income|Linear Models|Male|Mental Disorders|Middle Aged|Multivariate Analysis|Pandemics|Prospective Studies|Risk Factors|Social Isolation|Stress, Psychological|Surveys and Questionnaires|NA",2020-12-29,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04369690,1
33329103,NCT04555005,"Implementation of a Mindfulness-Based Crisis Intervention for Frontline Healthcare Workers During the COVID-19 Outbreak in a Public General Hospital in Madrid, Spain.",Journal Article, , ,2020-12-18,Frontiers in psychiatry,Abstract,https://clinicaltrials.gov/ct2/show/NCT04555005,1
33329400,NCT04334291,Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis.,Journal Article, ,"Aged|COVID-19|Female|Follow-Up Studies|Global Health|Hospital Mortality|Hospitalization|Humans|Hypernatremia|Hyponatremia|Male|Middle Aged|Outcome Assessment, Health Care|Prognosis|Registries|Retrospective Studies|SARS-CoV-2|Survival Rate|NA",2021-01-04,Frontiers in endocrinology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04334291,6
33332778,NCT04425629,"REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.","Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|Drug Combinations|Immunologic Factors|casirivimab and imdevimab drug combination|NA","Adult|Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|COVID-19|Double-Blind Method|Drug Combinations|Female|Humans|Immunologic Factors|Least-Squares Analysis|Male|Middle Aged|Outpatients|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Viral Load|NA",2021-02-03,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04425629,1
33332779,NCT04372186,Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|tocilizumab|NA","Adult|Aged|Antibodies, Monoclonal, Humanized|COVID-19|Disease Progression|Female|Hospitalization|Humans|Intention to Treat Analysis|Male|Middle Aged|Pneumonia, Viral|Respiration, Artificial|Survival Rate|NA",2021-01-12,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04372186,1
33335322,NCT04324606,Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.,"Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|COVID-19 Vaccines|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|ChAdOx1 COVID-19 vaccine|NA","Adolescent|Adult|Antibodies, Neutralizing|Antibody Formation|COVID-19|COVID-19 Vaccines|Dose-Response Relationship, Drug|Genetic Vectors|Humans|Immunization, Secondary|Middle Aged|SARS-CoV-2|Spike Glycoprotein, Coronavirus|Time Factors|Young Adult|NA",2021-02-23,Nature medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04324606,4
33335323,NCT04400838,T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.,"Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't","COVID-19 Vaccines|Immunoglobulin A|Immunoglobulin M|Protein Subunits|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|Interferon-gamma|ChAdOx1 COVID-19 vaccine|NA","Adolescent|Antibody Formation|CD4-Positive T-Lymphocytes|CD8-Positive T-Lymphocytes|COVID-19|COVID-19 Vaccines|Dose-Response Relationship, Immunologic|Female|Humans|Immunity, Cellular|Immunity, Humoral|Immunoglobulin A|Immunoglobulin M|Interferon-gamma|Lymphocyte Activation|Male|Middle Aged|Protein Subunits|SARS-CoV-2|Spike Glycoprotein, Coronavirus|T-Lymphocytes|Vaccination|Young Adult|NA",2021-02-23,Nature medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04400838,5
33339541,NCT04412655,Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry.,"Comparative Study|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't", ,Aged|COVID-19|Diabetes Mellitus|Europe|Female|Hospital Mortality|Humans|Hypertension|Male|Middle Aged|Percutaneous Coronary Intervention|Registries|Retrospective Studies|Risk Factors|ST Elevation Myocardial Infarction|Time Factors|Time-to-Treatment|Treatment Outcome|NA,2021-01-06,Cardiovascular diabetology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04412655,2
33342437,NCT04435041,Persistent symptoms after Covid-19: qualitative study of 114 &quot;long Covid&quot; patients and draft quality principles for services.,Journal Article, ,Adult|Aged|COVID-19|Female|Focus Groups|Health Personnel|Health Services Research|Hospitalization|Humans|Male|Middle Aged|Qualitative Research|Quality of Health Care|Time Factors|United Kingdom|NA,2020-12-22,BMC health services research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04435041,2
33347320,NCT04371419,Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities : A Randomized Controlled Trial.,"Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Video-Audio Media", ,"Adult|African Americans|COVID-19|Consumer Health Information|Female|Hispanic Americans|Humans|Incidence|Information Seeking Behavior|Male|Masks|Pandemics|Pneumonia, Viral|Public Health|SARS-CoV-2|Surveys and Questionnaires|Video Recording|NA",2021-04-30,Annals of internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04371419,1
33351775,NCT04492904,"Evaluating the Onset, Severity, and Recovery of Changes to Smell and Taste Associated With COVID-19 Infection in a Singaporean Population (the COVOSMIA-19 Trial): Protocol for a Prospective Case-Control Study.",Journal Article, , ,2021-01-11,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04492904,1
33356051,NCT04501978,A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|Antiviral Agents|Glucocorticoids|remdesivir|Adenosine Monophosphate|bamlanivimab|Alanine|NA","Adenosine Monophosphate|Adult|Aged|Alanine|Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|Antiviral Agents|COVID-19|Double-Blind Method|Drug Therapy, Combination|Female|Glucocorticoids|Hospitalization|Humans|Intention to Treat Analysis|Male|Middle Aged|Treatment Failure|NA",2021-03-23,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04501978,1
33359234,NCT04358380,Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.,Journal Article|Multicenter Study, ,COVID-19|Comorbidity|Female|Hospitalization|Humans|Latin America|Liver Diseases|Liver Function Tests|Male|Middle Aged|Prospective Studies|Risk Factors|SARS-CoV-2|NA,2021-03-10,Annals of hepatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04358380,2
33367731,NCT04579393,Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.,Journal Article,Oxazines|Pyridines|fostamatinib|NA,COVID-19|Extracellular Traps|Humans|Neutrophils|Oxazines|Pyridines|SARS-CoV-2|NA,2021-04-12,The Journal of infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04579393,1
33371905,NCT04344041,COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial.,Journal Article|Multicenter Study|Randomized Controlled Trial,Vitamins|Vitamin D|NA,"Aged|COVID-19|Dietary Supplements|Dose-Response Relationship, Drug|Female|Humans|Male|Nutrition Therapy|Pandemics|Risk Factors|SARS-CoV-2|Time Factors|Treatment Outcome|Vitamin D|Vitamins|NA",2021-01-06,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04344041,1
33377218,NCT04635241,INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies.,Journal Article, , ,2021-01-19,British journal of clinical pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04635241,1
33378609,NCT04470427,Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.,"Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't","COVID-19 Vaccines|Spike Glycoprotein, Coronavirus|mRNA-1273 vaccine|NA","Adolescent|Adult|Aged|COVID-19|COVID-19 Vaccines|Female|Humans|Incidence|Male|Middle Aged|Patient Acuity|SARS-CoV-2|Single-Blind Method|Spike Glycoprotein, Coronavirus|Treatment Outcome|Young Adult|NA",2021-02-09,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04470427,1
33384402,NCT04540029,Measuring the Outcomes of Maternal COVID-19-related Prenatal Exposure (MOM-COPE): study protocol for a multicentric longitudinal project.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|COVID-19|Child Development|DNA Methylation|Female|Humans|Infant|Italy|Longitudinal Studies|Maternal Exposure|Maternal-Fetal Relations|Mothers|Multicenter Studies as Topic|Outcome Assessment, Health Care|Pregnancy|Pregnancy Complications|Research Design|SARS-CoV-2|Stress, Psychological|NA",2021-01-12,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04540029,1
33388386,NCT04344327,Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort.,Journal Article, , ,2021-05-24,Diabetes &amp; metabolism,Abstract,https://clinicaltrials.gov/ct2/show/NCT04344327,1
33392485,NCT04336410,"Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.",Journal Article, , ,2021-01-30,EClinicalMedicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04336410,1
33394942,NCT04381936,Research Priorities for U.K. Pediatric Critical Care in 2019: Healthcare Professionals' and Parents' Perspectives.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Child|Critical Care|Delivery of Health Care|Humans|Intensive Care Units, Pediatric|Parents|Research|United Kingdom|NA",2021-05-19,Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,Abstract,https://clinicaltrials.gov/ct2/show/NCT04381936,4
33395553,NCT04382235,Noninvasive Ventilatory Support of Patients with COVID-19 outside the Intensive Care Units (WARd-COVID).,Journal Article, , ,2021-06-03,Annals of the American Thoracic Society,Abstract,https://clinicaltrials.gov/ct2/show/NCT04382235,1
33397432,NCT04549376,Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial.,Clinical Trial Protocol|Letter,"Anti-Infective Agents, Local|Nasal Sprays|Placebos|Povidone-Iodine|NA","Administration, Intranasal|Adolescent|Adult|Aged|Aged, 80 and over|Anti-Infective Agents, Local|Bangladesh|COVID-19|Clinical Trials, Phase II as Topic|Dose-Response Relationship, Drug|Female|Humans|Male|Middle Aged|Nasal Lavage|Nasal Sprays|Nasopharynx|Placebos|Povidone-Iodine|Randomized Controlled Trials as Topic|SARS-CoV-2|Treatment Outcome|Young Adult|NA",2021-01-12,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04549376,1
33397449,NCT04414631,"Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).",Clinical Trial Protocol|Letter,Complement C1 Inhibitor Protein|Recombinant Proteins|conestat alfa|NA,"Adolescent|Adult|Aged|Aged, 80 and over|Brazil|COVID-19|Clinical Trials, Phase II as Topic|Complement C1 Inhibitor Protein|Drug Administration Schedule|Female|Humans|Injections, Intravenous|Male|Mexico|Middle Aged|Multicenter Studies as Topic|Pilot Projects|Randomized Controlled Trials as Topic|Recombinant Proteins|SARS-CoV-2|Severity of Illness Index|Switzerland|Treatment Outcome|Young Adult|NA",2021-01-12,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04414631,1
33397457,NCT04459286,Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Comparative Study|Letter,"Antiviral Agents|Drug Combinations|RNA, Viral|Thiazoles|Atazanavir Sulfate|Ritonavir|nitazoxanide|NA","Administration, Oral|Adolescent|Adult|Aged|Antiviral Agents|Atazanavir Sulfate|COVID-19|COVID-19 Nucleic Acid Testing|Clinical Trials, Phase II as Topic|Drug Administration Schedule|Drug Combinations|Drug Repositioning|Drug Therapy, Combination|Female|Humans|Male|Middle Aged|Multicenter Studies as Topic|Nigeria|Pilot Projects|RNA, Viral|Randomized Controlled Trials as Topic|Ritonavir|SARS-CoV-2|Severity of Illness Index|Standard of Care|Thiazoles|Treatment Outcome|Viral Load|Young Adult|NA",2021-01-12,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04459286,1
33400164,NCT04463706,Predictors of mortality of COVID-19 in the general population and nursing homes.,Journal Article, , ,2021-01-11,Internal and emergency medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04463706,1
33403367,NCT04345536,Predicting severe COVID-19 in the Emergency Department.,Journal Article, , ,2021-05-25,Resuscitation plus,Abstract,https://clinicaltrials.gov/ct2/show/NCT04345536,1
33406353,NCT04479163,Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.,"Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Immunoglobulin G|NA,"Aged|Aged, 80 and over|Blood Component Transfusion|COVID-19|Disease Progression|Double-Blind Method|Female|Humans|Immunization, Passive|Immunoglobulin G|Intention to Treat Analysis|Kaplan-Meier Estimate|Male|Respiratory Insufficiency|SARS-CoV-2|Severity of Illness Index|NA",2021-02-23,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04479163,2
33407777,NCT04615429,"Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Letter,Antiviral Agents|Biomarkers|NA,"Administration, Intravenous|Adult|Antiviral Agents|Biomarkers|COVID-19|Clinical Trials, Phase II as Topic|Combined Modality Therapy|Double-Blind Method|Female|Humans|Male|Mesenchymal Stem Cell Transplantation|Randomized Controlled Trials as Topic|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|Severity of Illness Index|Spain|Standard of Care|Transplantation, Homologous|NA",2021-01-12,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04615429,1
33415114,NCT04422418,Impact of COVID-19 Pandemic Burnout on Cardiovascular Risk in Healthcare Professionals Study Protocol: A Multicenter Exploratory Longitudinal Study.,Journal Article, , ,2021-01-11,Frontiers in medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04422418,1
33422153,NCT04385121,Psychological effects of remote-only communication among reference persons of ICU patients during COVID-19 pandemic.,Journal Article, , ,2021-01-14,Journal of intensive care,Abstract,https://clinicaltrials.gov/ct2/show/NCT04385121,1
33422263,NCT04338009,"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.","Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|NA,"Aged|Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|COVID-19|Cardiovascular Diseases|Female|Hospitalization|Humans|Male|Middle Aged|Prospective Studies|Respiration, Artificial|SARS-CoV-2|Treatment Outcome|Withholding Treatment|NA",2021-03-19,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04338009,1
33429174,NCT04484493,Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial.,Journal Article|Randomized Controlled Trial,Anti-Inflammatory Agents|Nasal Sprays|Mometasone Furoate|NA,Adolescent|Adult|Age Factors|Anosmia|Anti-Inflammatory Agents|COVID-19|Diabetes Complications|Female|Humans|Male|Middle Aged|Mometasone Furoate|Nasal Sprays|Prospective Studies|Recovery of Function|Visual Analog Scale|Young Adult|NA,2021-03-08,American journal of otolaryngology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04484493,1
33430891,NCT04438980,Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Glucocorticoids|Interleukin-6|C-Reactive Protein|Ferritins|Methylprednisolone|NA,"C-Reactive Protein|COVID-19|Double-Blind Method|Ferritins|Glucocorticoids|Hospitalization|Humans|Infusions, Intravenous|Interleukin-6|Methylprednisolone|Pulse Therapy, Drug|Randomized Controlled Trials as Topic|SARS-CoV-2|Treatment Outcome|NA",2021-01-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04438980,1
33430924,NCT04472728,"Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Letter,"Proto-Oncogene Proteins|Receptors, Coronavirus|Receptors, G-Protein-Coupled|Spike Glycoprotein, Coronavirus|proto-oncogene proteins c-mas-1|spike protein, SARS-CoV-2|Ecdysterone|Angiotensin-Converting Enzyme 2|NA","Aged|Aged, 80 and over|Angiotensin-Converting Enzyme 2|COVID-19|Disease Progression|Double-Blind Method|Ecdysterone|Extracorporeal Membrane Oxygenation|Hospitalization|Humans|Hypoxia|Middle Aged|Mortality|Oxygen Inhalation Therapy|Proto-Oncogene Proteins|Randomized Controlled Trials as Topic|Receptors, Coronavirus|Receptors, G-Protein-Coupled|Renin-Angiotensin System|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Spike Glycoprotein, Coronavirus|Tachypnea|Treatment Outcome|NA",2021-01-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04472728,1
33434221,NCT04389645,Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19.,Clinical Trial|Journal Article|Observational Study,"Biomarkers|CXCL10 protein, human|Chemokine CXCL10|NA","Adult|Aged|Aged, 80 and over|Biomarkers|COVID-19|Chemokine CXCL10|Decision Support Systems, Clinical|Female|Humans|Male|Middle Aged|Practice Guidelines as Topic|NA",2021-01-18,PloS one,Abstract,https://clinicaltrials.gov/ct2/show/NCT04389645,1
33435865,NCT04292964,Clinical characteristics and predictive value of lower CD4<sup>+</sup>T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study.,Journal Article|Multicenter Study|Observational Study, ,Adult|Aged|CD4-Positive T-Lymphocytes|CD8-Positive T-Lymphocytes|COVID-19|Comorbidity|Female|Follow-Up Studies|Hospitalization|Humans|Lymphocyte Count|Male|Middle Aged|Pandemics|Patient Discharge|Prognosis|Retrospective Studies|SARS-CoV-2|NA,2021-01-25,BMC infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04292964,2
33435887,NCT04458337,Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study.,"Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't", ,COVID-19|Cohort Studies|Female|Humans|Male|Middle Aged|Patient Outcome Assessment|Postoperative Complications|Quebec|Survival Analysis|NA,2021-01-27,BMC anesthesiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04458337,1
33435973,NCT04357938,"Ruling out COVID-19 by chest CT at emergency admission when prevalence is low: the prospective, observational SCOUT study.",Journal Article|Observational Study, ,"Aged|Aged, 80 and over|COVID-19|Cohort Studies|Emergency Service, Hospital|Female|Germany|Humans|Male|Middle Aged|Patient Admission|Prevalence|Prospective Studies|Quarantine|Tomography, X-Ray Computed|NA",2021-01-19,Respiratory research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04357938,1
33440088,NCT04436276,Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.,"Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Ad26.COV2.S vaccine|NA","Adolescent|Adult|Antibodies, Neutralizing|Antibodies, Viral|CD4 Lymphocyte Count|CD4-Positive T-Lymphocytes|CD8-Positive T-Lymphocytes|COVID-19|COVID-19 Vaccines|Cohort Studies|Double-Blind Method|Humans|Immunogenicity, Vaccine|Male|Middle Aged|SARS-CoV-2|Young Adult|NA",2021-05-17,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04436276,3
33446655,NCT04368988,SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Spike Glycoprotein, Coronavirus|Vaccines, Subunit|spike glycoprotein, SARS-CoV|Angiotensin-Converting Enzyme 2|NA","Angiotensin-Converting Enzyme 2|Animals|Antibodies, Neutralizing|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Disease Models, Animal|Female|Humans|Male|Mice|Mice, Inbred BALB C|Papio|SARS-CoV-2|Spike Glycoprotein, Coronavirus|T-Lymphocytes|Vaccines, Subunit|NA",2021-01-19,Nature communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368988,3
33452195,NCT04330261,Prospective cohort study of children with suspected SARS-CoV-2 infection presenting to paediatric emergency departments: a Paediatric Emergency Research Networks (PERN) Study Protocol.,"Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't", ,"COVID-19|Child|Emergency Service, Hospital|Hospitalization|Humans|International Cooperation|Pediatric Emergency Medicine|Prospective Studies|Research Design|Risk Factors|SARS-CoV-2|NA",2021-02-01,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04330261,1
33464336,NCT04364893,Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.,Journal Article|Multicenter Study|Pragmatic Clinical Trial|Randomized Controlled Trial,Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|NA,"Aged|Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|COVID-19|Disease Progression|Female|Heart Failure|Hospitalization|Humans|Male|Middle Aged|Myocardial Infarction|Odds Ratio|Patient Discharge|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Sample Size|Shock|Time Factors|Treatment Outcome|Withholding Treatment|NA",2021-01-27,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04364893,1
33465342,NCT04405869,Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With Coronavirus Disease 2019 Pneumonia.,Journal Article, , ,2021-03-12,Chest,Abstract,https://clinicaltrials.gov/ct2/show/NCT04405869,1
33469439,NCT04344145,Mental Health Outcomes in Healthcare Workers in COVID-19 and Non-COVID-19 Care Units: A Cross-Sectional Survey in Belgium.,Journal Article, , ,2021-01-22,Frontiers in psychology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04344145,1
33469542,NCT04346602,Association Between Clinical Characteristics and Short-Term Outcomes in Adult Male COVID-19 Patients With Mild Clinical Symptoms: A Single-Center Observational Study.,Journal Article, , ,2021-01-22,Frontiers in medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04346602,1
33472681,NCT04345523,"Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.",Clinical Trial Protocol|Journal Article, ,"Adult|COVID-19|Clinical Trials, Phase II as Topic|Female|Hospitalization|Humans|Immunization, Passive|Male|Middle Aged|Multicenter Studies as Topic|Randomized Controlled Trials as Topic|SARS-CoV-2|Severity of Illness Index|Standard of Care|Treatment Outcome|NA",2021-01-26,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04345523,2
33472855,NCT04403685,Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Anti-Inflammatory Agents|Antibodies, Monoclonal, Humanized|tocilizumab|NA","Adolescent|Adult|Aged|Aged, 80 and over|Anti-Inflammatory Agents|Antibodies, Monoclonal, Humanized|COVID-19|Critical Illness|Female|Follow-Up Studies|Hospitalization|Humans|Infusions, Intravenous|Male|Middle Aged|Respiration, Artificial|Severity of Illness Index|Treatment Outcome|Young Adult|NA",2021-01-27,BMJ (Clinical research ed.),Abstract,https://clinicaltrials.gov/ct2/show/NCT04403685,1
33475701,NCT04427501,Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.,"Clinical Trial, Phase II|Clinical Trial, Phase III|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|Antiviral Agents|bamlanivimab|etesevimab|NA","Adult|Aged|Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|Antiviral Agents|COVID-19|Dose-Response Relationship, Drug|Double-Blind Method|Drug Therapy, Combination|Female|Hospitalization|Humans|Infusions, Intravenous|Male|Middle Aged|SARS-CoV-2|Severity of Illness Index|Viral Load|NA",2021-02-23,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04427501,2
33480608,NCT04454333,Pain Symptoms in COVID-19.,Journal Article, ,Adult|Aged|COVID-19|Female|Headache|Humans|Low Back Pain|Male|Middle Aged|Myalgia|Neck Pain|Pain Measurement|Physical Examination|Primary Health Care|Retrospective Studies|NA,2021-03-23,American journal of physical medicine &amp; rehabilitation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04454333,1
33482902,NCT04319731,A pilot trial of human amniotic fluid for the treatment of COVID-19.,Clinical Trial|Journal Article,Biomarkers|Inflammation Mediators|NA,Adult|Aged|Amniotic Fluid|Biomarkers|COVID-19|Female|Hospital Mortality|Humans|Inflammation Mediators|Male|Middle Aged|Pilot Projects|Pregnancy|Time Factors|Treatment Outcome|Young Adult|NA,2021-01-27,BMC research notes,Abstract,https://clinicaltrials.gov/ct2/show/NCT04319731,1
33485468,NCT04471519,"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.","Clinical Trial, Phase I|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Immunoglobulin G|Toll-Like Receptor 7|Toll-Like Receptor 8|Vaccines, Inactivated|NA","Adolescent|Adult|Antibodies, Neutralizing|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Double-Blind Method|Female|Humans|Immunoglobulin G|Male|Middle Aged|SARS-CoV-2|Toll-Like Receptor 7|Toll-Like Receptor 8|Vaccination|Vaccines, Inactivated|Young Adult|NA",2021-05-03,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04471519,3
33486496,NCT04273321,"Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial.",Journal Article|Multicenter Study|Randomized Controlled Trial,"Anti-Bacterial Agents|Antiviral Agents|CD3 Complex|Glucocorticoids|RNA, Viral|Methylprednisolone|NA","Adult|Aged|Anti-Bacterial Agents|Antiviral Agents|CD3 Complex|CD8-Positive T-Lymphocytes|COVID-19|COVID-19 Nucleic Acid Testing|Disease Progression|Early Medical Intervention|Extracorporeal Membrane Oxygenation|Female|Glucocorticoids|Hospitalization|Humans|Killer Cells, Natural|Lymphocyte Count|Male|Methylprednisolone|Middle Aged|Oxygen Inhalation Therapy|Patients' Rooms|Pharynx|Proportional Hazards Models|RNA, Viral|Respiration, Artificial|SARS-CoV-2|Single-Blind Method|T-Lymphocyte Subsets|T-Lymphocytes|Time Factors|Treatment Outcome|Virus Shedding|NA",2021-03-12,Respiration; international review of thoracic diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04273321,1
33492523,NCT04351295,Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.,"Clinical Trial, Phase II|Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial",Amides|Antiviral Agents|Pyrazines|Chloroquine|favipiravir|NA,"Adult|Amides|Antiviral Agents|COVID-19|Chloroquine|Female|Humans|Length of Stay|Male|Pyrazines|Respiration, Artificial|SARS-CoV-2|Treatment Outcome|NA",2021-02-22,Archives of virology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04351295,1
33495742,NCT04341038,"Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol.",Journal Article|Review, , ,2021-01-27,Contemporary clinical trials communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04341038,1
33495752,NCT04390022,"The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial.",Journal Article, , ,2021-03-01,EClinicalMedicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04390022,1
33499887,NCT04451174,Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial.,Letter,"RNA, Viral|NA","COVID-19|Critical Care|Hospitalization|Humans|RNA, Viral|Randomized Controlled Trials as Topic|Respiration, Artificial|SARS-CoV-2|Treatment Outcome|NA",2021-02-03,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04451174,1
33502567,NCT04394182,COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): aÂ single institution report of two cases.,Case Reports|Clinical Trial|Journal Article, ,"Aged|Aged, 80 and over|COVID-19|Female|Humans|Male|Preliminary Data|Prospective Studies|Radiotherapy|Radiotherapy Dosage|SARS-CoV-2|Treatment Outcome|NA",2021-05-03,Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],Abstract,https://clinicaltrials.gov/ct2/show/NCT04394182,1
33502773,NCT04362085,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04362085,2
33502773,NCT04373707,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04373707,1
33502773,NCT04354155,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04354155,1
33502773,NCT04359212,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04359212,1
33502773,NCT04372589,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04372589,3
33502773,NCT04401293,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04401293,2
33502773,NCT04416048,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04416048,1
33502773,NCT04366960,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04366960,2
33502773,NCT04368377,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368377,1
33502773,NCT04397510,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04397510,1
33502773,NCT04359277,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04359277,1
33502773,NCT04393805,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04393805,1
33502773,NCT04394377,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04394377,1
33502773,NCT04360824,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04360824,1
33502773,NCT04367831,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04367831,2
33502773,NCT04345848,Prophylactic anticoagulants for people hospitalised with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Anticoagulants|NA,Aged|Anticoagulants|Bias|COVID-19|Cause of Death|Hemorrhage|Hospitalization|Humans|Middle Aged|Retrospective Studies|SARS-CoV-2|Thromboembolism|NA,2021-02-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04345848,2
33505321,NCT04647604,Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the <i>COVID-Omega-F</i> Trial.,Journal Article|Review, , ,2021-01-30,Frontiers in physiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04647604,1
33516247,NCT04359836,Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing.,Journal Article, , ,2021-02-06,Gut pathogens,Abstract,https://clinicaltrials.gov/ct2/show/NCT04359836,1
33519339,NCT04347681,Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia.,Journal Article, , ,2021-02-02,Saudi journal of medicine &amp; medical sciences,Abstract,https://clinicaltrials.gov/ct2/show/NCT04347681,2
33522946,NCT04411446,High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).,Clinical Trial Protocol|Letter,Vitamins|Cholecalciferol|NA,"Aged|Aged, 80 and over|Argentina|COVID-19|Cholecalciferol|Double-Blind Method|Female|Humans|Male|Middle Aged|Multicenter Studies as Topic|Pandemics|Patient Admission|Pragmatic Clinical Trials as Topic|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Treatment Outcome|Vitamins|NA",2021-02-19,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04411446,1
33524311,NCT04405908,"Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.","Clinical Trial, Phase I|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Adjuvants, Immunologic|Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Immunoglobulin G|Protein Subunits|Vaccines, Subunit|NA","Adjuvants, Immunologic|Adult|Aged|Antibodies, Neutralizing|Antibodies, Viral|Australia|COVID-19|COVID-19 Vaccines|Double-Blind Method|Female|Humans|Immunogenicity, Vaccine|Immunoglobulin G|Male|Middle Aged|Protein Subunits|SARS-CoV-2|Vaccines, Subunit|NA",2021-02-26,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04405908,1
33524316,NCT04505722,SARS-CoV-2 evolution and vaccines: cause for concern?,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Viral|COVID-19 Vaccines|RNA, Viral|Spike Glycoprotein, Coronavirus|Vaccines, Synthetic|spike protein, SARS-CoV-2|NA","Antibodies, Viral|COVID-19|COVID-19 Vaccines|Humans|Immunogenicity, Vaccine|Mutation Rate|Pandemics|RNA, Viral|SARS-CoV-2|Sequence Analysis, RNA|Spike Glycoprotein, Coronavirus|Treatment Outcome|Vaccines, Synthetic|NA",2021-04-13,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04505722,2
33524462,NCT04371744,Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study.,Journal Article|Observational Study,Hydroxychloroquine|Azithromycin|NA,"Adult|Arrhythmias, Cardiac|Artificial Intelligence|Azithromycin|COVID-19|Electrocardiography|Female|Humans|Hydroxychloroquine|Long QT Syndrome|Male|Middle Aged|Pandemics|NA",2021-04-23,International journal of cardiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04371744,1
33524990,NCT04368728,BNT162b vaccines protect rhesus macaques from SARS-CoV-2.,Journal Article,"Antibodies, Neutralizing|Antibodies, Viral|Antigens, Viral|COVID-19 Vaccines|RNA, Viral|Spike Glycoprotein, Coronavirus|Vaccines, Synthetic|mRNA Vaccine|spike protein, SARS-CoV-2|BNT162 vaccine|NA","Aging|Animals|Antibodies, Neutralizing|Antibodies, Viral|Antigens, Viral|COVID-19|COVID-19 Vaccines|Cell Line|Clinical Trials as Topic|Disease Models, Animal|Female|Humans|Immunization, Passive|Internationality|Macaca mulatta|Male|Mice|Mice, Inbred BALB C|Models, Molecular|Protein Multimerization|RNA, Viral|Respiratory System|SARS-CoV-2|Solubility|Spike Glycoprotein, Coronavirus|T-Lymphocytes|Vaccination|Vaccines, Synthetic|NA",2021-04-14,Nature,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368728,5
33524990,NCT04380701,BNT162b vaccines protect rhesus macaques from SARS-CoV-2.,Journal Article,"Antibodies, Neutralizing|Antibodies, Viral|Antigens, Viral|COVID-19 Vaccines|RNA, Viral|Spike Glycoprotein, Coronavirus|Vaccines, Synthetic|mRNA Vaccine|spike protein, SARS-CoV-2|BNT162 vaccine|NA","Aging|Animals|Antibodies, Neutralizing|Antibodies, Viral|Antigens, Viral|COVID-19|COVID-19 Vaccines|Cell Line|Clinical Trials as Topic|Disease Models, Animal|Female|Humans|Immunization, Passive|Internationality|Macaca mulatta|Male|Mice|Mice, Inbred BALB C|Models, Molecular|Protein Multimerization|RNA, Viral|Respiratory System|SARS-CoV-2|Solubility|Spike Glycoprotein, Coronavirus|T-Lymphocytes|Vaccination|Vaccines, Synthetic|NA",2021-04-14,Nature,Abstract,https://clinicaltrials.gov/ct2/show/NCT04380701,1
33532807,NCT04334954,Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States.,Preprint, , ,2021-02-11,medRxiv : the preprint server for health sciences,Abstract,https://clinicaltrials.gov/ct2/show/NCT04334954,1
33534266,NCT04462393,National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|COVID-19|Cohort Studies|Female|Hospital Mortality|Humans|Intensive Care Units|Italy|Male|Middle Aged|Patient Admission|Prospective Studies|Registries|SARS-CoV-2|Sweden|NA",2021-03-16,European journal of anaesthesiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04462393,1
33538761,NCT04371965,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial.","Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Anti-Infective Agents, Local|Mouthwashes|Nasal Sprays|Povidone-Iodine|Thyrotropin|NA","Aged|Anti-Infective Agents, Local|COVID-19|Female|Humans|Male|Middle Aged|Mouthwashes|Nasal Sprays|Nasopharynx|Povidone-Iodine|SARS-CoV-2|Thyrotropin|Viral Load|NA",2021-04-26,JAMA otolaryngology-- head &amp; neck surgery,Abstract,https://clinicaltrials.gov/ct2/show/NCT04371965,1
33545083,NCT04411784,"Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.",Journal Article|Multicenter Study|Observational Study, ,"Acute Disease|Adult|COVID-19|Case-Control Studies|Cohort Studies|Colectomy|Colitis, Ulcerative|Colonoscopy|Female|Humans|Male|Middle Aged|Severity of Illness Index|NA",2021-04-08,The lancet. Gastroenterology &amp; hepatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04411784,1
33545094,NCT04530396,Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.,"Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Viral|COVID-19 Vaccines|Spike Glycoprotein, Coronavirus|Vaccines, Synthetic|NA","Adult|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Double-Blind Method|Female|Humans|Immunization, Secondary|Injections, Intramuscular|Male|Middle Aged|Moscow|Spike Glycoprotein, Coronavirus|Vaccines, Synthetic|NA",2021-02-26,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04530396,1
33547300,NCT04275414,Efficacy and tolerability of bevacizumab in patients with severe Covid-19.,"Clinical Trial|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't",Angiogenesis Inhibitors|Bevacizumab|NA,Aged|Angiogenesis Inhibitors|Bevacizumab|Body Temperature|COVID-19|China|Female|Fever|Humans|Italy|Male|Middle Aged|SARS-CoV-2|Treatment Outcome|NA,2021-02-22,Nature communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04275414,1
33548194,NCT04383574,"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.","Journal Article|Research Support, Non-U.S. Gov't", , ,2021-06-01,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04383574,1
33555436,NCT04334291,"Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart.",Comparative Study|Journal Article|Multicenter Study|Observational Study,Antiviral Agents|NA,"Adult|Age Factors|Aged|Aged, 80 and over|Aging|Antiviral Agents|COVID-19|Comorbidity|Female|Humans|Male|Middle Aged|Registries|Retrospective Studies|SARS-CoV-2|Treatment Outcome|Young Adult|NA",2021-04-26,Clinical and experimental medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04334291,6
33555777,NCT04323787,Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry.,Journal Article|Multicenter Study|Observational Study,Vasoconstrictor Agents|NA,"Adult|Aged|COVID-19|Critical Care Outcomes|Extracorporeal Membrane Oxygenation|Female|Hospital Mortality|Hospitalization|Humans|Length of Stay|Male|Middle Aged|Patient Discharge|Registries|Renal Replacement Therapy|Respiration, Artificial|Vasoconstrictor Agents|NA",2021-03-04,Critical care medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04323787,2
33555780,NCT04350723,Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.,"Journal Article|Research Support, U.S. Gov't, Non-P.H.S.",Adrenal Cortex Hormones|Anticoagulants|remdesivir|Adenosine Monophosphate|Hydroxychloroquine|Dexamethasone|Alanine|NA,"Adenosine Monophosphate|Adrenal Cortex Hormones|Alanine|Anticoagulants|COVID-19|Critical Care|Dexamethasone|Disease Management|Evidence-Based Medicine|Hemodynamics|Humans|Hydroxychloroquine|Immunization, Passive|Intensive Care Units|Patient Positioning|Practice Guidelines as Topic|Ventilation|NA",2021-03-04,Critical care medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04350723,1
33556319,NCT04354259,"Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.","Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antiviral Agents|Interleukins|RNA, Viral|peginterferon lambda-1a|Polyethylene Glycols|NA","Ambulatory Care|Antiviral Agents|COVID-19|Double-Blind Method|Drug Monitoring|Female|Humans|Intention to Treat Analysis|Interleukins|Male|Middle Aged|Polyethylene Glycols|RNA, Viral|SARS-CoV-2|Severity of Illness Index|Treatment Outcome|Viral Load|Virus Shedding|NA",2021-05-13,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04354259,3
33557591,NCT04521309,Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma.,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Viral|Caprylates|Immunoglobulins, Intravenous|NA","Antibodies, Viral|COVID-19|Caprylates|Chemical Fractionation|Humans|Immunization, Passive|Immunoglobulins, Intravenous|SARS-CoV-2|NA",2021-02-18,Immunotherapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04521309,2
33562419,NCT04568525,Passive Microwave Radiometry for the Diagnosis of Coronavirus Disease 2019 Lung Complications in Kyrgyzstan.,Journal Article, , ,2021-03-16,"Diagnostics (Basel, Switzerland)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04568525,1
33567087,NCT04533360,The seroprevalence of SARS-CoV-2 in a rural southwest community.,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Viral|NA","Adult|Antibodies, Viral|Arizona|COVID-19|COVID-19 Serological Testing|Female|Health Personnel|Humans|Male|Middle Aged|Prospective Studies|Retrospective Studies|Rural Population|SARS-CoV-2|Seroepidemiologic Studies|Socioeconomic Factors|NA",2021-02-22,Journal of osteopathic medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04533360,1
33568226,NCT04473261,A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Capsules|Iodine Compounds|Oral Sprays|Polymers|NA,Adult|COVID-19|Capsules|Female|Humans|Iodine Compounds|Male|Oral Sprays|Pakistan|Patient Admission|Polymers|Randomized Controlled Trials as Topic|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Severity of Illness Index|Treatment Outcome|NA,2021-02-19,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04473261,1
33568628,NCT04288102,"Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.","Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't", ,Aged|Allografts|COVID-19|Double-Blind Method|Female|Humans|Male|Mesenchymal Stem Cell Transplantation|Mesenchymal Stem Cells|Middle Aged|SARS-CoV-2|Treatment Outcome|Umbilical Cord|NA,2021-02-22,Signal transduction and targeted therapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04288102,1
33570583,NCT04308668,Nutritional perspectives for the prevention and mitigation of COVID-19.,Journal Article|Systematic Review,Micronutrients|Trace Elements|Vitamin A|Iron|Selenium|Zinc|NA,COVID-19|Diet|Dietary Supplements|Humans|Immune System|Iron|Micronutrients|Nutrition Therapy|Nutritional Status|Selenium|Trace Elements|Vitamin A|Zinc|NA,2021-03-01,Nutrition reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04308668,4
33570583,NCT04303507,Nutritional perspectives for the prevention and mitigation of COVID-19.,Journal Article|Systematic Review,Micronutrients|Trace Elements|Vitamin A|Iron|Selenium|Zinc|NA,COVID-19|Diet|Dietary Supplements|Humans|Immune System|Iron|Micronutrients|Nutrition Therapy|Nutritional Status|Selenium|Trace Elements|Vitamin A|Zinc|NA,2021-03-01,Nutrition reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04303507,1
33570583,NCT04312243,Nutritional perspectives for the prevention and mitigation of COVID-19.,Journal Article|Systematic Review,Micronutrients|Trace Elements|Vitamin A|Iron|Selenium|Zinc|NA,COVID-19|Diet|Dietary Supplements|Humans|Immune System|Iron|Micronutrients|Nutrition Therapy|Nutritional Status|Selenium|Trace Elements|Vitamin A|Zinc|NA,2021-03-01,Nutrition reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04312243,1
33570583,NCT04321174,Nutritional perspectives for the prevention and mitigation of COVID-19.,Journal Article|Systematic Review,Micronutrients|Trace Elements|Vitamin A|Iron|Selenium|Zinc|NA,COVID-19|Diet|Dietary Supplements|Humans|Immune System|Iron|Micronutrients|Nutrition Therapy|Nutritional Status|Selenium|Trace Elements|Vitamin A|Zinc|NA,2021-03-01,Nutrition reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321174,3
33570583,NCT04304053,Nutritional perspectives for the prevention and mitigation of COVID-19.,Journal Article|Systematic Review,Micronutrients|Trace Elements|Vitamin A|Iron|Selenium|Zinc|NA,COVID-19|Diet|Dietary Supplements|Humans|Immune System|Iron|Micronutrients|Nutrition Therapy|Nutritional Status|Selenium|Trace Elements|Vitamin A|Zinc|NA,2021-03-01,Nutrition reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04304053,2
33570583,NCT04251871,Nutritional perspectives for the prevention and mitigation of COVID-19.,Journal Article|Systematic Review,Micronutrients|Trace Elements|Vitamin A|Iron|Selenium|Zinc|NA,COVID-19|Diet|Dietary Supplements|Humans|Immune System|Iron|Micronutrients|Nutrition Therapy|Nutritional Status|Selenium|Trace Elements|Vitamin A|Zinc|NA,2021-03-01,Nutrition reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04251871,2
33570583,NCT04318444,Nutritional perspectives for the prevention and mitigation of COVID-19.,Journal Article|Systematic Review,Micronutrients|Trace Elements|Vitamin A|Iron|Selenium|Zinc|NA,COVID-19|Diet|Dietary Supplements|Humans|Immune System|Iron|Micronutrients|Nutrition Therapy|Nutritional Status|Selenium|Trace Elements|Vitamin A|Zinc|NA,2021-03-01,Nutrition reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318444,1
33571450,NCT04413968,"SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.","Clinical Trial|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't","Antibodies, Viral|Immunoglobulin G|Immunoglobulin M|NA","Adult|Antibodies, Viral|COVID-19|Child Day Care Centers|Child, Preschool|Cross-Sectional Studies|France|Humans|Immunoassay|Immunoglobulin G|Immunoglobulin M|Infant|SARS-CoV-2|Seroepidemiologic Studies|NA",2021-04-02,The Lancet. Child &amp; adolescent health,Abstract,https://clinicaltrials.gov/ct2/show/NCT04413968,1
33573681,NCT04609865,Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Voltage-Gated Sodium Channel Blockers|Lidocaine|NA,"Administration, Intravenous|COVID-19|Clinical Trials, Phase III as Topic|Equivalence Trials as Topic|Humans|Inflammation|Lidocaine|Pulmonary Gas Exchange|Randomized Controlled Trials as Topic|Respiratory Distress Syndrome|SARS-CoV-2|Treatment Outcome|Voltage-Gated Sodium Channel Blockers|NA",2021-02-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04609865,1
33573885,NCT04379440,Assessing the impact of COVID-19 on the health of geriatric patients: The European GeroCovid Observational Study.,Journal Article|Multicenter Study|Observational Study, ,"Adult|Aged|Aged, 80 and over|COVID-19|Female|Humans|Italy|Male|Middle Aged|Norway|Retrospective Studies|SARS-CoV-2|Spain|Treatment Outcome|NA",2021-05-11,European journal of internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04379440,2
33573928,NCT04383678,Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19.,Journal Article|Multicenter Study|Observational Study, ,Adult|COVID-19|Extracorporeal Membrane Oxygenation|Female|Humans|Middle Aged|Respiratory Distress Syndrome|Retrospective Studies|SARS-CoV-2|NA,2021-06-02,Journal of cardiothoracic and vascular anesthesia,Abstract,https://clinicaltrials.gov/ct2/show/NCT04383678,1
33574155,NCT04497389,"Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial.","Clinical Trial Protocol|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Biological Products|C-Reactive Protein|NA,Amniotic Fluid|Biological Products|C-Reactive Protein|COVID-19|Double-Blind Method|Feasibility Studies|Humans|Inflammation|Pilot Projects|Randomized Controlled Trials as Topic|Treatment Outcome|NA,2021-02-25,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04497389,1
33576820,NCT04342728,Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.,Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial,Antioxidants|Gluconates|Trace Elements|Zinc|Ascorbic Acid|gluconic acid|NA,Adult|Ambulatory Care|Antioxidants|Ascorbic Acid|COVID-19|Cough|Dietary Supplements|Dyspnea|Fatigue|Female|Fever|Gluconates|Humans|Male|Middle Aged|SARS-CoV-2|Severity of Illness Index|Standard of Care|Trace Elements|Treatment Outcome|Zinc|NA,2021-02-25,JAMA network open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04342728,1
33579579,NCT04471701,Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey.,Journal Article, ,"Aged|Aged, 80 and over|COVID-19|COVID-19 Testing|Humans|Internet|SARS-CoV-2|Surveys and Questionnaires|NA",2021-04-20,European journal of internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04471701,3
33580261,NCT04411576,High amounts of SARS-CoV-2 precede sickness among asymptomatic healthcare workers.,Journal Article, , ,2021-03-05,The Journal of infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04411576,2
33583027,NCT04509973,Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis.,Clinical Trial Protocol|Comparative Study|Journal Article,Dexamethasone|NA,Bayes Theorem|COVID-19|Dexamethasone|Humans|Hypoxia|Randomized Controlled Trials as Topic|SARS-CoV-2|NA,2021-05-03,Acta anaesthesiologica Scandinavica,Abstract,https://clinicaltrials.gov/ct2/show/NCT04509973,1
33585031,NCT04730323,"&quot;Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience&quot;, a retrospective study-original article.",Journal Article, , ,2021-03-23,Annals of medicine and surgery (2012),Abstract,https://clinicaltrials.gov/ct2/show/NCT04730323,1
33585799,NCT04569188,Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial.,Journal Article, , ,2021-05-04,"Mayo Clinic proceedings. Innovations, quality &amp; outcomes",Abstract,https://clinicaltrials.gov/ct2/show/NCT04569188,1
33591017,NCT04401293,d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019.,Journal Article|Multicenter Study,Biomarkers|Fibrin Fibrinogen Degradation Products|fibrin fragment D|NA,Aged|Biomarkers|COVID-19|Cohort Studies|Critical Illness|Female|Fibrin Fibrinogen Degradation Products|Hospital Mortality|Humans|Intensive Care Units|Male|Middle Aged|SARS-CoV-2|Severity of Illness Index|Thrombophilia|United States|NA,2021-04-28,Critical care medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04401293,2
33592888,NCT04479150,Postoperative complications and mortality following emergency digestive surgery during the COVID-19 pandemic: A multicenter collaborative retrospective cohort study protocol (COVID-CIR).,Journal Article, ,Adult|COVID-19|Digestive System Diseases|Digestive System Surgical Procedures|Emergencies|Emergency Treatment|Female|Humans|Incidence|Infection Control|Male|Mortality|Multicenter Studies as Topic|Observational Studies as Topic|Postoperative Complications|Research Design|Risk Assessment|Time-to-Treatment|NA,2021-02-22,Medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04479150,1
33595634,NCT04449718,Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Vitamins|Vitamin D|Cholecalciferol|25-hydroxyvitamin D|NA,"Adult|Brazil|COVID-19|Cholecalciferol|Double-Blind Method|Female|Hospital Mortality|Humans|Intensive Care Units|Length of Stay|Male|Middle Aged|Respiration, Artificial|Treatment Failure|Vitamin D|Vitamin D Deficiency|Vitamins|NA",2021-03-23,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04449718,2
33596161,NCT04363333,"Effect of High-Risk Obstructive Sleep Apnea on Clinical Outcomes in Adults with Coronavirus Disease 2019: A Multicenter, Prospective, Observational Cohort Study.",Journal Article, , ,2021-02-17,Annals of the American Thoracic Society,Abstract,https://clinicaltrials.gov/ct2/show/NCT04363333,1
33596668,NCT04314232,"SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.","Journal Article|Observational Study|Research Support, Non-U.S. Gov't","Biomarkers|Fibrin Fibrinogen Degradation Products|Interleukin-6|Peptide Fragments|Procalcitonin|Troponin T|fibrin fragment D|pro-brain natriuretic peptide (1-76)|Natriuretic Peptide, Brain|C-Reactive Protein|Ferritins|NA","Biomarkers|C-Reactive Protein|COVID-19|Correlation of Data|Female|Ferritins|Fibrin Fibrinogen Degradation Products|Humans|Inflammation|Interleukin-6|Male|Middle Aged|Natriuretic Peptide, Brain|Norway|Peptide Fragments|Procalcitonin|SARS-CoV-2|Troponin T|Viremia|NA",2021-05-13,Journal of the American Heart Association,Abstract,https://clinicaltrials.gov/ct2/show/NCT04314232,2
33596889,NCT04595123,Impact of the Covid-19 pandemic on perinatal mental health (Riseup-PPD-COVID-19): protocol for an international prospective cohort study.,Journal Article|Observational Study, ,Adult|COVID-19|Europe|Female|Global Health|Humans|Mental Disorders|Postpartum Period|Pregnancy|Pregnant Women|Prospective Studies|Protective Factors|Research Design|Risk Factors|NA,2021-02-24,BMC public health,Abstract,https://clinicaltrials.gov/ct2/show/NCT04595123,1
33597145,NCT04426084,Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation.,"Journal Article|Observational Study|Research Support, Non-U.S. Gov't",Angiotensin Receptor Antagonists|NA,"Adult|Aged|Aged, 80 and over|Angiotensin Receptor Antagonists|COVID-19|Case-Control Studies|Diabetes Mellitus, Type 2|Female|Hospitalization|Humans|Hypertension|Male|Middle Aged|Obesity|Renal Insufficiency, Chronic|Respiration, Artificial|Risk Factors|Young Adult|NA",2021-02-25,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04426084,1
33599800,NCT04324736,Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study.,"Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't", ,"Aged|Aged, 80 and over|COVID-19|Diabetes Complications|Diabetes Mellitus|Female|Follow-Up Studies|France|Hospital Mortality|Hospitalization|Humans|Length of Stay|Male|Middle Aged|Patient Discharge|Prognosis|Respiration, Artificial|Retrospective Studies|Risk Factors|SARS-CoV-2|NA",2021-03-17,Diabetologia,Abstract,https://clinicaltrials.gov/ct2/show/NCT04324736,3
33603701,NCT04433260,"Early and Mid-Term Implications of the COVID-19 Pandemic on the Physical, Behavioral and Mental Health of Healthcare Professionals: The CoPE-HCP Study Protocol.",Journal Article, , ,2021-02-20,Frontiers in psychology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04433260,1
33608030,NCT04343053,Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients.,"Journal Article|Research Support, Non-U.S. Gov't","Antigens, Neoplasm|Biomarkers|E-Selectin|ICAM1 protein, human|P-Selectin|SELE protein, human|VCAN protein, human|VPS51 protein, human|Vesicular Transport Proteins|Intercellular Adhesion Molecule-1|Versicans|MOK protein, human|Mitogen-Activated Protein Kinases|NA","Aged|Antigens, Neoplasm|Area Under Curve|Biomarkers|COVID-19|Cohort Studies|E-Selectin|Female|Humans|Intensive Care Units|Intercellular Adhesion Molecule-1|Lung Injury|Male|Middle Aged|Mitogen-Activated Protein Kinases|P-Selectin|Prospective Studies|ROC Curve|Respiration, Artificial|Respiratory Distress Syndrome|Versicans|Vesicular Transport Proteins|NA",2021-03-03,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04343053,3
33617777,NCT04400838,Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't",COVID-19 Vaccines|ChAdOx1 COVID-19 vaccine|NA,"Adolescent|Adult|Aged|Antibody Formation|Asymptomatic Infections|COVID-19|COVID-19 Vaccines|Humans|Immunization Schedule|Immunization, Secondary|Middle Aged|Randomized Controlled Trials as Topic|SARS-CoV-2|Young Adult|NA",2021-03-17,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04400838,5
33617777,NCT04324606,Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't",COVID-19 Vaccines|ChAdOx1 COVID-19 vaccine|NA,"Adolescent|Adult|Aged|Antibody Formation|Asymptomatic Infections|COVID-19|COVID-19 Vaccines|Humans|Immunization Schedule|Immunization, Secondary|Middle Aged|Randomized Controlled Trials as Topic|SARS-CoV-2|Young Adult|NA",2021-03-17,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04324606,4
33617777,NCT04444674,Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't",COVID-19 Vaccines|ChAdOx1 COVID-19 vaccine|NA,"Adolescent|Adult|Aged|Antibody Formation|Asymptomatic Infections|COVID-19|COVID-19 Vaccines|Humans|Immunization Schedule|Immunization, Secondary|Middle Aged|Randomized Controlled Trials as Topic|SARS-CoV-2|Young Adult|NA",2021-03-17,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04444674,3
33617781,NCT04340921,Delayed-onset myocarditis following COVID-19.,"Letter|Research Support, Non-U.S. Gov't","Biomarkers|RNA, Viral|NA","Adult|Biomarkers|COVID-19|COVID-19 Nucleic Acid Testing|Female|Humans|Magnetic Resonance Imaging|Male|Middle Aged|Myocarditis|RNA, Viral|SARS-CoV-2|Shock, Cardiogenic|Systemic Inflammatory Response Syndrome|Time Factors|Young Adult|NA",2021-04-13,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04340921,1
33621601,NCT04365127,"Progesterone in Addition to Standard of Care vsÂ Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19: A Randomized, Controlled Pilot Trial.",Journal Article, , ,2021-04-01,Chest,Abstract,https://clinicaltrials.gov/ct2/show/NCT04365127,1
33625799,NCT04610554,Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19.,Journal Article,Nitric Oxide|Carbon Monoxide|NA,"COVID-19|Carbon Monoxide|Female|Humans|Lung|Male|Middle Aged|Nitric Oxide|Pulmonary Diffusing Capacity|Radiography, Thoracic|Respiratory Function Tests|Severity of Illness Index|NA",2021-03-08,Physiological reports,Abstract,https://clinicaltrials.gov/ct2/show/NCT04610554,1
33627169,NCT04424992,Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak.,"Journal Article|Observational Study|Research Support, Non-U.S. Gov't", ,"Aged|COVID-19|Continuous Positive Airway Pressure|Disease Outbreaks|Feasibility Studies|Female|Humans|Hypoxia|Intensive Care Units|Male|Middle Aged|Noninvasive Ventilation|Pneumonia, Viral|Treatment Outcome|NA",2021-03-01,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04424992,1
33627313,NCT04318366,Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study.,Journal Article|Multicenter Study, ,"Aged|COVID-19|Colitis, Ischemic|Cross-Sectional Studies|Duodenum|Endoscopy, Gastrointestinal|Female|Gastric Mucosa|Gastrointestinal Hemorrhage|Humans|Male|Middle Aged|Pandemics|Prospective Studies|Risk Factors|SARS-CoV-2|Stomach Ulcer|NA",2021-03-12,BMJ open gastroenterology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
33627448,NCT04542915,COVID-19 Prevalence and Related Practices among Dental Hygienists in the United States.,Journal Article, ,COVID-19|Dental Hygienists|Humans|Pandemics|Prevalence|SARS-CoV-2|United States|NA,2021-02-26,Journal of dental hygiene : JDH,Abstract,https://clinicaltrials.gov/ct2/show/NCT04542915,1
33629225,NCT04557046,"A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study.",Journal Article, , ,2021-05-13,Infectious diseases and therapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04557046,1
33630747,NCT04502108,"Physical Activity, Nutritional Habits, and Sleeping Behavior in Students and Employees of a Swiss University During the COVID-19 Lockdown Period: Questionnaire Survey Study.",Journal Article, ,Adult|COVID-19|Exercise|Faculty|Feeding Behavior|Female|Humans|Male|Quarantine|Sleep|Students|Surveys and Questionnaires|Switzerland|Universities|Young Adult|NA,2021-04-20,JMIR public health and surveillance,Abstract,https://clinicaltrials.gov/ct2/show/NCT04502108,2
33631066,NCT04320615,Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.,"Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|Receptors, Interleukin-6|tocilizumab|NA","Adult|Aged|Antibodies, Monoclonal, Humanized|COVID-19|Double-Blind Method|Female|Hospital Mortality|Hospitalization|Humans|Infusions, Intravenous|Intensive Care Units|Male|Middle Aged|Receptors, Interleukin-6|Respiration, Artificial|Treatment Failure|NA",2021-04-26,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04320615,1
33631357,NCT04366050,"RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19.","Clinical Trial Protocol|Journal Article|Research Support, N.I.H., Extramural",Angiotensin-Converting Enzyme Inhibitors|Biomarkers|Ramipril|NA,"Adult|Angiotensin-Converting Enzyme Inhibitors|Biomarkers|COVID-19|Critical Care|Disease Transmission, Infectious|Double-Blind Method|Female|Humans|Male|Mortality|Ramipril|Randomized Controlled Trials as Topic|Respiration, Artificial|SARS-CoV-2|Treatment Outcome|NA",2021-05-13,Contemporary clinical trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04366050,1
33632171,NCT04377815,"Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.",Journal Article,"Antibodies, Viral|Immunoglobulin M|NA","Adult|Ageusia|Antibodies, Viral|COVID-19|Cohort Studies|Female|Humans|Immunoglobulin M|London|Male|Middle Aged|Olfaction Disorders|SARS-CoV-2|Sex Factors|Smell|Surveys and Questionnaires|Treatment Outcome|NA",2021-03-10,BMC infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04377815,2
33636568,NCT04407260,"The use of oxygen hoods in patients failing on conventional high-flow oxygen delivery systems, the effects on oxygenation, mechanical ventilation and mortality rates in hypoxic patients with COVID-19. A Prospective Controlled Cohort Study.",Journal Article|Randomized Controlled Trial, ,"Adult|Aged|Aged, 80 and over|COVID-19|Equipment Failure|Female|Humans|Hypoxia|Male|Middle Aged|Oxygen Consumption|Oxygen Inhalation Therapy|Pandemics|Prognosis|Prospective Studies|Respiration, Artificial|Survival Rate|Treatment Failure|United States|NA",2021-03-31,Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04407260,1
33638057,NCT04719234,Comparison of lung ultrasonography findings with chest computed tomography results in coronavirus (COVID-19) pneumonia.,Comparative Study|Journal Article, ,"COVID-19|Female|Humans|Lung|Male|Middle Aged|Prospective Studies|Tomography, X-Ray Computed|Ultrasonography|NA",2021-05-19,Journal of medical ultrasonics (2001),Abstract,https://clinicaltrials.gov/ct2/show/NCT04719234,1
33647225,NCT04344587,Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) Study Protocol.,Journal Article, , ,2021-03-01,Annals of the American Thoracic Society,Abstract,https://clinicaltrials.gov/ct2/show/NCT04344587,1
33648555,NCT04380909,An internet-based self-help intervention for people with psychological distress due to COVID-19: study protocol for a randomized controlled trial.,Clinical Trial Protocol|Journal Article, ,"Anxiety|COVID-19|Depression|Emotional Regulation|Humans|Internet-Based Intervention|Loneliness|Optimism|Patient Health Questionnaire|Patient Satisfaction|Pessimism|Psychological Distress|Quality of Life|Randomized Controlled Trials as Topic|Resilience, Psychological|SARS-CoV-2|Self Care|Self Efficacy|Self-Management|Stress, Psychological|Suicidal Ideation|NA",2021-03-12,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04380909,1
33648563,NCT04350580,Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.,Clinical Trial Protocol|Journal Article,"Immunoglobulins, Intravenous|Immunologic Factors|NA","Activities of Daily Living|COVID-19|Clinical Trials, Phase III as Topic|Double-Blind Method|Early Medical Intervention|Functional Status|Humans|Immunoglobulins, Intravenous|Immunologic Factors|Intensive Care Units|Length of Stay|Randomized Controlled Trials as Topic|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|Survival Rate|NA",2021-03-12,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04350580,1
33648568,NCT04663555,"Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Letter,Glucocorticoids|Dexamethasone|NA,"COVID-19|Clinical Trials, Phase II as Topic|Dexamethasone|Disease Progression|Dose-Response Relationship, Drug|Equivalence Trials as Topic|Glucocorticoids|Humans|Length of Stay|Multicenter Studies as Topic|Randomized Controlled Trials as Topic|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|NA",2021-03-12,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04663555,1
33650967,NCT04549831,Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study.,"Journal Article|Research Support, Non-U.S. Gov't","TLR7 protein, human|Toll-Like Receptor 7|NA","Adult|COVID-19|Case-Control Studies|Genetic Predisposition to Disease|HEK293 Cells|Humans|Italy|Male|Middle Aged|Polymorphism, Single Nucleotide|SARS-CoV-2|Severity of Illness Index|Toll-Like Receptor 7|NA",2021-04-06,eLife,Abstract,https://clinicaltrials.gov/ct2/show/NCT04549831,1
33654090,NCT04471519,"Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques.","Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|NA","Animals|Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Enzyme-Linked Immunosorbent Assay|Female|Immunohistochemistry|Lymphocytes|Macaca mulatta|Male|Pneumonia|SARS-CoV-2|NA",2021-03-11,Nature communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04471519,3
33657114,NCT04375098,Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.,"Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|COVID-19|Chile|Disease Progression|Early Medical Intervention|Female|Hospital Mortality|Humans|Immunization, Passive|Length of Stay|Male|Middle Aged|Mortality|Respiration, Artificial|Time-to-Treatment|Treatment Outcome|NA",2021-03-11,PLoS medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04375098,2
33662102,NCT04405843,Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Anti-Infective Agents|Ivermectin|NA,Adult|Aged|Anti-Infective Agents|COVID-19|Double-Blind Method|Drug Administration Schedule|Female|Humans|Ivermectin|Male|Middle Aged|Patient Acuity|SARS-CoV-2|Time Factors|Treatment Failure|NA,2021-04-19,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04405843,1
33664279,NCT04411576,Antibodies to SARS-CoV-2 and risk of past or future sick leave.,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Viral|NA","Adult|Antibodies, Viral|COVID-19|Female|Follow-Up Studies|Humans|Male|Middle Aged|SARS-CoV-2|Sick Leave|Sweden|NA",2021-03-12,Scientific reports,Abstract,https://clinicaltrials.gov/ct2/show/NCT04411576,2
33665371,NCT04318431,Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional study.,Journal Article, , ,2021-03-06,BMJ paediatrics open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318431,1
33666246,NCT04323787,Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry.,Journal Article, , ,2021-05-27,Journal of medical virology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04323787,2
33668011,NCT04471701,Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey.,Journal Article|Observational Study, ,Adult|COVID-19|Cross-Sectional Studies|Female|Humans|Internet|Italy|Male|Middle Aged|Smoking|Surveys and Questionnaires|NA,2021-05-03,JMIR public health and surveillance,Abstract,https://clinicaltrials.gov/ct2/show/NCT04471701,3
33673929,NCT04351152,Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019.,Letter|Comment,"Antibodies, Monoclonal, Humanized|Granulocyte-Macrophage Colony-Stimulating Factor|lenzilumab|NA","Antibodies, Monoclonal, Humanized|COVID-19|Cohort Studies|Granulocyte-Macrophage Colony-Stimulating Factor|Humans|SARS-CoV-2|NA",2021-03-11,Mayo Clinic proceedings,Abstract,https://clinicaltrials.gov/ct2/show/NCT04351152,3
33675247,NCT04393818,Effect of a mobile-based intervention on mental health in frontline healthcare workers against COVID-19: Protocol for a randomized controlled trial.,Journal Article, , ,2021-05-17,Journal of advanced nursing,Abstract,https://clinicaltrials.gov/ct2/show/NCT04393818,2
33676590,NCT04327388,"Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.","Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Monoclonal, Humanized|Immunologic Factors|Receptors, Interleukin-6|sarilumab|NA","Antibodies, Monoclonal, Humanized|COVID-19|Critical Care|Cytokine Release Syndrome|Dose-Response Relationship, Drug|Drug Monitoring|Female|Humans|Immunologic Factors|International Cooperation|Male|Middle Aged|Mortality|Receptors, Interleukin-6|Respiratory Distress Syndrome|SARS-CoV-2|Severity of Illness Index|Treatment Outcome|NA",2021-05-13,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04327388,1
33681731,NCT04354428,Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial.,Journal Article, , ,2021-04-02,EClinicalMedicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04354428,1
33682678,NCT04357366,An open label trial of anakinra to prevent respiratory failure in COVID-19.,"Clinical Trial|Journal Article|Research Support, Non-U.S. Gov't","Anti-Inflammatory Agents|Antigens, CD|Antigens, Differentiation, Myelomonocytic|CD163 antigen|Interleukin 1 Receptor Antagonist Protein|Interleukin-6|Receptors, Cell Surface|Receptors, Urokinase Plasminogen Activator|Interleukin-10|NA","Aged|Aged, 80 and over|Anti-Inflammatory Agents|Antigens, CD|Antigens, Differentiation, Myelomonocytic|COVID-19|Female|Humans|Incidence|Injections, Subcutaneous|Interleukin 1 Receptor Antagonist Protein|Interleukin-10|Interleukin-6|Male|Middle Aged|Receptors, Cell Surface|Receptors, Urokinase Plasminogen Activator|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Standard of Care|Treatment Outcome|NA",2021-04-14,eLife,Abstract,https://clinicaltrials.gov/ct2/show/NCT04357366,1
33683342,NCT04385017,Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity.,"Journal Article|Research Support, Non-U.S. Gov't","Biomarkers|Inflammasomes|NLR Family, Pyrin Domain-Containing 3 Protein|NLRP3 protein, human|NA","Biomarkers|COVID-19|Case-Control Studies|Humans|Inflammasomes|Middle Aged|Myeloid Cells|NLR Family, Pyrin Domain-Containing 3 Protein|Prospective Studies|SARS-CoV-2|NA",2021-03-16,Blood advances,Abstract,https://clinicaltrials.gov/ct2/show/NCT04385017,1
33685502,NCT04499677,Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,Amides|Antiviral Agents|Drug Combinations|Pyrazines|lopinavir-ritonavir drug combination|Lopinavir|favipiravir|Ritonavir|NA,"Ambulatory Care|Amides|Antiviral Agents|COVID-19|Clinical Trials, Phase II as Topic|Double-Blind Method|Drug Combinations|Drug Therapy, Combination|Early Medical Intervention|Humans|Lopinavir|Pyrazines|Randomized Controlled Trials as Topic|Ritonavir|SARS-CoV-2|United Kingdom|Viral Load|NA",2021-03-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04499677,1
33688640,NCT04362176,Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.,Preprint, , ,2021-03-30,Research square,Abstract,https://clinicaltrials.gov/ct2/show/NCT04362176,2
33689985,NCT04636294,Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19.,Journal Article, ,COVID-19|COVID-19 Testing|Early Diagnosis|Follow-Up Studies|Humans|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|NA,2021-05-18,Diagnostic microbiology and infectious disease,Abstract,https://clinicaltrials.gov/ct2/show/NCT04636294,1
33691765,NCT04362085,Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,"Anticoagulants|Fibrin Fibrinogen Degradation Products|Heparin, Low-Molecular-Weight|fibrin fragment D|Heparin|NA","Anticoagulants|Blood Coagulation Disorders|COVID-19|Clinical Trials, Phase III as Topic|Fibrin Fibrinogen Degradation Products|Heparin|Heparin, Low-Molecular-Weight|Hospitalization|Humans|Intensive Care Units|Noninvasive Ventilation|Pragmatic Clinical Trials as Topic|Randomized Controlled Trials as Topic|Respiration, Artificial|SARS-CoV-2|NA",2021-03-18,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04362085,2
33694071,NCT04342806,Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO Registry.,"Journal Article|Research Support, Non-U.S. Gov't", ,Adult|COVID-19|Cross-Sectional Studies|Female|Health Personnel|Humans|Male|Pandemics|Registries|SARS-CoV-2|NA,2021-05-21,Journal of general internal medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04342806,1
33704352,NCT04436276,Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.,"Clinical Trial, Phase I|Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|NA","Adult|Antibodies, Neutralizing|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Double-Blind Method|Female|Humans|Immunity, Cellular|Immunity, Humoral|Immunogenicity, Vaccine|Male|Middle Aged|Vaccine Potency|Young Adult|NA",2021-05-03,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04436276,3
33705727,NCT04471519,"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.",Journal Article, , ,2021-03-11,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04471519,3
33707061,NCT04405076,A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.,"Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural","Antibodies, Viral|COVID-19 Vaccines|RNA, Messenger|Vaccines|NA","Adolescent|Adult|Antibodies, Viral|COVID-19|COVID-19 Vaccines|Double-Blind Method|Humans|Immunization, Passive|Immunogenicity, Vaccine|RNA, Messenger|SARS-CoV-2|Vaccines|NA",2021-05-06,Vaccine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04405076,1
33709945,NCT04331171,A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study.,Journal Article|Observational Study, ,COVID-19|France|Humans|Internet|Mobile Applications|Pandemics|SARS-CoV-2|Self-Assessment|Triage|NA,2021-04-07,Journal of medical Internet research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331171,3
33712920,NCT04420806,Detraining Effects on Musculoskeletal Parameters in Early Postmenopausal Osteopenic Women: 3-Month Follow-Up of the Randomized Controlled ACTLIFE Study.,Journal Article, , ,2021-03-16,Calcified tissue international,Abstract,https://clinicaltrials.gov/ct2/show/NCT04420806,1
33715160,NCT04546581,Brief report: Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.,Journal Article, , ,2021-03-22,Transfusion,Abstract,https://clinicaltrials.gov/ct2/show/NCT04546581,1
33716889,NCT04537858,Comparison Between Conventional Intervention and Non-immersive Virtual Reality in the Rehabilitation of Individuals in an Inpatient Unit for the Treatment of COVID-19: A Study Protocol for a Randomized Controlled Crossover Trial.,Journal Article, , ,2021-03-16,Frontiers in psychology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04537858,1
33723507,NCT04431466,Use of ivermectin in the treatment of Covid-19: A pilot trial.,Journal Article, , ,2021-03-17,Toxicology reports,Abstract,https://clinicaltrials.gov/ct2/show/NCT04431466,1
33725432,NCT04444674,Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.,"Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|COVID-19 Vaccines|ChAdOx1 COVID-19 vaccine|NA","Adenoviridae|Adolescent|Adult|Antibodies, Neutralizing|COVID-19|COVID-19 Serological Testing|COVID-19 Vaccines|Double-Blind Method|Humans|Immunogenicity, Vaccine|Middle Aged|SARS-CoV-2|South Africa|T-Lymphocytes|Treatment Failure|Vaccine Potency|Young Adult|NA",2021-05-25,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04444674,3
33726804,NCT04475601,"COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Letter,Antiviral Agents|Phenylthiohydantoin|enzalutamide|NA,"Antiviral Agents|COVID-19|Clinical Trials, Phase II as Topic|Female|Host-Pathogen Interactions|Humans|Male|Middle Aged|Multicenter Studies as Topic|Phenylthiohydantoin|Prospective Studies|Randomized Controlled Trials as Topic|SARS-CoV-2|Sweden|Time Factors|Treatment Outcome|Virus Internalization|NA",2021-03-25,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04475601,1
33726819,NCT04534569,Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method.,Journal Article, ,COVID-19|Consensus|Delphi Technique|Humans|Respiratory Insufficiency|NA,2021-03-22,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04534569,1
33727235,NCT04334291,Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registry.,Journal Article, , ,2021-03-20,Emergency medicine journal : EMJ,Abstract,https://clinicaltrials.gov/ct2/show/NCT04334291,6
33731327,NCT04448717,"Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.","Journal Article|Research Support, Non-U.S. Gov't", ,Adolescent|COVID-19|COVID-19 Serological Testing|Child|Cluster Analysis|Cohort Studies|Female|Humans|Longitudinal Studies|Male|Prospective Studies|SARS-CoV-2|Seroconversion|Seroepidemiologic Studies|Students|Switzerland|NA,2021-03-25,BMJ (Clinical research ed.),Abstract,https://clinicaltrials.gov/ct2/show/NCT04448717,3
33731427,NCT04702945,Development of the Canadian COVID-19 Emergency Department Rapid Response Network population-based registry: a methodology study.,"Journal Article|Research Support, Non-U.S. Gov't", ,"COVID-19|Canada|Data Accuracy|Data Collection|Data Management|Emergency Medicine|Emergency Service, Hospital|Evidence-Based Emergency Medicine|Follow-Up Studies|Humans|Information Storage and Retrieval|Patient Reported Outcome Measures|Prospective Studies|Quality of Life|Registries|Retrospective Studies|SARS-CoV-2|Telephone|NA",2021-03-25,CMAJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04702945,1
33734299,NCT04486508,"Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.","Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Anticoagulants|Enoxaparin|NA,"Aged|Anticoagulants|COVID-19|Drug Administration Schedule|Enoxaparin|Extracorporeal Membrane Oxygenation|Female|Hemorrhage|Hospitalization|Humans|Intensive Care Units|Iran|Length of Stay|Male|Middle Aged|Odds Ratio|Outcome Assessment, Health Care|Oxygen Inhalation Therapy|Pulmonary Embolism|Thrombocytopenia|Thrombosis|Treatment Outcome|Venous Thrombosis|NA",2021-05-05,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04486508,1
33734539,NCT04484207,Increasing treatment-seeking intentions of US veterans in the Covid-19 era: A randomized controlled trial.,Journal Article|Randomized Controlled Trial, ,"COVID-19|Female|Humans|Intention|Male|Pandemics|Patient Acceptance of Health Care|SARS-CoV-2|Stress Disorders, Post-Traumatic|Veterans|NA",2021-06-03,Depression and anxiety,Abstract,https://clinicaltrials.gov/ct2/show/NCT04484207,1
33737439,NCT04382508,COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study.,"Journal Article|Observational Study|Research Support, Non-U.S. Gov't", ,Adolescent|Anxiety|COVID-19|COVID-19 Testing|Child|Female|Humans|Male|Prospective Studies|State Medicine|United Kingdom|NA,2021-03-23,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04382508,1
33740028,NCT04351503,SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event.,Journal Article, ,"Adult|COVID-19|Contact Tracing|Crowding|Female|Genome, Viral|Humans|Longitudinal Studies|Male|Mass Screening|Middle Aged|Mutation|SARS-CoV-2|Switzerland|NA",2021-04-12,PLoS pathogens,Abstract,https://clinicaltrials.gov/ct2/show/NCT04351503,1
33743799,NCT04362176,Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.,Clinical Trial Protocol|Journal Article, ,"COVID-19|Hospitalization|Host-Pathogen Interactions|Humans|Immunization, Passive|Multicenter Studies as Topic|Randomized Controlled Trials as Topic|SARS-CoV-2|Time Factors|Treatment Outcome|United States|NA",2021-03-25,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04362176,2
33746047,NCT04354701,Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.,"Journal Article|Research Support, N.I.H., Extramural", ,Aged|COVID-19|COVID-19 Testing|Female|Humans|Male|Neoplasms|Pandemics|SARS-CoV-2|NA,2021-05-13,Annals of oncology : official journal of the European Society for Medical Oncology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04354701,2
33750432,NCT04453384,"Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial.",Clinical Trial Protocol|Journal Article,"Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|Immunoglobulin G|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|NA","Animals|Antibodies, Monoclonal, Humanized|Antibodies, Neutralizing|COVID-19|Clinical Trials, Phase II as Topic|Double-Blind Method|Humans|Immunization, Passive|Immunoglobulin G|Oxygen Inhalation Therapy|Randomized Controlled Trials as Topic|SARS-CoV-2|Severity of Illness Index|Spike Glycoprotein, Coronavirus|Swine|Time Factors|NA",2021-03-29,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04453384,1
33752741,NCT04321174,Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial.,Clinical Trial Protocol|Journal Article,Antiviral Agents|Drug Combinations|lopinavir-ritonavir drug combination|Lopinavir|Ritonavir|NA,Antiviral Agents|COVID-19|Drug Combinations|Hospitalization|Humans|Lopinavir|Post-Exposure Prophylaxis|Randomized Controlled Trials as Topic|Ritonavir|SARS-CoV-2|Severity of Illness Index|Treatment Outcome|NA,2021-03-29,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321174,3
33754144,NCT04399980,"Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.",Journal Article, , ,2021-05-29,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04399980,1
33754144,NCT04463004,"Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.",Journal Article, , ,2021-05-29,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04463004,1
33754144,NCT04492514,"Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.",Journal Article, , ,2021-05-29,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04492514,1
33757598,NCT04353934,Multinational dietary changes and anxiety during the coronavirus pandemic-findings from Israel.,Journal Article, ,Adult|Anxiety|COVID-19|Cross-Sectional Studies|Diet|Female|Global Health|Health Behavior|Health Status|Humans|Male|Middle Aged|Pandemics|SARS-CoV-2|Socioeconomic Factors|NA,2021-04-02,Israel journal of health policy research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04353934,1
33767713,NCT04343053,"Blood Interferon-Î± Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.",Journal Article,Biomarkers|Inflammation Mediators|Interferon-alpha|NA,Aged|Biomarkers|COVID-19|Case-Control Studies|Female|Hospitalization|Host-Pathogen Interactions|Humans|Inflammation Mediators|Interferon-alpha|Male|Middle Aged|Prognosis|Prospective Studies|SARS-CoV-2|Severity of Illness Index|NA,2021-04-09,Frontiers in immunology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343053,3
33773111,NCT04466085,"Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.",Journal Article, , ,2021-03-29,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04466085,1
33773111,NCT04445194,"Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.",Journal Article, , ,2021-03-29,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04445194,1
33776910,NCT04365634,Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.,"Journal Article|Observational Study|Research Support, Non-U.S. Gov't",Cytokines|NA,"Adult|Aged|CD4-Positive T-Lymphocytes|CD8-Positive T-Lymphocytes|COVID-19|China|Cytokines|Diabetes Mellitus, Type 2|Female|Humans|Hyperglycemia|Immune System|Killer Cells, Natural|Lymphocyte Count|Lymphopenia|Male|Middle Aged|Retrospective Studies|SARS-CoV-2|Th1 Cells|Th2 Cells|NA",2021-04-07,Frontiers in endocrinology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04365634,1
33783269,NCT04306393,Right Ventricular Strain Is Common in Intubated COVID-19 Patients and Does Not Reflect Severity of Respiratory Illness.,Journal Article, , ,2021-04-22,Journal of intensive care medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04306393,2
33785495,NCT04369807,"Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.","Journal Article|Observational Study|Research Support, Non-U.S. Gov't", ,"Activities of Daily Living|Adult|Aged|COVID-19|Case-Control Studies|Community-Based Participatory Research|Diabetes Mellitus, Type 2|Female|Hospitalization|Humans|Male|Middle Aged|Prospective Studies|SARS-CoV-2|Severity of Illness Index|NA",2021-04-06,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04369807,1
33785743,NCT04331899,Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial.,"Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Antiviral Agents|Interleukins|peginterferon lambda-1a|Polyethylene Glycols|NA,"Adult|Aged|Antiviral Agents|COVID-19|Female|Humans|Injections, Subcutaneous|Interleukins|Male|Middle Aged|Outpatients|Polyethylene Glycols|SARS-CoV-2|Single-Blind Method|Treatment Failure|Virus Shedding|Young Adult|NA",2021-04-12,Nature communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331899,1
33785784,NCT04316884,"The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients.","Journal Article|Observational Study|Research Support, Non-U.S. Gov't","Biomarkers|IL6 protein, human|Interleukin-6|RNA, Viral|NA","Aged|Biomarkers|COVID-19|Comorbidity|Critical Illness|Female|Humans|Hypertension|Interleukin-6|Male|Middle Aged|Multiple Organ Failure|Prospective Studies|RNA, Viral|Renal Replacement Therapy|Respiration, Artificial|Sweden|Viremia|NA",2021-05-03,Scientific reports,Abstract,https://clinicaltrials.gov/ct2/show/NCT04316884,2
33786454,NCT04353609,COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.,Journal Article, , ,2021-05-29,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04353609,1
33794531,NCT04427332,Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection.,Journal Article|Observational Study, ,"Age Factors|Aged|Anosmia|COVID-19|Dysgeusia|Emergency Service, Hospital|Female|Hospitalization|Humans|Hypersensitivity|Logistic Models|Male|Middle Aged|Multivariate Analysis|Olfaction Disorders|Prevalence|Respiratory Hypersensitivity|Retrospective Studies|Risk Factors|SARS-CoV-2|Smoking|Taste Disorders|NA",2021-04-30,Neuroepidemiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04427332,1
33796490,NCT04448717,Surveillance of Acute SARS-CoV-2 Infections in School Children and Point-Prevalence During a Time of High Community Transmission in Switzerland.,Journal Article, , ,2021-04-03,Frontiers in pediatrics,Abstract,https://clinicaltrials.gov/ct2/show/NCT04448717,3
33798499,NCT04400838,Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.,"Clinical Trial, Phase II|Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|COVID-19 Vaccines|ChAdOx1 COVID-19 vaccine|NA","Adolescent|Adult|Antibodies, Neutralizing|COVID-19|COVID-19 Nucleic Acid Testing|COVID-19 Vaccines|Female|Humans|Male|Middle Aged|Nucleic Acid Amplification Techniques|Pandemics|SARS-CoV-2|Single-Blind Method|United Kingdom|Viral Load|Young Adult|NA",2021-04-23,"Lancet (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04400838,5
33810796,NCT04486482,"Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.",Clinical Trial Protocol|Letter,"Fatty Acids, Volatile|Polysaccharides|NA","Ambulatory Care|COVID-19|Fatty Acids, Volatile|Gastrointestinal Microbiome|Humans|Polysaccharides|Randomized Controlled Trials as Topic|SARS-CoV-2|Self Care|Severity of Illness Index|Telemedicine|Treatment Outcome|NA",2021-04-12,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04486482,1
33811823,NCT04578210,47th Annual Meeting of the EBMT.,Congress, ,"Adolescent|Blood Transfusion|COVID-19|Child|Clinical Trials as Topic|Graft vs Host Disease|Hematopoietic Stem Cell Transplantation|Humans|Immunotherapy, Adoptive|Lymphoma|Randomized Controlled Trials as Topic|Thalassemia|Transplantation Conditioning|NA",2021-05-05,The Lancet. Haematology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04578210,1
33813110,NCT04325893,Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial.,Journal Article, , ,2021-06-02,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04325893,1
33819166,NCT04368923,Telemanagement of Home-Isolated COVID-19 Patients Using Oxygen Therapy With Noninvasive Positive Pressure Ventilation and Physical Therapy Techniques: Randomized Clinical Trial.,Journal Article, , ,2021-05-07,Journal of medical Internet research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368923,1
33823862,NCT04388670,"Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients.","Comparative Study|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't", ,"Aged|COVID-19|Cohort Studies|Critical Care|Female|Humans|Intubation|Italy|Male|Middle Aged|Patient Positioning|Practice Guidelines as Topic|Prone Position|Respiration, Artificial|Retrospective Studies|Supine Position|NA",2021-04-19,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04388670,2
33826106,NCT04369469,Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019.,Journal Article, , ,2021-05-13,Infectious diseases and therapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04369469,3
33832543,NCT04678843,Adapting and adopting highly specialized pediatric eating disorder treatment to virtual care: a protocol for an implementation study in the COVID-19 context.,Journal Article, , ,2021-04-11,Implementation science communications,Abstract,https://clinicaltrials.gov/ct2/show/NCT04678843,1
33832565,NCT04715607,"SARS-CoV-2 in saliva, oropharyngeal and nasopharyngeal specimens.",Clinical Trial Protocol|Comparative Study|Journal Article, ,COVID-19|COVID-19 Nucleic Acid Testing|Humans|Logistic Models|Nasopharynx|Oropharynx|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Saliva|Specimen Handling|NA,2021-04-16,Danish medical journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04715607,1
33834847,NCT04379453,Use of robotic assistance to reduce proximity and air-sharing during percutaneous cardiovascular intervention.,Journal Article, , ,2021-04-09,Future cardiology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04379453,1
33835265,NCT04347694,COVID-19 serology in nephrology healthcare workers.,Journal Article, , ,2021-04-11,Wiener klinische Wochenschrift,Abstract,https://clinicaltrials.gov/ct2/show/NCT04347694,1
33835830,NCT04482647,"Yoga-Based Breathing Techniques for Health Care Workers During COVID-19 Pandemic: Interests, Feasibility, and Acceptance.",Journal Article, , ,2021-04-09,"Journal of alternative and complementary medicine (New York, N.Y.)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04482647,1
33836826,NCT04635943,Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.,Clinical Trial Protocol|Letter,"RNA, Viral|Ivermectin|NA","COVID-19|COVID-19 Nucleic Acid Testing|Humans|Ivermectin|Multicenter Studies as Topic|Nasopharynx|Peru|Polymerase Chain Reaction|RNA, Viral|Randomized Controlled Trials as Topic|Treatment Outcome|NA",2021-05-13,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04635943,1
33839489,NCT04569825,Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study.,Journal Article, , ,2021-04-30,American journal of otolaryngology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04569825,1
33844036,NCT04649996,The decrease of non-complicated acute appendicitis and the negative appendectomy rate during pandemic.,Journal Article, , ,2021-06-01,European journal of trauma and emergency surgery : official publication of the European Trauma Society,Abstract,https://clinicaltrials.gov/ct2/show/NCT04649996,1
33844996,NCT04416399,"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.",Journal Article, , ,2021-04-17,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04416399,2
33845867,NCT04581954,Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.,Clinical Trial Protocol|Letter,INCB018424|Oxazines|Pyrazoles|Pyridines|fostamatinib|NA,"Adult|COVID-19|Humans|Oxazines|Pandemics|Pyrazoles|Pyridines|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Venous Thromboembolism|NA",2021-05-13,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04581954,1
33849629,NCT04582344,"A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.",Clinical Trial Protocol|Letter,COVID-19 Vaccines|NA,"Animals|COVID-19|COVID-19 Vaccines|China|Chlorocebus aethiops|Clinical Trials, Phase III as Topic|Double-Blind Method|Female|Humans|Male|Pregnancy|Randomized Controlled Trials as Topic|SARS-CoV-2|Treatment Outcome|Vero Cells|NA",2021-05-13,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04582344,1
33850184,NCT04343768,Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial.,Journal Article|Randomized Controlled Trial,"Antiviral Agents|RNA, Viral|Interferon beta-1b|Interferon beta-1a|NA","Aged|Aged, 80 and over|Antiviral Agents|COVID-19|Female|Humans|Interferon beta-1a|Interferon beta-1b|Male|Middle Aged|RNA, Viral|Real-Time Polymerase Chain Reaction|SARS-CoV-2|Thorax|Treatment Outcome|NA",2021-04-21,Scientific reports,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343768,2
33853806,NCT04464408,Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19.,"Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't",Amides|Pyrazines|favipiravir|NA,Adult|Amides|COVID-19|Female|Humans|Male|Multicenter Studies as Topic|Pyrazines|Randomized Controlled Trials as Topic|Treatment Outcome|NA,2021-04-23,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04464408,1
33857475,NCT04388670,Hospital-Acquired Infections in Critically Ill Patients With COVID-19.,Journal Article, , ,2021-05-11,Chest,Abstract,https://clinicaltrials.gov/ct2/show/NCT04388670,2
33864948,NCT04358380,Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.,Journal Article, , ,2021-05-21,Annals of hepatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04358380,2
33870149,NCT04494984,"RBD-specific polyclonal F(abÂ´)<sub>2</sub> fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial.",Journal Article, , ,2021-05-04,EClinicalMedicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04494984,2
33873199,NCT04742738,Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.,Journal Article, , ,2021-05-18,Nature,Abstract,https://clinicaltrials.gov/ct2/show/NCT04742738,1
33873199,NCT04750343,Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.,Journal Article, , ,2021-05-18,Nature,Abstract,https://clinicaltrials.gov/ct2/show/NCT04750343,1
33874987,NCT04321265,The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study.,"Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't", ,"Aged|Aged, 80 and over|COVID-19|Critical Care|Female|Frail Elderly|Frailty|Humans|Male|Prognosis|Prospective Studies|Survival Analysis|NA",2021-04-22,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04321265,2
33875266,NCT04412538,"The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59Â years: A phase I randomized, double-blinded, controlled trial.","Clinical Trial, Phase I|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Viral|COVID-19 Vaccines|Vaccines|NA","Adolescent|Adult|Antibodies, Viral|COVID-19|COVID-19 Vaccines|China|Double-Blind Method|Humans|Immunogenicity, Vaccine|Middle Aged|SARS-CoV-2|Vaccines|Young Adult|NA",2021-05-06,Vaccine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04412538,2
33876439,NCT04262921,Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.,Journal Article, , ,2021-05-16,Fundamental &amp; clinical pharmacology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04262921,3
33878018,NCT04670003,Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study.,Journal Article|Observational Study, ,Adult|COVID-19|Cohort Studies|Communicable Disease Control|Female|France|Humans|Male|Middle Aged|Pandemics|SARS-CoV-2|Self-Assessment|Surveys and Questionnaires|NA,2021-05-24,Journal of medical Internet research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04670003,1
33879078,NCT04642196,COVID-19 as the sole cause of death is uncommon in frail home healthcare individuals: a population-based study.,Journal Article, ,"Activities of Daily Living|Aged|Aged, 80 and over|COVID-19|COVID-19 Testing|Cause of Death|Delivery of Health Care|Female|Frail Elderly|Home Care Services|Humans|Male|Pandemics|Retrospective Studies|SARS-CoV-2|Sweden|NA",2021-04-23,BMC geriatrics,Abstract,https://clinicaltrials.gov/ct2/show/NCT04642196,1
33880438,NCT04318314,Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.,Journal Article, , ,2021-05-04,EClinicalMedicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04318314,1
33882225,NCT04505722,Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.,Journal Article, , ,2021-04-21,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04505722,2
33885775,NCT04403100,Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Lopinavir|Hydroxychloroquine|Ritonavir|NA,"Antiviral Agents|Brazil|COVID-19|Drug Monitoring|Drug Therapy, Combination|Early Medical Intervention|Female|Hospitalization|Humans|Hydroxychloroquine|Lopinavir|Male|Medical Futility|Middle Aged|Risk Adjustment|Ritonavir|Symptom Assessment|Treatment Outcome|NA",2021-05-04,JAMA network open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04403100,1
33887208,NCT04495933,"Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.",Journal Article, , ,2021-04-26,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04495933,1
33887209,NCT04537208,"Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.",Journal Article, , ,2021-04-26,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04537208,1
33890580,NCT04581187,"The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study.",Journal Article, , ,2021-06-02,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04581187,1
33895322,NCT04528641,Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.,Journal Article, , ,2021-05-07,Molecular therapy : the journal of the American Society of Gene Therapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04528641,1
33899008,NCT04335279,"Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trial.",Journal Article, , ,2021-05-29,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04335279,1
33903092,NCT04747782,Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients.,Journal Article, , ,2021-04-29,Annals of the rheumatic diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04747782,2
33903855,NCT04321096,Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.,Journal Article, , ,2021-05-28,EClinicalMedicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321096,1
33907251,NCT04420247,An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients.,"Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial",Antiviral Agents|Hydroxychloroquine|Chloroquine|NA,"Adult|Antiviral Agents|COVID-19|Chloroquine|Drug Therapy, Combination|Female|Humans|Hydroxychloroquine|Male|Middle Aged|SARS-CoV-2|Survival Rate|Treatment Outcome|NA",2021-05-11,Scientific reports,Abstract,https://clinicaltrials.gov/ct2/show/NCT04420247,1
33909587,NCT04393818,A Mobile Phone-Based Intervention to Reduce Mental Health Problems in Health Care Workers During the COVID-19 Pandemic (PsyCovidApp): Randomized Controlled Trial.,Journal Article|Randomized Controlled Trial, ,COVID-19|Cell Phone|Health Personnel|Humans|Mental Health|Pandemics|SARS-CoV-2|Spain|NA,2021-05-21,JMIR mHealth and uHealth,Abstract,https://clinicaltrials.gov/ct2/show/NCT04393818,2
33909588,NCT04385797,Cognitive Outcomes During COVID-19 Confinement Among Older People and Their Caregivers Using Technologies for Dementia: Protocol for an Observational Cohort Study.,Journal Article, , ,2021-05-25,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04385797,1
33910614,NCT04403646,Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial.,Letter, , ,2021-05-02,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04403646,1
33920489,NCT04408209,A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis.,Journal Article, , ,2021-05-18,Microorganisms,Abstract,https://clinicaltrials.gov/ct2/show/NCT04408209,1
33926540,NCT04813770,The impact of theory-based messages on COVID-19 vaccination intentions: a structured summary of a study protocol for a randomised controlled trial.,Letter, , ,2021-05-02,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04813770,1
33928414,NCT04747782,COVID-19-associated autoimmunity as a feature of acute respiratory failure.,Letter, , ,2021-05-02,Intensive care medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04747782,2
33937603,NCT04368312,Gender Differences in Anger Among Hospital Medical Staff Exposed to Patients with COVID-19.,Journal Article, , ,2021-05-04,Health equity,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368312,1
33942031,NCT04397237,SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.,Journal Article, , ,2021-05-07,The Lancet. Rheumatology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04397237,1
33945497,NCT04756869,Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology: Protocol for an Observational mHealth Study.,Journal Article, , ,2021-05-26,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04756869,1
33947446,NCT04348656,"Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial.",Journal Article, , ,2021-05-08,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04348656,1
33948050,NCT04605692,Attitudes and predictive factors of psychological distress and occupational burnout among dentists during COVID-19 pandemic in Turkey.,Journal Article, , ,2021-05-07,"Current psychology (New Brunswick, N.J.)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04605692,1
33948606,NCT04339790,Identifying the Factor Structure of the DSM-5 Level 1 Cross-Cutting Symptom Measure.,Preprint, , ,2021-05-08,medRxiv : the preprint server for health sciences,Abstract,https://clinicaltrials.gov/ct2/show/NCT04339790,1
33949966,NCT04575532,Personalized Analytics and a Wearable Biosensor Platform for Early Detection of COVID-19 Decompensation (DeCODe): Protocol for the Development of the COVID-19 Decompensation Index.,Journal Article, , ,2021-05-27,JMIR research protocols,Abstract,https://clinicaltrials.gov/ct2/show/NCT04575532,1
33951374,NCT04533399,Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.,"Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|COVID-19 Vaccines|recombinant SARS-CoV-2 vaccine NVX-cov2373|NA","Adolescent|Adult|Aged|Aged, 80 and over|Antibodies, Neutralizing|COVID-19|COVID-19 Serological Testing|COVID-19 Vaccines|Double-Blind Method|HIV Seronegativity|HIV Seropositivity|Humans|Immunogenicity, Vaccine|Middle Aged|SARS-CoV-2|South Africa|Young Adult|NA",2021-05-25,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04533399,1
33952552,NCT04399252,"Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol.","Clinical Trial Protocol|Journal Article|Research Support, Non-U.S. Gov't","RNA, Ribosomal, 16S|NA","COVID-19|Double-Blind Method|Humans|Pandemics|Probiotics|RNA, Ribosomal, 16S|Randomized Controlled Trials as Topic|SARS-CoV-2|Treatment Outcome|NA",2021-05-12,BMJ open,Abstract,https://clinicaltrials.gov/ct2/show/NCT04399252,1
33956667,NCT04387929,One dose of SARS-CoV-2 vaccine exponentially increases antibodies in recovered individuals with symptomatic COVID-19.,Journal Article, , ,2021-05-06,The Journal of clinical investigation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04387929,1
33957663,NCT04329533,Mindfulness Effects in Obstetric and Gynecology Patients During the Coronavirus Disease 2019 (COVID-19) Pandemic: A Randomized Controlled Trial.,Journal Article|Randomized Controlled Trial, ,"Adult|COVID-19|Female|Gynecology|Humans|Meditation|Middle Aged|Mindfulness|Mobile Applications|Obstetrics|Pandemics|Pregnancy|Prenatal Care|Primary Health Care|Stress, Psychological|NA",2021-05-28,Obstetrics and gynecology,Abstract,https://clinicaltrials.gov/ct2/show/NCT04329533,1
33962480,NCT04379440,COVID-19 and atrial fibrillation in older patients. Does oral anticoagulant therapy provide a survival benefit? An insight from the GeroCovid Registry.,Clinical Trial, , ,2021-05-07,Thrombosis and haemostasis,Abstract,https://clinicaltrials.gov/ct2/show/NCT04379440,2
33966355,NCT04391738,BMI and pneumonia outcomes in critically ill COVID-19 patients: an international multicenter study.,Journal Article, , ,2021-05-09,"Obesity (Silver Spring, Md.)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04391738,1
33966886,NCT04320017,[Differences of characteristics and outcomes between cancer patients and patients with no active cancer hospitalised for a SARS-CoV-2 infection].,English Abstract|Journal Article, , ,2021-05-13,Bulletin du cancer,Abstract,https://clinicaltrials.gov/ct2/show/NCT04320017,1
33972083,NCT04558996,Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study.,Journal Article, , ,2021-05-13,Fertility and sterility,Abstract,https://clinicaltrials.gov/ct2/show/NCT04558996,1
33972256,NCT04441918,"Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab in Chinese Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, First-In-Human Phase 1 Study.",Journal Article, , ,2021-05-11,Antimicrobial agents and chemotherapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04441918,1
33972949,NCT04351152,LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.,Preprint, , ,2021-05-15,medRxiv : the preprint server for health sciences,Abstract,https://clinicaltrials.gov/ct2/show/NCT04351152,3
33973161,NCT04366141,The impact of a barrier enclosure on time to tracheal intubation: a randomized controlled trial.,Journal Article, , ,2021-05-13,Canadian journal of anaesthesia = Journal canadien d'anesthesie,Abstract,https://clinicaltrials.gov/ct2/show/NCT04366141,1
33974559,NCT04359810,A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.,Journal Article, , ,2021-05-11,The Journal of clinical investigation,Abstract,https://clinicaltrials.gov/ct2/show/NCT04359810,3
33975597,NCT04361877,Altered alcohol consumption during COVID-19 pandemic lockdown.,Journal Article, ,Adult|Age Factors|Aged|Alcohol Drinking|COVID-19|Cross-Sectional Studies|Europe|Female|Humans|Male|Pandemics|Physical Distancing|SARS-CoV-2|Surveys and Questionnaires|Young Adult|NA,2021-05-24,Nutrition journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04361877,2
33976287,NCT04356534,Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Ferritins|NA,"Adult|Aged|COVID-19|Female|Ferritins|Humans|Immunization, Passive|Male|Middle Aged|Pilot Projects|Prospective Studies|Respiration, Artificial|SARS-CoV-2|Severity of Illness Index|Survival Rate|Treatment Outcome|NA",2021-05-24,Scientific reports,Abstract,https://clinicaltrials.gov/ct2/show/NCT04356534,2
33977415,NCT04411459,Quality of life of COVID-19 critically ill survivors after ICU discharge: 90Â days follow-up.,Journal Article, , ,2021-05-14,"Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation",Abstract,https://clinicaltrials.gov/ct2/show/NCT04411459,2
33977506,NCT04340557,Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia.,Journal Article, , ,2021-05-14,Infectious diseases and therapy,Abstract,https://clinicaltrials.gov/ct2/show/NCT04340557,1
33982128,NCT04450017,Low Circulating Vitamin D in Intensive Care Unit-Admitted COVID-19 Patients as a Predictor of Negative Outcomes.,Journal Article, , ,2021-05-13,The Journal of nutrition,Abstract,https://clinicaltrials.gov/ct2/show/NCT04450017,1
33983065,NCT04523831,Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial.,Journal Article|Randomized Controlled Trial,Ivermectin|Doxycycline|NA,Adult|COVID-19|Doxycycline|Female|Humans|Ivermectin|Male|SARS-CoV-2|Treatment Outcome|NA,2021-05-17,The Journal of international medical research,Abstract,https://clinicaltrials.gov/ct2/show/NCT04523831,1
34000236,NCT04324528,"Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial.",Journal Article, , ,2021-05-20,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04324528,1
34001174,NCT04497324,Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.,Letter, , ,2021-05-21,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04497324,1
34001215,NCT04681430,Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.,Letter, , ,2021-05-21,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04681430,1
34002039,NCT04318366,Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity.,Journal Article, , ,2021-05-21,International journal of obesity (2005),Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
34004154,NCT04338841,Outpatient Management of Patients With COVID-19: Multicenter Prospective Validation of the Hospitalization or Outpatient Management of Patients With SARS-CoV-2 Infection Rule to Discharge Patients Safely.,Journal Article, , ,2021-06-01,Chest,Abstract,https://clinicaltrials.gov/ct2/show/NCT04338841,2
34013254,NCT04373135,Rapid Deployment of A Community Engagement Study And Educational Trial Via Social Media: Implementation of The UC-COVID Study.,Preprint, , ,2021-05-25,Research square,Abstract,https://clinicaltrials.gov/ct2/show/NCT04373135,1
34013969,NCT04345523,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04345523,2
34013969,NCT04356534,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04356534,2
34013969,NCT04381936,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04381936,4
34013969,NCT04434131,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04434131,3
34013969,NCT04479163,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04479163,2
34013969,NCT04392414,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04392414,1
34013969,NCT04343261,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04343261,4
34013969,NCT04340050,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04340050,2
34013969,NCT04342182,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04342182,2
34013969,NCT04530370,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04530370,1
34013969,NCT04359810,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04359810,3
34013969,NCT04375098,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04375098,2
34013969,NCT04383535,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04383535,2
34013969,NCT04344535,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04344535,1
34013969,NCT04381858,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04381858,1
34013969,NCT04494984,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04494984,2
34013969,NCT04357106,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04357106,2
34013969,NCT04346446,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04346446,1
34013969,NCT04441424,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04441424,2
34013969,NCT04321421,Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Bias|COVID-19|Cause of Death|Humans|Immunization, Passive|Non-Randomized Controlled Trials as Topic|Pandemics|Randomized Controlled Trials as Topic|Respiration, Artificial|Treatment Outcome|Ventilator Weaning|NA",2021-05-26,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04321421,4
34019535,NCT04370288,"METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2.","Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial",Methylene Blue|NA,Adult|Aged|COVID-19|Female|Hospitalization|Humans|Male|Methylene Blue|Middle Aged|NA,2021-06-03,Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,Abstract,https://clinicaltrials.gov/ct2/show/NCT04370288,2
34021827,NCT04716088,Usefulness of rapid antigen testing for SARS-CoV-2 screening of healthcare workers: a pilot study.,Letter, , ,2021-05-25,Clinical and experimental medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04716088,1
34029377,NCT04459247,Vitamin D supplementation for the treatment of COVID-19: a living systematic review.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Adrenal Cortex Hormones|Vitamins|Cholecalciferol|25-Hydroxyvitamin D 2|Hydroxychloroquine|Ceftriaxone|Azithromycin|Calcifediol|NA,"25-Hydroxyvitamin D 2|Adrenal Cortex Hormones|Adult|Azithromycin|Bias|COVID-19|Calcifediol|Cause of Death|Ceftriaxone|Cholecalciferol|Drug Therapy, Combination|Humans|Hydroxychloroquine|Middle Aged|Quality of Life|Randomized Controlled Trials as Topic|Vitamin D Deficiency|Vitamins|NA",2021-06-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04459247,2
34029377,NCT04449718,Vitamin D supplementation for the treatment of COVID-19: a living systematic review.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Adrenal Cortex Hormones|Vitamins|Cholecalciferol|25-Hydroxyvitamin D 2|Hydroxychloroquine|Ceftriaxone|Azithromycin|Calcifediol|NA,"25-Hydroxyvitamin D 2|Adrenal Cortex Hormones|Adult|Azithromycin|Bias|COVID-19|Calcifediol|Cause of Death|Ceftriaxone|Cholecalciferol|Drug Therapy, Combination|Humans|Hydroxychloroquine|Middle Aged|Quality of Life|Randomized Controlled Trials as Topic|Vitamin D Deficiency|Vitamins|NA",2021-06-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04449718,2
34029377,NCT04366908,Vitamin D supplementation for the treatment of COVID-19: a living systematic review.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Adrenal Cortex Hormones|Vitamins|Cholecalciferol|25-Hydroxyvitamin D 2|Hydroxychloroquine|Ceftriaxone|Azithromycin|Calcifediol|NA,"25-Hydroxyvitamin D 2|Adrenal Cortex Hormones|Adult|Azithromycin|Bias|COVID-19|Calcifediol|Cause of Death|Ceftriaxone|Cholecalciferol|Drug Therapy, Combination|Humans|Hydroxychloroquine|Middle Aged|Quality of Life|Randomized Controlled Trials as Topic|Vitamin D Deficiency|Vitamins|NA",2021-06-03,The Cochrane database of systematic reviews,Abstract,https://clinicaltrials.gov/ct2/show/NCT04366908,1
34031519,NCT04435223,High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia.,"Journal Article|Research Support, Non-U.S. Gov't","Apolipoproteins E|Arachidonic Acids|Cholesterol, HDL|Cytokines|Fatty Acids, Nonesterified|Linoleic Acids|NA","Aged|Apolipoproteins E|Arachidonic Acids|COVID-19|Cholesterol, HDL|Cytokines|Fatty Acids, Nonesterified|Female|Humans|Linoleic Acids|Male|Middle Aged|Principal Component Analysis|SARS-CoV-2|Severity of Illness Index|NA",2021-06-02,Scientific reports,Abstract,https://clinicaltrials.gov/ct2/show/NCT04435223,1
34034777,NCT04359693,Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort.,"Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't", ,"Aged|COVID-19|Europe|Female|Hospital Mortality|Humans|Intensive Care Units|Length of Stay|Male|Middle Aged|Pneumonia, Ventilator-Associated|Respiration, Artificial|Retrospective Studies|NA",2021-06-01,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04359693,1
34034784,NCT04790786,"The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.",Letter, , ,2021-05-29,Trials,Abstract,https://clinicaltrials.gov/ct2/show/NCT04790786,1
34037666,NCT04510207,Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.,Journal Article, , ,2021-05-26,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04510207,1
34037911,NCT04652648,"Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic.",Journal Article, , ,2021-05-28,Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing,Abstract,https://clinicaltrials.gov/ct2/show/NCT04652648,1
34043668,NCT04484545,The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts.,Journal Article, , ,2021-06-01,PloS one,Abstract,https://clinicaltrials.gov/ct2/show/NCT04484545,1
34043894,NCT04368728,"Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.",Journal Article, , ,2021-05-27,The New England journal of medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04368728,5
34049308,NCT04420468,Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.,Journal Article, , ,2021-05-31,Critical care medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04420468,1
34051877,NCT04322682,"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.",Journal Article, , ,2021-05-30,The Lancet. Respiratory medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04322682,1
34051886,NCT04668625,Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial.,Journal Article, , ,2021-05-30,The Lancet. Infectious diseases,Abstract,https://clinicaltrials.gov/ct2/show/NCT04668625,1
34055928,NCT04331574,Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients.,Journal Article, , ,2021-06-01,Frontiers in cardiovascular medicine,Abstract,https://clinicaltrials.gov/ct2/show/NCT04331574,3
34059384,NCT04318366,"Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study.",Journal Article, , ,2021-06-01,"Nutrition, metabolism, and cardiovascular diseases : NMCD",Abstract,https://clinicaltrials.gov/ct2/show/NCT04318366,10
34074313,NCT04337983,COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study.,Journal Article, , ,2021-06-03,"Critical care (London, England)",Abstract,https://clinicaltrials.gov/ct2/show/NCT04337983,1
34078399,NCT04316884,"Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study.",Journal Article, , ,2021-06-03,Thrombosis journal,Abstract,https://clinicaltrials.gov/ct2/show/NCT04316884,2
34081073,NCT04497987,Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.,Journal Article, , ,2021-06-03,JAMA,Abstract,https://clinicaltrials.gov/ct2/show/NCT04497987,1
21475695,NCT04780126,An overview of sarcopenia: facts and numbers on prevalence and clinical impact.,Journal Article, , ,2021-03-10,"Journal of cachexia, sarcopenia and muscle",Registry,https://clinicaltrials.gov/ct2/show/NCT04780126,0
27856406,NCT04407507,"Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya.",Journal Article, , ,2020-09-30,JMIR research protocols,Registry,https://clinicaltrials.gov/ct2/show/NCT04407507,0
29264361,NCT04466670,Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies.,Journal Article|Review, , ,2020-10-01,Annals of translational medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
29420257,NCT04779944,Psychological resilience and post-traumatic growth in disaster-exposed organisations: overview of the literature.,Journal Article|Review, ,"Adaptation, Psychological|Disasters|Health Personnel|Humans|Occupational Exposure|Posttraumatic Growth, Psychological|Protective Factors|Relief Work|Rescue Work|Resilience, Psychological|Self Efficacy|Social Support|NA",2020-12-29,BMJ military health,Registry,https://clinicaltrials.gov/ct2/show/NCT04779944,0
29619244,NCT04333550,Antiviral effects of ferric ammonium citrate.,Journal Article, , ,2020-09-29,Cell discovery,Registry,https://clinicaltrials.gov/ct2/show/NCT04333550,0
29772761,NCT04382768,High Concentrations of Sodium Chloride Improve Microbicidal Activity of Ibuprofen against Common Cystic Fibrosis Pathogens.,Journal Article, , ,2020-10-01,"Pharmaceuticals (Basel, Switzerland)",Registry,https://clinicaltrials.gov/ct2/show/NCT04382768,0
30127696,NCT04503434,Implementation of Home Hospitalization and Early Discharge as an Integrated Care Service: A Ten Years Pragmatic Assessment.,Journal Article, , ,2020-09-30,International journal of integrated care,Registry,https://clinicaltrials.gov/ct2/show/NCT04503434,0
30206520,NCT04468893,The acceptability of an online intervention using positive psychology for depression: A qualitative study.,Journal Article, , ,2020-09-30,Internet interventions,Registry,https://clinicaltrials.gov/ct2/show/NCT04468893,1
30505605,NCT04424953,Haemodynamic Response to Four Different Laryngoscopes.,Journal Article, , ,2020-10-01,Turkish journal of anaesthesiology and reanimation,Registry,https://clinicaltrials.gov/ct2/show/NCT04424953,0
30535520,NCT04445961,Driving pressure and long-term outcomes in moderate/severe acute respiratory distress syndrome.,Journal Article, , ,2020-10-01,Annals of intensive care,Registry,https://clinicaltrials.gov/ct2/show/NCT04445961,0
30760036,NCT04632615,Athletes' rest-activity circadian rhythm differs in accordance with the sport discipline.,Journal Article|Observational Study, ,Adult|Circadian Rhythm|Exercise|Female|Humans|Male|Prospective Studies|Rest|Sleep|Sports|Young Adult|NA,2020-06-10,Chronobiology international,Registry,https://clinicaltrials.gov/ct2/show/NCT04632615,0
30805949,NCT04369807,NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.,"Clinical Trial|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't",Biomarkers|Fibroblast Growth Factors|aldafermin|NA,"Adolescent|Adult|Aged|Biomarkers|Female|Fibroblast Growth Factors|Humans|Injections, Subcutaneous|Liver Cirrhosis|Male|Middle Aged|Non-alcoholic Fatty Liver Disease|Young Adult|NA",2021-04-14,"Hepatology (Baltimore, Md.)",Registry,https://clinicaltrials.gov/ct2/show/NCT04369807,1
30863805,NCT04542512,Gangrenous cholecystitis in male patients: A study of prevalence and predictive risk factors.,Journal Article, , ,2020-10-01,Annals of hepato-biliary-pancreatic surgery,Registry,https://clinicaltrials.gov/ct2/show/NCT04542512,0
30958989,NCT04482634,Optimizing Post-Intensive Care Unit Rehabilitation.,Journal Article|Review, , ,2020-09-28,Turkish thoracic journal,Registry,https://clinicaltrials.gov/ct2/show/NCT04482634,0
30976418,NCT04359095,Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010-2014.,Journal Article, , ,2020-09-30,Multidisciplinary respiratory medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04359095,0
31024197,NCT04668404,A/H1N1/09 Influenza is Associated With High Mortality in Liver Cirrhosis.,Journal Article, , ,2020-09-28,Journal of clinical and experimental hepatology,Registry,https://clinicaltrials.gov/ct2/show/NCT04668404,0
31077821,NCT04668404,"Heparin-like Effect Associated With Risk of Bleeding, Sepsis, and Death in Patients With Severe Alcohol-Associated Hepatitis.",Journal Article, , ,2020-10-19,Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,Registry,https://clinicaltrials.gov/ct2/show/NCT04668404,0
31168572,NCT04441814,Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.,Journal Article|Published Erratum, , ,2020-04-05,Annals of oncology : official journal of the European Society for Medical Oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04441814,0
31262511,NCT04511429,Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients.,Journal Article, ,Adult|Aged|Cohort Studies|Community-Acquired Infections|Critical Illness|Disease Susceptibility|Female|Hematopoietic Stem Cell Transplantation|Humans|Immunocompromised Host|Immunosuppression|Male|Middle Aged|Organ Transplantation|Republic of Korea|Respiratory Tract Infections|Retrospective Studies|Risk Factors|Transplant Recipients|NA,2021-04-29,"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi",Registry,https://clinicaltrials.gov/ct2/show/NCT04511429,0
31264386,NCT04610554,Value of lung diffusing capacity for nitric oxide in systemic sclerosis.,Evaluation Study|Journal Article,Nitric Oxide|Carbon Monoxide|NA,"Adult|Aged|Carbon Monoxide|Female|Humans|Male|Middle Aged|Nitric Oxide|Pulmonary Diffusing Capacity|Pulmonary Fibrosis|Scleroderma, Systemic|Sensitivity and Specificity|NA",2020-06-02,Physiological reports,Registry,https://clinicaltrials.gov/ct2/show/NCT04610554,1
31282542,NCT04410328,"A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.","Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural",Biomarkers|Phosphodiesterase Inhibitors|Dipyridamole|NA,Adolescent|Adult|Biomarkers|Chronic Disease|Dipyridamole|Double-Blind Method|HIV Infections|HIV-1|Humans|Inflammation|Middle Aged|Phosphodiesterase Inhibitors|Pilot Projects|Young Adult|NA,2021-02-05,The Journal of infectious diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04410328,0
31346914,NCT04338568,The diagnostic accuracy for ARDS of global versus regional lung ultrasound scores - a post hoc analysis of an observational study in invasively ventilated ICU patients.,Journal Article, , ,2020-09-30,Intensive care medicine experimental,Registry,https://clinicaltrials.gov/ct2/show/NCT04338568,0
31406926,NCT04668404,Noninvasive estimation of intravascular volume status in cirrhosis by dynamic size and collapsibility indices of the inferior vena cava using bedside echocardiography.,Journal Article, , ,2020-09-30,JGH open : an open access journal of gastroenterology and hepatology,Registry,https://clinicaltrials.gov/ct2/show/NCT04668404,0
31464823,NCT04841785,Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood Samples.,Journal Article,Adalimumab|NA,"Adalimumab|Adult|Bayes Theorem|Colitis, Ulcerative|Crohn Disease|Drug Monitoring|Female|Humans|Male|Middle Aged|Prospective Studies|Specimen Handling|NA",2021-05-05,Therapeutic drug monitoring,Registry,https://clinicaltrials.gov/ct2/show/NCT04841785,0
31606437,NCT04642326,"Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.","Clinical Trial|Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Canada|Disease Transmission, Infectious|Female|Graft Survival|Hepacivirus|Hepatitis C|Humans|Lung|Lung Transplantation|Male|Middle Aged|Perfusion|Pilot Projects|Proof of Concept Study|Prospective Studies|Tissue Donors|Transplants|Treatment Outcome|Viremia|NA",2020-08-24,The Lancet. Respiratory medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04642326,0
31682582,NCT04374786,"Characteristics and Usage Patterns Among 12,151 Paid Subscribers of the Calm Meditation App: Cross-Sectional Survey.",Journal Article, ,"Adolescent|Aged|Aged, 80 and over|Arizona|Cross-Sectional Studies|Female|Humans|Male|Meditation|Middle Aged|Mobile Applications|Patients|Surveys and Questionnaires|NA",2020-09-15,JMIR mHealth and uHealth,Registry,https://clinicaltrials.gov/ct2/show/NCT04374786,0
31756987,NCT04441814,<i>In Silico</i> Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis.,Journal Article,"Biomarkers, Tumor|MicroRNAs|NA","Biomarkers, Tumor|Breast Neoplasms|Female|Gene Regulatory Networks|Humans|Machine Learning|Magnetic Resonance Imaging|MicroRNAs|Transcriptome|NA",2020-04-13,International journal of molecular sciences,Registry,https://clinicaltrials.gov/ct2/show/NCT04441814,0
31762329,NCT04282902,The efficacy of pirfenidone in a sheep model of pulmonary fibrosis.,Journal Article,Indoles|Pyridones|Bleomycin|pirfenidone|nintedanib|NA,"Animals|Bleomycin|Disease Models, Animal|Extracellular Matrix|Female|Idiopathic Pulmonary Fibrosis|Indoles|Lung|Myofibroblasts|Pyridones|Sheep|NA",2020-05-26,Experimental lung research,Registry,https://clinicaltrials.gov/ct2/show/NCT04282902,0
31818628,NCT04673214,Rivaroxaban for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Design of the PRO-LAPS II STUDY.,"Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Anticoagulants|Fibrinolytic Agents|Rivaroxaban|NA,Anticoagulants|Colorectal Neoplasms|Fibrinolytic Agents|Humans|Laparoscopy|Rivaroxaban|Venous Thromboembolism|NA,2021-02-15,European journal of internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04673214,0
31849989,NCT04594356,Neutrophil Extracellular Traps in Autoimmunity and Allergy: Immune Complexes at Work.,Journal Article|Review,Antigen-Antibody Complex|NA,Anaphylaxis|Animals|Antigen-Antibody Complex|Autoimmune Diseases|Autoimmunity|Extracellular Traps|Humans|Hypersensitivity|Neutrophils|NA,2020-11-19,Frontiers in immunology,Registry,https://clinicaltrials.gov/ct2/show/NCT04594356,0
31853861,NCT04480034,Weight Regain and Diabetes Evolution After Sleeve Gastrectomy: a Cohort Study with over 5Â Years of Follow-Up.,Journal Article, ,"Adult|Cohort Studies|Diabetes Mellitus, Type 2|Female|Follow-Up Studies|Gastrectomy|Humans|Laparoscopy|Male|Middle Aged|Obesity, Morbid|Retrospective Studies|Treatment Outcome|Weight Gain|Weight Loss|NA",2021-04-14,Obesity surgery,Registry,https://clinicaltrials.gov/ct2/show/NCT04480034,0
31930543,NCT04642326,"Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.",Journal Article,Methylene Blue|NA,"Blood Platelets|Blood Transfusion|Hemorrhagic Fever Virus, Crimean-Congo|Humans|Light|Methylene Blue|Nipah Virus|Plasma|SARS Virus|Ultraviolet Rays|Virus Inactivation|NA",2020-10-19,Vox sanguinis,Registry,https://clinicaltrials.gov/ct2/show/NCT04642326,0
31933547,NCT04394182,Application of Low Doses of Ionizing Radiation in Medical Therapies.,Journal Article, , ,2020-09-30,Dose-response : a publication of International Hormesis Society,Registry,https://clinicaltrials.gov/ct2/show/NCT04394182,1
31936284,NCT04501965,The Use of Antimalarial Drugs against Viral Infection.,Journal Article|Review, , ,2020-09-30,Microorganisms,Registry,https://clinicaltrials.gov/ct2/show/NCT04501965,0
31986264,NCT04567927,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Age Distribution|Aged|COVID-19|China|Comorbidity|Coronavirus Infections|Cough|Female|Fever|Hospitalization|Humans|Intensive Care Units|Male|Middle Aged|Myalgia|Pneumonia, Viral|Prognosis|Radiography, Thoracic|Respiratory Distress Syndrome|Time Factors|Tomography, X-Ray Computed|Young Adult|NA",2020-03-13,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04567927,0
31986264,NCT04459819,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Age Distribution|Aged|COVID-19|China|Comorbidity|Coronavirus Infections|Cough|Female|Fever|Hospitalization|Humans|Intensive Care Units|Male|Middle Aged|Myalgia|Pneumonia, Viral|Prognosis|Radiography, Thoracic|Respiratory Distress Syndrome|Time Factors|Tomography, X-Ray Computed|Young Adult|NA",2020-03-13,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04459819,0
31988433,NCT04780152,Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review.,Journal Article|Review|Systematic Review,Antidepressive Agents|NA,"Antidepressive Agents|Clinical Trials, Phase II as Topic|Clinical Trials, Phase III as Topic|Depressive Disorder, Major|Double-Blind Method|Humans|Randomized Controlled Trials as Topic|Sample Size|Single-Blind Method|Treatment Outcome|NA",2021-05-14,Molecular psychiatry,Registry,https://clinicaltrials.gov/ct2/show/NCT04780152,0
31999307,NCT04631861,"The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.",Journal Article, ,"Betacoronavirus|COVID-19|China|Communicable Disease Control|Coronavirus Infections|Global Health|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|World Health Organization|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04631861,0
32000806,NCT04407468,Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study.,Journal Article|Multicenter Study|Observational Study, ,Adult|Cannula|Cohort Studies|Female|Humans|Hypoxia|Male|Middle Aged|Patient Positioning|Patient Safety|Prone Position|Prospective Studies|Respiratory Distress Syndrome|Respiratory Insufficiency|NA,2020-10-30,"Critical care (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04407468,0
32025779,NCT04374422,"Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China.",Journal Article, ,"Betacoronavirus|COVID-19|China|Coronavirus Infections|Epidemics|Health Planning|Hospitals|Humans|Intensive Care Units|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-16,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04374422,0
32031570,NCT04753762,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32031570,NCT04442178,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04442178,0
32031570,NCT04340921,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04340921,1
32031570,NCT04445961,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04445961,0
32031570,NCT04567927,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04567927,0
32031570,NCT04499378,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04499378,0
32031570,NCT04497311,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04497311,0
32031570,NCT04407689,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04407689,0
32031570,NCT04422535,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Disease Transmission, Infectious|Female|Hospitalization|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Vital Signs|Young Adult|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04422535,0
32039812,NCT04374786,Cancer Patients' and Survivors' Perceptions of the Calm App: Cross-Sectional Descriptive Study.,Journal Article, , ,2020-09-28,JMIR cancer,Registry,https://clinicaltrials.gov/ct2/show/NCT04374786,0
32043986,NCT04325061,"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.","Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Glucocorticoids|Dexamethasone|NA,"Administration, Intravenous|Adult|Aged|Dexamethasone|Female|Glucocorticoids|Humans|Intensive Care Units|Male|Middle Aged|Respiration, Artificial|Respiratory Distress Syndrome|Severity of Illness Index|Treatment Outcome|NA",2020-09-30,The Lancet. Respiratory medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04325061,1
32052466,NCT04367883,Potential interventions for novel coronavirus in China: A systematic review.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review",Antiviral Agents|COVID-19 Vaccines|Immunologic Factors|Trace Elements|Viral Vaccines|Vitamins|NA,"Antiviral Agents|Betacoronavirus|COVID-19|COVID-19 Vaccines|China|Coronavirus Infections|Humans|Immunization, Passive|Immunologic Factors|Nutritional Status|Plasma|Pneumonia, Viral|SARS-CoV-2|Trace Elements|Viral Vaccines|Vitamins|NA",2020-03-18,Journal of medical virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04367883,0
32053470,NCT04441814,Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19).,Journal Article, ,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Radiography, Thoracic|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|NA",2020-05-21,Radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04441814,0
32077115,NCT04407169,"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.",Journal Article,C-Reactive Protein|NA,"Adult|Aged|Aged, 80 and over|Betacoronavirus|C-Reactive Protein|COVID-19|China|Community-Acquired Infections|Comorbidity|Coronavirus Infections|Diabetes Mellitus|Eosinophils|Female|Hospitalization|Humans|Hypertension|Lymphopenia|Male|Middle Aged|Pandemics|Pneumonia, Viral|Risk Factors|SARS-CoV-2|Severity of Illness Index|NA",2020-08-03,Allergy,Registry,https://clinicaltrials.gov/ct2/show/NCT04407169,0
32077789,NCT04661631,Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.,Journal Article, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Lung|Lung Diseases|Male|Middle Aged|Pandemics|Pneumonia, Viral|Radiography, Thoracic|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Young Adult|NA",2020-05-21,Radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32083985,NCT04497311,Coronavirus Disease 2019 (COVID-19): A Perspective from China.,"Journal Article|Research Support, Non-U.S. Gov't|Review", ,"Betacoronavirus|COVID-19|COVID-19 Testing|China|Clinical Laboratory Techniques|Coronavirus Infections|Diagnosis, Differential|Early Diagnosis|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|Severity of Illness Index|Tomography, X-Ray Computed|NA",2020-07-31,Radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04497311,0
32085846,NCT04753762,Pathological findings of COVID-19 associated with acute respiratory distress syndrome.,Case Reports, , ,2020-04-14,The Lancet. Respiratory medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32089354,NCT04517162,Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?,Journal Article|Meta-Analysis|Systematic Review,"Biomarkers|CCL18 protein, human|Chemokines, CC|MUC1 protein, human|Mucin-1|NA","Aged|Biomarkers|Chemokines, CC|Connective Tissue Diseases|Female|Humans|Idiopathic Pulmonary Fibrosis|Lung Diseases, Interstitial|Male|Mucin-1|NA",2021-04-27,Seminars in arthritis and rheumatism,Registry,https://clinicaltrials.gov/ct2/show/NCT04517162,0
32091533,NCT04475471,Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72â€¯314 Cases From the Chinese Center for Disease Control and Prevention.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|China|Communicable Disease Control|Coronavirus Infections|Disease Outbreaks|Humans|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Severe Acute Respiratory Syndrome|World Health Organization|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04475471,0
32091533,NCT04366232,Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72â€¯314 Cases From the Chinese Center for Disease Control and Prevention.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|China|Communicable Disease Control|Coronavirus Infections|Disease Outbreaks|Humans|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Severe Acute Respiratory Syndrome|World Health Organization|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04366232,0
32091533,NCT04661631,Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72â€¯314 Cases From the Chinese Center for Disease Control and Prevention.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|China|Communicable Disease Control|Coronavirus Infections|Disease Outbreaks|Humans|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Severe Acute Respiratory Syndrome|World Health Organization|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32091533,NCT04353674,Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72â€¯314 Cases From the Chinese Center for Disease Control and Prevention.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|China|Communicable Disease Control|Coronavirus Infections|Disease Outbreaks|Humans|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Severe Acute Respiratory Syndrome|World Health Organization|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04353674,0
32091533,NCT04753762,Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72â€¯314 Cases From the Chinese Center for Disease Control and Prevention.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|China|Communicable Disease Control|Coronavirus Infections|Disease Outbreaks|Humans|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Severe Acute Respiratory Syndrome|World Health Organization|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32091533,NCT04567927,Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72â€¯314 Cases From the Chinese Center for Disease Control and Prevention.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|China|Communicable Disease Control|Coronavirus Infections|Disease Outbreaks|Humans|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Severe Acute Respiratory Syndrome|World Health Organization|NA",2020-09-22,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04567927,0
32096367,NCT04368351,[Management of corona virus disease-19 (COVID-19): the Zhejiang experience].,Journal Article,Antiviral Agents|NA,"Antibiotic Prophylaxis|Antiviral Agents|COVID-19|China|Coronavirus Infections|Critical Illness|Humans|Medicine, Chinese Traditional|Nutritional Support|Pneumonia, Viral|Respiration, Artificial|Shock|Stress, Psychological|Water-Electrolyte Balance|NA",2020-03-16,Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,Registry,https://clinicaltrials.gov/ct2/show/NCT04368351,0
32101510,NCT04407468,Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.,Comparative Study|Journal Article, ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|COVID-19 Testing|Child|Child, Preschool|China|Clinical Laboratory Techniques|Coronavirus Infections|Female|Follow-Up Studies|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Reproducibility of Results|Retrospective Studies|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Sensitivity and Specificity|Tomography, X-Ray Computed|Young Adult|NA",2020-07-31,Radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04407468,0
32101510,NCT04661631,Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.,Comparative Study|Journal Article, ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|COVID-19 Testing|Child|Child, Preschool|China|Clinical Laboratory Techniques|Coronavirus Infections|Female|Follow-Up Studies|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Reproducibility of Results|Retrospective Studies|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Sensitivity and Specificity|Tomography, X-Ray Computed|Young Adult|NA",2020-07-31,Radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32102726,NCT04424953,Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease 2019.,Journal Article, , ,2020-07-21,Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,Registry,https://clinicaltrials.gov/ct2/show/NCT04424953,0
32103284,NCT04611269,Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus|Coronavirus Infections|Critical Care|Decision Making|Humans|Intensive Care Units|Pandemics|Pneumonia, Viral|Practice Guidelines as Topic|SARS-CoV-2|NA",2020-04-03,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04611269,0
32105632,NCT04567927,"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.",Journal Article|Observational Study, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Female|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Pneumonia, Viral|Respiration, Artificial|Respiratory Distress Syndrome|Retrospective Studies|SARS-CoV-2|Treatment Outcome|NA",2020-05-14,The Lancet. Respiratory medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04567927,0
32105637,NCT04577105,"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.",Journal Article, ,"Adult|Aged|Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|Tomography, X-Ray Computed|NA",2020-04-08,The Lancet. Infectious diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04577105,0
32107577,NCT04627467,Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.,Journal Article, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|China|Clinical Laboratory Techniques|Coronavirus Infections|Cough|Disease Progression|Female|Fever|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|Tomography, X-Ray Computed|Young Adult|NA",2020-04-03,European journal of nuclear medicine and molecular imaging,Registry,https://clinicaltrials.gov/ct2/show/NCT04627467,0
32109013,NCT04611269,Clinical Characteristics of Coronavirus Disease 2019 in China.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Child|China|Coronavirus Infections|Disease Outbreaks|Female|Fever|Humans|Male|Middle Aged|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Young Adult|NA",2020-05-05,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04611269,0
32109013,NCT04369807,Clinical Characteristics of Coronavirus Disease 2019 in China.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Child|China|Coronavirus Infections|Disease Outbreaks|Female|Fever|Humans|Male|Middle Aged|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Young Adult|NA",2020-05-05,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04369807,1
32109013,NCT04896918,Clinical Characteristics of Coronavirus Disease 2019 in China.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Child|China|Coronavirus Infections|Disease Outbreaks|Female|Fever|Humans|Male|Middle Aged|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Young Adult|NA",2020-05-05,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04896918,0
32125452,NCT04353674,"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.",Letter, ,"Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Humans|Male|Pandemics|Pneumonia, Viral|Risk Assessment|Risk Factors|SARS-CoV-2|NA",2020-05-14,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04353674,0
32125452,NCT04340921,"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.",Letter, ,"Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Humans|Male|Pandemics|Pneumonia, Viral|Risk Assessment|Risk Factors|SARS-CoV-2|NA",2020-05-14,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04340921,1
32125458,NCT04344951,COVID-19: a novel coronavirus and a novel challenge for critical care.,Journal Article, ,"COVID-19|Capacity Building|Coronavirus Infections|Health Personnel|Hospital Bed Capacity|Humans|Intensive Care Units|Pandemics|Personal Protective Equipment|Pneumonia, Viral|Surge Capacity|NA",2020-05-14,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04344951,0
32129478,NCT04385043,Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States.,"Clinical Trial, Phase I|Journal Article|Research Support, N.I.H., Extramural","Antibodies, Neutralizing|Antibodies, Viral|Ficusin|NA","Animals|Antibodies, Neutralizing|Antibodies, Viral|Blood Donors|Chlorocebus aethiops|Convalescence|Ebolavirus|Ficusin|Hemorrhagic Fever, Ebola|Humans|Immunity, Active|Immunization, Passive|Neutralization Tests|Plasma|Seroconversion|United States|Vero Cells|Viral Load|NA",2020-09-08,Transfusion,Registry,https://clinicaltrials.gov/ct2/show/NCT04385043,0
32129518,NCT04369807,Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.,Journal Article,"Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists|Peptidyl-Dipeptidase A|ACE2 protein, human|Angiotensin-Converting Enzyme 2|NA","Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme 2|Betacoronavirus|Binding Sites|COVID-19|Coronavirus Infections|Humans|Pandemics|Peptidyl-Dipeptidase A|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-10,Drug development research,Registry,https://clinicaltrials.gov/ct2/show/NCT04369807,1
32134116,NCT04661631,Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.,"Journal Article|Research Support, Non-U.S. Gov't|Review",Antiviral Agents|COVID-19 Vaccines|Viral Vaccines|NA,"Antiviral Agents|Betacoronavirus|COVID-19|COVID-19 Vaccines|China|Communicable Disease Control|Coronavirus Infections|Humans|Immunization, Passive|Lymphopenia|Middle East Respiratory Syndrome Coronavirus|Pandemics|Pneumonia, Viral|Prevalence|SARS Virus|SARS-CoV-2|Severe Acute Respiratory Syndrome|Survival Analysis|Thrombocytopenia|Viral Vaccines|NA",2020-06-30,Journal of medical virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32135219,NCT04407507,The broad spectrum antiviral ivermectin targets the host nuclear transport importin Î±/Î²1 heterodimer.,"Journal Article|Research Support, Non-U.S. Gov't",alpha Karyopherins|beta Karyopherins|Ivermectin|NA,"Active Transport, Cell Nucleus|Animals|Cell Line|Chlorocebus aethiops|Cricetinae|Flavivirus Infections|Ivermectin|Kidney|Protein Binding|Vero Cells|alpha Karyopherins|beta Karyopherins|NA",2021-04-01,Antiviral research,Registry,https://clinicaltrials.gov/ct2/show/NCT04407507,0
32140081,NCT04394182,Low-Dose radiation therapy for benign pathologies.,Journal Article|Review, , ,2021-03-02,Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04394182,1
32150618,NCT04627467,In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).,"Journal Article|Research Support, Non-U.S. Gov't",Antiviral Agents|Hydroxychloroquine|Chloroquine|NA,"Animals|Antiviral Agents|Betacoronavirus|COVID-19|Cell Line|Chlorocebus aethiops|Chloroquine|Coronavirus Infections|Hydroxychloroquine|Lung|Pandemics|Pneumonia, Viral|SARS-CoV-2|Severe Acute Respiratory Syndrome|Vero Cells|NA",2020-08-10,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Registry,https://clinicaltrials.gov/ct2/show/NCT04627467,0
32150748,NCT04661631,The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.,Journal Article, ,"Adult|Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Humans|Infectious Disease Incubation Period|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|NA",2020-05-13,Annals of internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32155105,NCT04497311,Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT.,"Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Competence|Clinical Laboratory Techniques|Coronavirus Infections|Diagnosis, Differential|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Predictive Value of Tests|Radiologists|Retrospective Studies|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Sensitivity and Specificity|Tomography, X-Ray Computed|NA",2020-07-31,Radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04497311,0
32159775,NCT04661631,Detection of SARS-CoV-2 in Different Types of Clinical Specimens.,"Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't","RNA, Viral|NA","Adolescent|Adult|Aged|Betacoronavirus|Bronchoalveolar Lavage Fluid|Bronchoscopy|COVID-19|Child|Child, Preschool|China|Coronavirus Infections|Feces|Female|Gene Dosage|Genes, Viral|Humans|Male|Middle Aged|Nose|Open Reading Frames|Pandemics|Pharynx|Pneumonia, Viral|RNA, Viral|Real-Time Polymerase Chain Reaction|SARS-CoV-2|Sputum|Viral Load|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32159775,NCT04517162,Detection of SARS-CoV-2 in Different Types of Clinical Specimens.,"Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't","RNA, Viral|NA","Adolescent|Adult|Aged|Betacoronavirus|Bronchoalveolar Lavage Fluid|Bronchoscopy|COVID-19|Child|Child, Preschool|China|Coronavirus Infections|Feces|Female|Gene Dosage|Genes, Viral|Humans|Male|Middle Aged|Nose|Open Reading Frames|Pandemics|Pharynx|Pneumonia, Viral|RNA, Viral|Real-Time Polymerase Chain Reaction|SARS-CoV-2|Sputum|Viral Load|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04517162,0
32162702,NCT04441814,"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Review",Biomarkers|C-Reactive Protein|NA,"Betacoronavirus|Biomarkers|C-Reactive Protein|COVID-19|China|Coronavirus Infections|Cough|Dyspnea|Female|Fever|Humans|Incidence|Lymphopenia|Male|Pandemics|Patient Discharge|Pneumonia, Viral|SARS-CoV-2|Sex Factors|Survival Analysis|NA",2020-06-30,Journal of medical virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04441814,0
32164834,NCT04321369,How will country-based mitigation measures influence the course of the COVID-19 epidemic?,Journal Article, ,"Basic Reproduction Number|Betacoronavirus|COVID-19|Contact Tracing|Coronavirus Infections|Humans|Mortality|Pneumonia, Viral|Quarantine|SARS-CoV-2|NA",2020-03-26,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04321369,0
32166241,NCT04459819,Factors Associated With Discharge Home Among Medical ICU Patients in an Early Mobilization Program.,Journal Article, , ,2021-03-23,Critical care explorations,Registry,https://clinicaltrials.gov/ct2/show/NCT04459819,0
32166346,NCT04661631,Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic.,Letter, ,COVID-19|Epidemics|Humans|Lung|Pneumonia|SARS-CoV-2|Ultrasonography|NA,2021-04-27,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32167524,NCT04661631,"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Age Factors|Aged|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Female|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Patient Care Planning|Pneumonia, Viral|Respiratory Distress Syndrome|Retrospective Studies|SARS-CoV-2|NA",2020-09-30,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32167524,NCT04353674,"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Age Factors|Aged|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Female|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Patient Care Planning|Pneumonia, Viral|Respiratory Distress Syndrome|Retrospective Studies|SARS-CoV-2|NA",2020-09-30,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04353674,0
32167524,NCT04441814,"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Age Factors|Aged|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Female|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Patient Care Planning|Pneumonia, Viral|Respiratory Distress Syndrome|Retrospective Studies|SARS-CoV-2|NA",2020-09-30,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04441814,0
32167524,NCT04611269,"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Age Factors|Aged|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Female|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Patient Care Planning|Pneumonia, Viral|Respiratory Distress Syndrome|Retrospective Studies|SARS-CoV-2|NA",2020-09-30,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04611269,0
32167524,NCT04494724,"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Age Factors|Aged|Betacoronavirus|COVID-19|China|Coronavirus Infections|Critical Illness|Female|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Patient Care Planning|Pneumonia, Viral|Respiratory Distress Syndrome|Retrospective Studies|SARS-CoV-2|NA",2020-09-30,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04494724,0
32167538,NCT04369807,"Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.",Journal Article, ,"Betacoronavirus|COVID-19|Communicable Disease Control|Coronavirus Infections|Critical Care|Humans|Intensive Care Units|Italy|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04369807,1
32170806,NCT04369807,Liver injury during highly pathogenic human coronavirus infections.,"Journal Article|Research Support, Non-U.S. Gov't|Review", ,"Betacoronavirus|COVID-19|Coronavirus Infections|Disease Progression|Humans|Liver|Middle East Respiratory Syndrome Coronavirus|Pandemics|Pneumonia, Viral|SARS Virus|SARS-CoV-2|NA",2020-05-04,Liver international : official journal of the International Association for the Study of the Liver,Registry,https://clinicaltrials.gov/ct2/show/NCT04369807,1
32171076,NCT04611269,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.",Journal Article,Fibrin Fibrinogen Degradation Products|fibrin fragment D|NA,"Adolescent|Adult|Age Factors|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|Cardiovascular Diseases|China|Clinical Laboratory Techniques|Cohort Studies|Comorbidity|Coronavirus Infections|Diabetes Complications|Disease Progression|Female|Fibrin Fibrinogen Degradation Products|Humans|Hypertension|Male|Middle Aged|Mortality|Organ Dysfunction Scores|Pandemics|Patient Care Planning|Patient Isolation|Pneumonia, Viral|Prognosis|Retrospective Studies|Risk Assessment|Risk Factors|SARS-CoV-2|Young Adult|NA",2020-04-03,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04611269,0
32171076,NCT04479202,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.",Journal Article,Fibrin Fibrinogen Degradation Products|fibrin fragment D|NA,"Adolescent|Adult|Age Factors|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|Cardiovascular Diseases|China|Clinical Laboratory Techniques|Cohort Studies|Comorbidity|Coronavirus Infections|Diabetes Complications|Disease Progression|Female|Fibrin Fibrinogen Degradation Products|Humans|Hypertension|Male|Middle Aged|Mortality|Organ Dysfunction Scores|Pandemics|Patient Care Planning|Patient Isolation|Pneumonia, Viral|Prognosis|Retrospective Studies|Risk Assessment|Risk Factors|SARS-CoV-2|Young Adult|NA",2020-04-03,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04479202,0
32171076,NCT04333875,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.",Journal Article,Fibrin Fibrinogen Degradation Products|fibrin fragment D|NA,"Adolescent|Adult|Age Factors|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|Cardiovascular Diseases|China|Clinical Laboratory Techniques|Cohort Studies|Comorbidity|Coronavirus Infections|Diabetes Complications|Disease Progression|Female|Fibrin Fibrinogen Degradation Products|Humans|Hypertension|Male|Middle Aged|Mortality|Organ Dysfunction Scores|Pandemics|Patient Care Planning|Patient Isolation|Pneumonia, Viral|Prognosis|Retrospective Studies|Risk Assessment|Risk Factors|SARS-CoV-2|Young Adult|NA",2020-04-03,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04333875,0
32171740,NCT04344951,New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?,Journal Article,Antiviral Agents|Chloroquine|NA,"Antiviral Agents|Betacoronavirus|COVID-19|Chloroquine|Coronavirus Infections|Drug Evaluation, Preclinical|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-05-28,International journal of antimicrobial agents,Registry,https://clinicaltrials.gov/ct2/show/NCT04344951,0
32172242,NCT04511429,Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum.,Editorial, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Critical Care|Cytokine Release Syndrome|Extracorporeal Circulation|Extracorporeal Membrane Oxygenation|Humans|Pandemics|Plasmapheresis|Pneumonia, Viral|Renal Replacement Therapy|Respiratory Distress Syndrome|SARS-CoV-2|Sorption Detoxification|Ventilator-Induced Lung Injury|NA",2020-09-18,Blood purification,Registry,https://clinicaltrials.gov/ct2/show/NCT04511429,0
32173110,NCT04384380,A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.,Journal Article|Systematic Review,Antimalarials|Chloroquine|NA,"Antimalarials|Betacoronavirus|COVID-19|China|Chloroquine|Clinical Trials as Topic|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|Treatment Outcome|World Health Organization|NA",2020-05-22,Journal of critical care,Registry,https://clinicaltrials.gov/ct2/show/NCT04384380,0
32178769,NCT04342637,COVID-19 and Italy: what next?,Journal Article|Review, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Global Health|Health Policy|Hospital Bed Capacity|Humans|Intensive Care Units|Italy|Male|Middle Aged|Models, Biological|Pandemics|Pneumonia, Viral|Respiration, Artificial|SARS-CoV-2|NA",2020-04-23,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04342637,0
32179124,NCT04627467,"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.",Journal Article|Meta-Analysis|Systematic Review, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Cough|Fever|Hospitalization|Humans|Intensive Care Units|Pandemics|Pneumonia, Viral|Respiratory Distress Syndrome|SARS-CoV-2|NA",2020-05-18,Travel medicine and infectious disease,Registry,https://clinicaltrials.gov/ct2/show/NCT04627467,0
32179701,NCT04779944,Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).,"Journal Article|Research Support, N.I.H., Extramural", ,"Bayes Theorem|Betacoronavirus|COVID-19|China|Coronavirus Infections|Epidemiological Monitoring|Humans|Missed Diagnosis|Models, Theoretical|Pandemics|Pneumonia, Viral|Prevalence|SARS-CoV-2|Travel|NA",2020-05-05,"Science (New York, N.Y.)",Registry,https://clinicaltrials.gov/ct2/show/NCT04779944,0
32180188,NCT04623697,Mouse Models of Virus-Induced Type 1 Diabetes.,Journal Article,"Antigens, Viral|NA","Adoptive Transfer|Animals|Antigens, Viral|CD8-Positive T-Lymphocytes|Coxsackievirus Infections|Diabetes Mellitus, Experimental|Diabetes Mellitus, Type 1|Enterovirus B, Human|Female|Immunization|Lymphocytic Choriomeningitis|Lymphocytic choriomeningitis virus|Male|Mice|Mice, Inbred NOD|Mice, Transgenic|Spleen|NA",2021-03-10,"Methods in molecular biology (Clifton, N.J.)",Registry,https://clinicaltrials.gov/ct2/show/NCT04623697,0
32181795,NCT04627467,Coronavirus Disease 2019 (COVID-19) in Italy.,Journal Article, , ,2020-09-16,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04627467,0
32187459,NCT04353674,"Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line.",Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Equipment and Supplies, Hospital|Health Care Rationing|Humans|Italy|Pandemics|Pneumonia, Viral|Resource Allocation|SARS-CoV-2|Triage|NA",2020-05-18,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04353674,0
32189136,NCT04407468,Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province.,Letter, , ,2020-09-28,Annals of intensive care,Registry,https://clinicaltrials.gov/ct2/show/NCT04407468,0
32190290,NCT04516811,SARS-CoV-2 and COVID-19: The most important research questions.,Journal Article, , ,2020-09-28,Cell &amp; bioscience,Registry,https://clinicaltrials.gov/ct2/show/NCT04516811,0
32191675,NCT04631861,WHO Declares COVID-19 a Pandemic.,Journal Article, ,"Betacoronavirus|COVID-19|China|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|World Health Organization|NA",2020-03-24,Acta bio-medica : Atenei Parmensis,Registry,https://clinicaltrials.gov/ct2/show/NCT04631861,0
32196083,NCT04627467,COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.,Journal Article,Hydroxychloroquine|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Cytokine Release Syndrome|Disease Progression|Humans|Hydroxychloroquine|Lymphocyte Activation|Pandemics|Pneumonia, Viral|Respiratory Distress Syndrome|SARS-CoV-2|T-Lymphocytes|NA",2020-06-24,The Journal of antimicrobial chemotherapy,Registry,https://clinicaltrials.gov/ct2/show/NCT04627467,0
32196933,NCT04511429,Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.,Letter, ,Coronavirus|Coronavirus Infections|Epidemics|Humans|Immunocompromised Host|Liver Transplantation|NA,2021-03-18,Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,Registry,https://clinicaltrials.gov/ct2/show/NCT04511429,0
32198501,NCT04567979,Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Viral|NA","Adult|Amino Acid Sequence|Antibodies, Viral|Betacoronavirus|COVID-19|Child|Child, Preschool|Coronavirus Infections|Enzyme-Linked Immunosorbent Assay|Female|Humans|Immunity, Humoral|Male|Middle Aged|Pandemics|Pneumonia, Viral|Polymerase Chain Reaction|SARS-CoV-2|NA",2020-08-10,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Registry,https://clinicaltrials.gov/ct2/show/NCT04567979,0
32199468,NCT04627467,Use of antiviral drugs to reduce COVID-19 transmission.,Letter|Comment,Antiviral Agents|NA,"Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Disease Outbreaks|Feasibility Studies|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-05-05,The Lancet. Global health,Registry,https://clinicaltrials.gov/ct2/show/NCT04627467,0
32201335,NCT04369807,"Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.","Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review", ,"Arrhythmias, Cardiac|Betacoronavirus|COVID-19|Coronavirus Infections|Health Personnel|Heart Diseases|Humans|Myocarditis|Pandemics|Pneumonia, Viral|Risk Factors|SARS-CoV-2|Triage|NA",2020-05-19,Journal of the American College of Cardiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04369807,1
32201335,NCT04753762,"Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.","Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review", ,"Arrhythmias, Cardiac|Betacoronavirus|COVID-19|Coronavirus Infections|Health Personnel|Heart Diseases|Humans|Myocarditis|Pandemics|Pneumonia, Viral|Risk Factors|SARS-CoV-2|Triage|NA",2020-05-19,Journal of the American College of Cardiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32203977,NCT04712292,Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.,Journal Article|Video-Audio Media, ,"Adolescent|Adult|Age Distribution|Age Factors|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|Child|Child, Preschool|China|Clinical Laboratory Techniques|Cluster Analysis|Comorbidity|Coronavirus Infections|Data Collection|Female|Humans|Infant|Infant, Newborn|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Population Surveillance|Real-Time Polymerase Chain Reaction|SARS-CoV-2|Sex Factors|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04712292,0
32203977,NCT04480034,Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.,Journal Article|Video-Audio Media, ,"Adolescent|Adult|Age Distribution|Age Factors|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|Child|Child, Preschool|China|Clinical Laboratory Techniques|Cluster Analysis|Comorbidity|Coronavirus Infections|Data Collection|Female|Humans|Infant|Infant, Newborn|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Population Surveillance|Real-Time Polymerase Chain Reaction|SARS-CoV-2|Sex Factors|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04480034,0
32203977,NCT04567979,Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.,Journal Article|Video-Audio Media, ,"Adolescent|Adult|Age Distribution|Age Factors|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|Child|Child, Preschool|China|Clinical Laboratory Techniques|Cluster Analysis|Comorbidity|Coronavirus Infections|Data Collection|Female|Humans|Infant|Infant, Newborn|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Population Surveillance|Real-Time Polymerase Chain Reaction|SARS-CoV-2|Sex Factors|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04567979,0
32204907,NCT04353583,The Novel Coronavirus 2019 epidemic and kidneys.,Editorial, ,"Acute Kidney Injury|Betacoronavirus|COVID-19|Coronavirus Infections|Host-Pathogen Interactions|Humans|Kidney|Kidney Diseases|Pandemics|Pneumonia, Viral|Prognosis|Risk Assessment|Risk Factors|SARS-CoV-2|NA",2020-09-16,Kidney international,Registry,https://clinicaltrials.gov/ct2/show/NCT04353583,0
32205204,NCT04344951,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.,Clinical Trial|Journal Article,Hydroxychloroquine|Azithromycin|NA,"Adult|Azithromycin|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Therapy, Combination|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Pandemics|Pneumonia, Viral|Polymerase Chain Reaction|SARS-CoV-2|Viral Load|NA",2020-08-04,International journal of antimicrobial agents,Registry,https://clinicaltrials.gov/ct2/show/NCT04344951,0
32205204,NCT04627467,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.,Clinical Trial|Journal Article,Hydroxychloroquine|Azithromycin|NA,"Adult|Azithromycin|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Therapy, Combination|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Pandemics|Pneumonia, Viral|Polymerase Chain Reaction|SARS-CoV-2|Viral Load|NA",2020-08-04,International journal of antimicrobial agents,Registry,https://clinicaltrials.gov/ct2/show/NCT04627467,0
32205204,NCT04384380,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.,Clinical Trial|Journal Article,Hydroxychloroquine|Azithromycin|NA,"Adult|Azithromycin|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Therapy, Combination|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Pandemics|Pneumonia, Viral|Polymerase Chain Reaction|SARS-CoV-2|Viral Load|NA",2020-08-04,International journal of antimicrobial agents,Registry,https://clinicaltrials.gov/ct2/show/NCT04384380,0
32209890,NCT04353674,"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.",Journal Article,C-Reactive Protein|Oxygen|NA,"Adult|Aged|Aged, 80 and over|Betacoronavirus|C-Reactive Protein|COVID-19|Coronavirus Infections|Female|Humans|Male|Middle Aged|Oxygen|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|NA",2020-06-16,Chinese medical journal,Registry,https://clinicaltrials.gov/ct2/show/NCT04353674,0
32209891,NCT04392323,Managing COVID-19 in Surgical Systems.,Journal Article, ,"Betacoronavirus|COVID-19|Clinical Protocols|Coronavirus Infections|Elective Surgical Procedures|Epidemics|Humans|Infectious Disease Transmission, Patient-to-Professional|Pandemics|Pneumonia, Viral|SARS-CoV-2|Surgery Department, Hospital|Surgical Procedures, Operative|United States|NA",2020-07-01,Annals of surgery,Registry,https://clinicaltrials.gov/ct2/show/NCT04392323,0
32211816,NCT04422535,"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Cohort Studies|Coronavirus Infections|Female|Heart Diseases|Hospital Mortality|Hospitalization|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|Survival Rate|Young Adult|NA",2020-09-30,JAMA cardiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04422535,0
32211820,NCT04567979,"SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.",Journal Article, ,"Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Humans|Male|Medical Records|Middle Aged|Neoplasms|Pandemics|Pneumonia, Viral|Risk Factors|SARS-CoV-2|Tertiary Care Centers|NA",2020-09-29,JAMA oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04567979,0
32211963,NCT04661631,Coronavirus disease 2019: initial chest CT findings.,Journal Article, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Thorax|Tomography, X-Ray Computed|Young Adult|NA",2020-07-14,European radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32211963,NCT04577105,Coronavirus disease 2019: initial chest CT findings.,Journal Article, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Thorax|Tomography, X-Ray Computed|Young Adult|NA",2020-07-14,European radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04577105,0
32213556,NCT04479202,"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Betacoronavirus|COVID-19|COVID-19 Testing|China|Clinical Laboratory Techniques|Coronavirus Infections|Female|Gastrointestinal Tract|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Risk Factors|SARS-CoV-2|NA",2020-05-13,Gut,Registry,https://clinicaltrials.gov/ct2/show/NCT04479202,0
32215581,NCT04418557,Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn.,"Case Reports|Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Viral|Immunoglobulin G|Immunoglobulin M|NA","Adult|Antibodies, Viral|Antibody Specificity|Betacoronavirus|COVID-19|COVID-19 Testing|Cesarean Section|Clinical Laboratory Techniques|Coronavirus Infections|Female|Fetal Diseases|Humans|Immunoglobulin G|Immunoglobulin M|Infant, Newborn|Infectious Disease Transmission, Vertical|Mothers|Nasopharynx|Pandemics|Pneumonia, Viral|Pregnancy|Pregnancy Complications, Infectious|Real-Time Polymerase Chain Reaction|SARS-CoV-2|Sensitivity and Specificity|Time Factors|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04418557,0
32215691,NCT04338568,CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19).,Evaluation Study|Journal Article, ,"Adult|Aged|Aged, 80 and over|Area Under Curve|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|ROC Curve|Retrospective Studies|SARS-CoV-2|Thorax|Tomography, X-Ray Computed|Vision, Ocular|NA",2020-07-14,European radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04338568,0
32216717,NCT04661631,Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19.,Journal Article|Multicenter Study, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|COVID-19 Vaccines|Clinical Laboratory Techniques|Coronavirus Infections|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Radiographic Image Interpretation, Computer-Assisted|Reproducibility of Results|Retrospective Studies|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Severity of Illness Index|Tomography, X-Ray Computed|Young Adult|NA",2020-07-31,Radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32217113,NCT04515108,Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.,Journal Article|Review, ,"Betacoronavirus|Breast Feeding|COVID-19|Coronavirus Infections|Delivery, Obstetric|Female|Humans|Infectious Disease Transmission, Vertical|Obstetrics|Pandemics|Personal Protective Equipment|Pneumonia, Viral|Pregnancy|Pregnancy Complications, Infectious|SARS-CoV-2|NA",2020-06-04,American journal of obstetrics and gynecology,Registry,https://clinicaltrials.gov/ct2/show/NCT04515108,0
32219357,NCT04753762,Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).,Case Reports|Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Middle Aged|Myocarditis|Pandemics|Pericarditis|Pneumonia, Viral|SARS-CoV-2|Ventricular Dysfunction, Left|NA",2020-09-30,JAMA cardiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32219428,NCT04356482,Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.,"Case Reports|Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|Antiviral Agents|Glucocorticoids|Immunoglobulin G|Immunoglobulin M|Methylprednisolone|NA","Adult|Aged|Antibodies, Neutralizing|Antibodies, Viral|Antiviral Agents|Betacoronavirus|Blood Donors|COVID-19|Coronavirus Infections|Critical Illness|Female|Glucocorticoids|Humans|Immunization, Passive|Immunoglobulin G|Immunoglobulin M|Male|Methylprednisolone|Middle Aged|Organ Dysfunction Scores|Pandemics|Pneumonia, Viral|Respiratory Distress Syndrome|SARS-CoV-2|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04356482,0
32219428,NCT04393727,Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.,"Case Reports|Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|Antiviral Agents|Glucocorticoids|Immunoglobulin G|Immunoglobulin M|Methylprednisolone|NA","Adult|Aged|Antibodies, Neutralizing|Antibodies, Viral|Antiviral Agents|Betacoronavirus|Blood Donors|COVID-19|Coronavirus Infections|Critical Illness|Female|Glucocorticoids|Humans|Immunization, Passive|Immunoglobulin G|Immunoglobulin M|Male|Methylprednisolone|Middle Aged|Organ Dysfunction Scores|Pandemics|Pneumonia, Viral|Respiratory Distress Syndrome|SARS-CoV-2|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04393727,0
32221970,NCT04344145,"Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists.",Journal Article|Practice Guideline,Oxygen|NA,"Anesthesiologists|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Care|Emergency Medical Services|Humans|Intubation, Intratracheal|Oxygen|Pandemics|Personal Protective Equipment|Pneumonia, Viral|Risk Factors|SARS-CoV-2|Societies, Medical|NA",2020-05-11,Anaesthesia,Registry,https://clinicaltrials.gov/ct2/show/NCT04344145,1
32221979,NCT04424953,Videolaryngoscopy increases 'mouth-to-mouth' distance compared with direct laryngoscopy.,Comparative Study|Letter, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Laryngoscopy|Mouth|Pandemics|Pneumonia, Viral|SARS-CoV-2|Video Recording|NA",2020-06-24,Anaesthesia,Registry,https://clinicaltrials.gov/ct2/show/NCT04424953,0
32222164,NCT04661631,CT screening for early diagnosis of SARS-CoV-2 infection.,Letter|Comment, ,"Betacoronavirus|COVID-19|China|Coronavirus Infections|Early Diagnosis|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|Tomography, X-Ray Computed|NA",2020-09-03,The Lancet. Infectious diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32222346,NCT04501965,Corrigendum to &quot;Traditional Chinese medicine for COVID-19 treatment&quot; [Pharmacol. Res. 155 (2020) 104743].,Journal Article|Published Erratum, , ,2020-06-06,Pharmacological research,Registry,https://clinicaltrials.gov/ct2/show/NCT04501965,0
32223047,NCT04798677,"Î²-1,3/1,6-Glucans and Immunity: State of the Art and Future Directions.","Journal Article|Review|Research Support, Non-U.S. Gov't", , ,2021-01-29,Molecular nutrition &amp; food research,Registry,https://clinicaltrials.gov/ct2/show/NCT04798677,0
32223336,NCT04333875,"Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.","Journal Article|Research Support, Non-U.S. Gov't", , ,2021-06-01,Circulation,Registry,https://clinicaltrials.gov/ct2/show/NCT04333875,0
32224151,NCT04567979,"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.","Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't", ,"Aged|Betacoronavirus|COVID-19|China|Cohort Studies|Coronavirus Infections|Female|Hospitalization|Humans|Male|Middle Aged|Neoplasms|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|NA",2020-07-01,Annals of oncology : official journal of the European Society for Medical Oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04567979,0
32224769,NCT04353674,Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Critical Illness|Diagnostic Techniques and Procedures|Humans|Infection Control|Intensive Care Units|Pandemics|Pneumonia, Viral|Practice Guidelines as Topic|Respiration, Artificial|SARS-CoV-2|Shock|NA",2020-06-04,Critical care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04353674,0
32227492,NCT04661631,"Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method.",Journal Article, ,"Anatomic Landmarks|Artificial Intelligence|Betacoronavirus|COVID-19|Coronavirus Infections|Databases, Factual|Forecasting|Humans|Image Processing, Computer-Assisted|Internationality|Lung|Pandemics|Pneumonia, Viral|Point-of-Care Systems|Reproducibility of Results|SARS-CoV-2|Ultrasonography|NA",2020-06-26,Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32227758,NCT04411459,Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.,"Journal Article|Multicenter Study|Research Support, N.I.H., Extramural",Glucocorticoids|NA,"Aged|Asthma|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Critical Illness|Glucocorticoids|Hospitalization|Humans|Intensive Care Units|Length of Stay|Lung|Middle Aged|Pandemics|Pneumonia, Viral|Radiography|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Shock|Tomography, X-Ray Computed|Washington|NA",2020-05-26,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04411459,2
32228825,NCT04366089,How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.,Editorial,Interleukin-1|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Inflammation|Interleukin-1|Lung|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-10,Journal of biological regulators and homeostatic agents,Registry,https://clinicaltrials.gov/ct2/show/NCT04366089,0
32234250,NCT04392323,"Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study.","Journal Article|Observational Study|Research Support, Non-U.S. Gov't", ,"Adult|Anesthesia, Spinal|Anesthesiologists|Anesthetists|Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Humans|Male|Pandemics|Personal Protective Equipment|Pneumonia, Viral|Retrospective Studies|Risk|SARS-CoV-2|NA",2020-05-20,British journal of anaesthesia,Registry,https://clinicaltrials.gov/ct2/show/NCT04392323,0
32234312,NCT04374123,COVID-19 in endoscopy: Time to do more?,Letter|Comment, ,"Betacoronavirus|COVID-19|Coronavirus|Coronavirus Infections|Endoscopy|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-07-29,Gastrointestinal endoscopy,Registry,https://clinicaltrials.gov/ct2/show/NCT04374123,0
32236089,NCT04459819,Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR).,Journal Article|Practice Guideline, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Critical Care|Dyspnea|Humans|Hypoxia|Infection Control|Infectious Disease Transmission, Patient-to-Professional|Italy|Noninvasive Ventilation|Pandemics|Physical Therapy Modalities|Pneumonia, Viral|Pronation|Respiration, Artificial|Respiratory Distress Syndrome|Respiratory Insufficiency|Respiratory Protective Devices|Respiratory Therapy|SARS-CoV-2|NA",2020-04-02,Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,Registry,https://clinicaltrials.gov/ct2/show/NCT04459819,0
32237190,NCT04368897,What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy.,Letter,"Receptors, Androgen|NA","Adult|Alopecia|Animals|COVID-19|Coronavirus Infections|Female|Humans|Male|Pandemics|Pneumonia, Viral|Receptors, Androgen|Risk Factors|Sex Factors|NA",2020-11-30,Dermatologic therapy,Registry,https://clinicaltrials.gov/ct2/show/NCT04368897,0
32238084,NCT04401540,Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review.,Journal Article|Review, ,"Betacoronavirus|COVID-19|Canada|China|Coronavirus Infections|Female|Hong Kong|Humans|Infant, Newborn|Infectious Disease Transmission, Vertical|Iran|Maternal Mortality|Pandemics|Pneumonia, Viral|Pregnancy|Pregnancy Complications, Infectious|Respiration Disorders|Risk|SARS-CoV-2|United States|NA",2020-06-22,Fetal and pediatric pathology,Registry,https://clinicaltrials.gov/ct2/show/NCT04401540,1
32240634,NCT04369807,Estimates of the severity of coronavirus disease 2019: a model-based analysis.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Child|Child, Preschool|China|Coronavirus Infections|Hospitalization|Humans|Incidence|Infant|Infant, Newborn|Middle Aged|Models, Statistical|Pandemics|Pneumonia, Viral|SARS-CoV-2|Young Adult|NA",2020-06-03,The Lancet. Infectious diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04369807,1
32241022,NCT04437940,SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|Bodily Secretions|Body Fluids|COVID-19|Coronavirus Infections|Female|Humans|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Severe Acute Respiratory Syndrome|Vagina|NA",2020-08-10,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Registry,https://clinicaltrials.gov/ct2/show/NCT04437940,0
32241897,NCT04342637,Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements).,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Endoscopy, Gastrointestinal|Equipment Contamination|Humans|Infectious Disease Transmission, Patient-to-Professional|Pandemics|Pneumonia, Viral|Practice Guidelines as Topic|Risk Assessment|SARS-CoV-2|NA",2020-05-13,Gut,Registry,https://clinicaltrials.gov/ct2/show/NCT04342637,0
32242947,NCT04661631,Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Adult|COVID-19|Female|Humans|Lung|Male|Middle Aged|Respiratory Insufficiency|Tomography, X-Ray Computed|NA",2020-12-16,Journal of medical virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32247018,NCT04342637,AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic.,Journal Article|Review, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Endoscopy, Gastrointestinal|Gastroenterology|Humans|Infectious Disease Transmission, Patient-to-Professional|Pandemics|Pneumonia, Viral|Practice Guidelines as Topic|SARS-CoV-2|United States|NA",2020-09-08,Gastroenterology,Registry,https://clinicaltrials.gov/ct2/show/NCT04342637,0
32247631,NCT04369807,Kidney disease is associated with in-hospital death of patients with COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Acute Kidney Injury|Betacoronavirus|COVID-19|China|Comorbidity|Coronavirus Infections|Female|Hospital Mortality|Hospitalization|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Proportional Hazards Models|Prospective Studies|Proteinuria|Risk Factors|SARS-CoV-2|NA",2020-04-29,Kidney international,Registry,https://clinicaltrials.gov/ct2/show/NCT04369807,1
32250280,NCT04378738,The Use of Technology for Communicating With Clinicians or Seeking Health Information in a Multilingual Urban Cohort: Cross-Sectional Survey.,"Journal Article|Research Support, N.I.H., Extramural", ,Adult|Aged|Cohort Studies|Communication|Cross-Sectional Studies|Female|Health Literacy|Humans|Information Seeking Behavior|Male|Middle Aged|Multilingualism|Surveys and Questionnaires|Urban Health|NA,2020-11-05,Journal of medical Internet research,Registry,https://clinicaltrials.gov/ct2/show/NCT04378738,0
32250347,NCT04763213,[Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)].,Journal Article, ,"Betacoronavirus|COVID-19|Cardiology|Cardiovascular Diseases|Consensus|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|Societies, Medical|Turkey|NA",2020-04-10,Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,Registry,https://clinicaltrials.gov/ct2/show/NCT04763213,0
32250385,NCT04424836,"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Age Distribution|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Critical Care|Critical Illness|Female|Hospital Mortality|Hospitalization|Humans|Intensive Care Units|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Positive-Pressure Respiration|Respiration, Artificial|Retrospective Studies|SARS-CoV-2|Sex Distribution|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04424836,0
32250385,NCT04567927,"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Age Distribution|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Critical Care|Critical Illness|Female|Hospital Mortality|Hospitalization|Humans|Intensive Care Units|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Positive-Pressure Respiration|Respiration, Artificial|Retrospective Studies|SARS-CoV-2|Sex Distribution|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04567927,0
32250385,NCT04360837,"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Age Distribution|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Critical Care|Critical Illness|Female|Hospital Mortality|Hospitalization|Humans|Intensive Care Units|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Positive-Pressure Respiration|Respiration, Artificial|Retrospective Studies|SARS-CoV-2|Sex Distribution|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04360837,0
32250385,NCT04411459,"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.","Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Age Distribution|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Critical Care|Critical Illness|Female|Hospital Mortality|Hospitalization|Humans|Intensive Care Units|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Positive-Pressure Respiration|Respiration, Artificial|Retrospective Studies|SARS-CoV-2|Sex Distribution|Young Adult|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04411459,2
32251768,NCT04407507,The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.,"Journal Article|Research Support, Non-U.S. Gov't",Antiviral Agents|Ivermectin|NA,"Animals|Antiviral Agents|Australia|Betacoronavirus|COVID-19|Chlorocebus aethiops|Coronavirus Infections|Drug Approval|Humans|Ivermectin|Pandemics|Pneumonia, Viral|SARS-CoV-2|Vero Cells|Virus Replication|NA",2020-07-06,Antiviral research,Registry,https://clinicaltrials.gov/ct2/show/NCT04407507,0
32252338,NCT04441814,Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.,Journal Article|Review,Vitamin D|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Dietary Supplements|Humans|Influenza, Human|Nutrition Therapy|Pandemics|Pneumonia, Viral|Risk Factors|SARS-CoV-2|Seasons|Vitamin D|Vitamin D Deficiency|NA",2020-04-10,Nutrients,Registry,https://clinicaltrials.gov/ct2/show/NCT04441814,0
32253449,NCT04494724,"Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.",Journal Article|Published Erratum, , ,2020-09-30,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04494724,0
32255673,NCT04346264,Factors Associated with Low Lung Function in Different Age Bins in the General Population.,"Comparative Study|Letter|Research Support, Non-U.S. Gov't", ,Age Factors|Cystic Fibrosis|Female|Humans|Lung|Male|Population Surveillance|Respiratory Function Tests|NA,2020-09-04,American journal of respiratory and critical care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04346264,0
32257537,NCT04517162,Transplantation of ACE2<sup>-</sup> Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.,Journal Article, , ,2021-02-23,Aging and disease,Registry,https://clinicaltrials.gov/ct2/show/NCT04517162,0
32257537,NCT04361942,Transplantation of ACE2<sup>-</sup> Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.,Journal Article, , ,2021-02-23,Aging and disease,Registry,https://clinicaltrials.gov/ct2/show/NCT04361942,0
32259322,NCT04392323,Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records.,Journal Article, ,"Adult|Betacoronavirus|COVID-19|China|Coronavirus Infections|Female|Genital Neoplasms, Female|Gynecologic Surgical Procedures|Hospitalization|Humans|Incidence|Male|Mass Screening|Medical Records|Middle Aged|Pandemics|Pneumonia, Viral|Postoperative Complications|Retrospective Studies|SARS-CoV-2|NA",2020-06-23,The oncologist,Registry,https://clinicaltrials.gov/ct2/show/NCT04392323,0
32259546,NCT04392323,Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.,Case Reports|Journal Article, ,"Betacoronavirus|COVID-19|Contact Tracing|Coronavirus Infections|Cross Infection|Disease Transmission, Infectious|Female|Hong Kong|Hospitals|Humans|Infection Control|Middle Aged|Pandemics|Patients' Rooms|Pneumonia, Viral|SARS-CoV-2|NA",2020-06-16,The Journal of hospital infection,Registry,https://clinicaltrials.gov/ct2/show/NCT04392323,0
32268134,NCT04374123,Preventing the spread of COVID-19 in digestive endoscopy during the resuming period: meticulous execution of screening procedures.,Letter|Comment, ,"Betacoronavirus|COVID-19|Coronavirus|Coronavirus Infections|Endoscopy, Gastrointestinal|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-07-29,Gastrointestinal endoscopy,Registry,https://clinicaltrials.gov/ct2/show/NCT04374123,0
32275742,NCT04753762,"COVID-19 Autopsies, Oklahoma, USA.",Case Reports|Journal Article, ,"Adult|Aged|Autopsy|Betacoronavirus|COVID-19|COVID-19 Testing|COVID-19 Vaccines|Clinical Laboratory Techniques|Coronavirus Infections|Diagnosis|Humans|Hypertension|Lung|Male|Myotonic Dystrophy|Obesity|Oklahoma|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-05-07,American journal of clinical pathology,Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32278361,NCT04567927,Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.,Journal Article,Anticoagulants|NA,"Anticoagulants|Attention|Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|Risk Factors|SARS-CoV-2|Venous Thromboembolism|NA",2020-05-07,The Lancet. Haematology,Registry,https://clinicaltrials.gov/ct2/show/NCT04567927,0
32282022,NCT04480593,Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.,Journal Article|Review,Adrenal Cortex Hormones|Amides|Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|Antiviral Agents|Immunoglobulins|Immunologic Factors|Indoles|Pyrazines|Oseltamivir|Lopinavir|remdesivir|Adenosine Monophosphate|Ribavirin|Hydroxychloroquine|Azithromycin|Chloroquine|umifenovir|favipiravir|Ritonavir|Alanine|NA,"Adenosine Monophosphate|Adrenal Cortex Hormones|Alanine|Amides|Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|Antiviral Agents|Azithromycin|Betacoronavirus|COVID-19|Chloroquine|Coronavirus Infections|Humans|Hydroxychloroquine|Immunoglobulins|Immunologic Factors|Indoles|Lopinavir|Oseltamivir|Pandemics|Pneumonia, Viral|Pyrazines|Ribavirin|Ritonavir|SARS-CoV-2|Withholding Treatment|NA",2020-09-23,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04480593,0
32283102,NCT04374123,Endoscopy Units and the Coronavirus Disease 2019 Outbreak: AÂ Multicenter Experience From Italy.,Journal Article|Multicenter Study, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Critical Pathways|Endoscopy, Digestive System|Gastrointestinal Diseases|Humans|Infection Control|Infectious Disease Transmission, Patient-to-Professional|Infectious Disease Transmission, Professional-to-Patient|Italy|Pandemics|Personal Protective Equipment|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-07,Gastroenterology,Registry,https://clinicaltrials.gov/ct2/show/NCT04374123,0
32283245,NCT04368897,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.,Journal Article,"AR protein, human|Androgens|Receptors, Androgen|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|Peptidyl-Dipeptidase A|ACE2 protein, human|Angiotensin-Converting Enzyme 2|Serine Endopeptidases|TMPRSS2 protein, human|NA","Androgens|Angiotensin-Converting Enzyme 2|Betacoronavirus|COVID-19|Chromosomes, Human, X|Coronavirus Infections|Genetic Loci|Humans|Pandemics|Peptidyl-Dipeptidase A|Pneumonia, Viral|Promoter Regions, Genetic|Receptors, Androgen|SARS-CoV-2|Serine Endopeptidases|Sex Factors|Spike Glycoprotein, Coronavirus|Transcription, Genetic|Viral Load|Virus Internalization|NA",2020-06-30,Journal of the American Academy of Dermatology,Registry,https://clinicaltrials.gov/ct2/show/NCT04368897,0
32283294,NCT04861402,Encephalitis as a clinical manifestation of COVID-19.,Letter|Comment, ,"Betacoronavirus|COVID-19|Coronavirus|Coronavirus Infections|Encephalitis|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-10,"Brain, behavior, and immunity",Registry,https://clinicaltrials.gov/ct2/show/NCT04861402,0
32285380,NCT04401540,Clinical characteristics of 19 neonates born to mothers with COVID-19.,Journal Article, ,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Infant, Newborn|Infectious Disease Transmission, Vertical|Mothers|Pandemics|Pneumonia, Viral|Pregnancy|Prospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|NA",2020-05-15,Frontiers of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04401540,1
32289051,NCT04407468,"COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review.",Journal Article, , ,2021-04-28,European journal of radiology open,Registry,https://clinicaltrials.gov/ct2/show/NCT04407468,0
32291463,NCT04445961,COVID-19 pneumonia: different respiratory treatments for different phenotypes?,Editorial, ,"Airway Resistance|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Guidelines as Topic|Humans|Hypoxia|Lung|Lung Compliance|Organ Size|Pandemics|Phenotype|Pneumonia, Viral|Radiography, Thoracic|Respiratory Dead Space|SARS-CoV-2|Severity of Illness Index|Ventilation-Perfusion Ratio|NA",2020-06-25,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04445961,0
32291748,NCT04763213,Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease.,Journal Article, ,"Aged|Aged, 80 and over|Coronary Artery Disease|Female|Heart Diseases|Heart Failure|Hospitalization|Humans|Inflammation|Leukocyte Count|Lymphocyte Count|Male|Middle Aged|Myocardial Infarction|Neutrophils|Percutaneous Coronary Intervention|Platelet Count|Prognosis|Proportional Hazards Models|Stroke|NA",2021-03-23,European journal of clinical investigation,Registry,https://clinicaltrials.gov/ct2/show/NCT04763213,0
32292899,NCT04392323,Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection.,Journal Article, , ,2021-02-09,EClinicalMedicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04392323,0
32292899,NCT04661631,Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection.,Journal Article, , ,2021-02-09,EClinicalMedicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32293834,NCT04392713,Antiviral treatment of COVID-19,Journal Article|Review,Amides|Antiviral Agents|Drug Combinations|Pyrazines|Thiazoles|lopinavir-ritonavir drug combination|Lopinavir|remdesivir|Adenosine Monophosphate|Hydroxychloroquine|Ivermectin|Chloroquine|favipiravir|Ritonavir|Alanine|nitazoxanide|NA,"Adenosine Monophosphate|Alanine|Amides|Antiviral Agents|Betacoronavirus|COVID-19|Chloroquine|Coronavirus Infections|Drug Combinations|Humans|Hydroxychloroquine|Ivermectin|Lopinavir|Pandemics|Pneumonia, Viral|Pyrazines|Ritonavir|SARS-CoV-2|Thiazoles|NA",2020-04-22,Turkish journal of medical sciences,Registry,https://clinicaltrials.gov/ct2/show/NCT04392713,0
32294297,NCT04453579,The Impact of Coronavirus Disease 2019 on Bariatric Surgery: Redefining Psychosocial Care.,Journal Article|Comment, ,"Bariatric Surgery|Betacoronavirus|COVID-19|China|Coronavirus|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|Quality of Life|SARS-CoV-2|NA",2020-06-15,"Obesity (Silver Spring, Md.)",Registry,https://clinicaltrials.gov/ct2/show/NCT04453579,0
32294339,NCT04468035,Neurologic Features in Severe SARS-CoV-2 Infection.,Letter, ,"Adult|Aged|Betacoronavirus|Brain|Brain Diseases|COVID-19|Confusion|Coronavirus Infections|Humans|Magnetic Resonance Imaging|Middle Aged|Pandemics|Pneumonia, Viral|Respiratory Distress Syndrome|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Stroke|NA",2020-06-10,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04468035,0
32298251,NCT04530617,"Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.",Published Erratum, , ,2021-01-11,MMWR. Morbidity and mortality weekly report,Registry,https://clinicaltrials.gov/ct2/show/NCT04530617,0
32299202,NCT04819165,"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs",Journal Article|Review,Anti-Inflammatory Agents|Antirheumatic Agents|Cytokines|Immunosuppressive Agents|NA,"Anti-Inflammatory Agents|Antirheumatic Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Cytokines|Drug Repositioning|Humans|Immune System|Immunity, Cellular|Immunosuppressive Agents|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-04-22,Turkish journal of medical sciences,Registry,https://clinicaltrials.gov/ct2/show/NCT04819165,0
32301221,NCT04368897,A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity.,Letter,Androgens|Biomarkers|NA,"Adult|Age Distribution|Aged|Alopecia|Androgens|Biomarkers|COVID-19|Comorbidity|Coronavirus Infections|Disease Outbreaks|Humans|Incidence|Male|Middle Aged|Pandemics|Pneumonia, Viral|Risk Assessment|Severity of Illness Index|Spain|Young Adult|NA",2020-06-29,Journal of cosmetic dermatology,Registry,https://clinicaltrials.gov/ct2/show/NCT04368897,0
32302438,NCT04466670,Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.,Journal Article,Biomarkers|Inflammation Mediators|NA,"Adult|Aged|Betacoronavirus|Biomarkers|Blood Coagulation|COVID-19|Case-Control Studies|Coronavirus Infections|Host-Pathogen Interactions|Humans|Inflammation Mediators|Intensive Care Units|Middle Aged|Pandemics|Pneumonia, Viral|Predictive Value of Tests|SARS-CoV-2|Thrombelastography|Thrombophilia|Young Adult|NA",2020-07-15,Journal of thrombosis and haemostasis : JTH,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32302462,NCT04466670,ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment.,Letter|Comment, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-06,Journal of thrombosis and haemostasis : JTH,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32303365,NCT04366089,Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19.,Journal Article,Antioxidants|Ascorbic Acid|NA,"Antioxidants|Ascorbic Acid|Betacoronavirus|COVID-19|Coronavirus Infections|Critical Illness|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-05-21,Revista espanola de anestesiologia y reanimacion,Registry,https://clinicaltrials.gov/ct2/show/NCT04366089,0
32311145,NCT04526405,SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.,Letter, ,"Adult|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Female|Humans|Italy|Male|Middle Aged|Pandemics|Pneumonia, Viral|Preliminary Data|SARS-CoV-2|beta-Thalassemia|NA",2020-07-22,American journal of hematology,Registry,https://clinicaltrials.gov/ct2/show/NCT04526405,0
32312790,NCT04479202,Faecal calprotectin indicates intestinal inflammation in COVID-19.,Letter,Biomarkers|Leukocyte L1 Antigen Complex|NA,"Adult|Aged|Aged, 80 and over|Betacoronavirus|Biomarkers|COVID-19|Coronavirus Infections|Feces|Female|Humans|Inflammatory Bowel Diseases|Leukocyte L1 Antigen Complex|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-07-16,Gut,Registry,https://clinicaltrials.gov/ct2/show/NCT04479202,0
32313880,NCT04480593,PAK1-blockers: Potential Therapeutics against COVID-19.,Journal Article|Review, , ,2021-01-10,Medicine in drug discovery,Registry,https://clinicaltrials.gov/ct2/show/NCT04480593,0
32314249,NCT04392323,Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak.,Journal Article,Anti-Retroviral Agents|Immunosuppressive Agents|Hydroxychloroquine|NA,"Adult|Anti-Retroviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Cough|Dyspnea|Fatigue|Female|Fever|Gastric Bypass|Humans|Hydroxychloroquine|Immunosuppressive Agents|Iran|Male|Middle Aged|Off-Label Use|Pandemics|Patient Readmission|Pneumonia, Viral|Postoperative Complications|SARS-CoV-2|NA",2020-08-10,Obesity surgery,Registry,https://clinicaltrials.gov/ct2/show/NCT04392323,0
32314810,NCT04861402,Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).,Case Reports|Journal Article,"RNA, Viral|NA","Aged|Ageusia|Ataxia|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Endothelial Cells|Fatal Outcome|Frontal Lobe|Hospitalization|Humans|Lung|Male|Neurons|Olfaction Disorders|Pandemics|Pneumonia, Viral|RNA, Viral|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Seizures|NA",2020-06-24,Journal of medical virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04861402,0
32315809,NCT04568356,Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously.,Comparative Study|Journal Article, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|China|Clinical Laboratory Techniques|Coronavirus Infections|Diagnostic Tests, Routine|Female|Humans|Male|Middle Aged|Nasopharynx|Pandemics|Pneumonia, Viral|SARS-CoV-2|Young Adult|NA",2020-05-20,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32319029,NCT04407468,Patient self-proning with high-flow nasal cannula improves oxygenation in COVID-19 pneumonia.,Case Reports|Letter, ,"Aged|COVID-19|Cannula|Coronavirus Infections|Humans|Male|Oxygen Inhalation Therapy|Pandemics|Pneumonia, Viral|Prone Position|NA",2020-08-24,Canadian journal of anaesthesia = Journal canadien d'anesthesie,Registry,https://clinicaltrials.gov/ct2/show/NCT04407468,0
32320003,NCT04411459,"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.","Journal Article|Research Support, N.I.H., Extramural", ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Child|Child, Preschool|Comorbidity|Coronavirus Infections|Diabetes Complications|Female|Hospitalization|Humans|Hypertension|Infant|Infant, Newborn|Male|Middle Aged|New York City|Pandemics|Pneumonia, Viral|Risk Factors|SARS-CoV-2|Treatment Outcome|Young Adult|NA",2020-09-25,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04411459,2
32320506,NCT04407468,"Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED's Experience During the COVID-19 Pandemic.",Journal Article,Oxygen|NA,"Adult|Betacoronavirus|COVID-19|Cannula|Coronavirus Infections|Emergency Service, Hospital|Female|Humans|Hypoxia|Intubation, Intratracheal|Male|Middle Aged|New York City|Oximetry|Oxygen|Pandemics|Pilot Projects|Pneumonia, Viral|Prone Position|Respiration, Artificial|SARS-CoV-2|Wakefulness|NA",2020-05-15,Academic emergency medicine : official journal of the Society for Academic Emergency Medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04407468,0
32320517,NCT04466670,High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.,Journal Article|Multicenter Study,Anticoagulants|NA,"Aged|Anticoagulants|Betacoronavirus|Blood Coagulation|COVID-19|Coronavirus Infections|Female|France|Host-Parasite Interactions|Humans|Incidence|Male|Middle Aged|Pandemics|Pneumonia, Viral|Pulmonary Embolism|Retrospective Studies|Risk Factors|SARS-CoV-2|Severity of Illness Index|Treatment Outcome|Venous Thromboembolism|Venous Thrombosis|NA",2020-07-15,Journal of thrombosis and haemostasis : JTH,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32322397,NCT04673214,"Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance.",Journal Article|Review, , ,2021-01-10,New microbes and new infections,Registry,https://clinicaltrials.gov/ct2/show/NCT04673214,0
32323460,NCT04367896,Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach.,Journal Article, ,"Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Consensus|Coronavirus Infections|Critical Care|Evidence-Based Medicine|Health Policy|Humans|Immunocompromised Host|Internationality|Living Donors|Organ Transplantation|Pandemics|Personal Protective Equipment|Pneumonia, Viral|Polymerase Chain Reaction|Radiography, Thoracic|Resource Allocation|SARS-CoV-2|Societies, Medical|Tissue Donors|Tomography, X-Ray Computed|Transplant Recipients|NA",2020-07-20,American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,Registry,https://clinicaltrials.gov/ct2/show/NCT04367896,0
32325282,NCT04661631,Chest CT findings of COVID-19 pneumonia by duration of symptoms.,Journal Article, ,"Adult|Aged|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|Thorax|Tomography, X-Ray Computed|NA",2020-05-15,European journal of radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04661631,0
32325282,NCT04577105,Chest CT findings of COVID-19 pneumonia by duration of symptoms.,Journal Article, ,"Adult|Aged|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|Thorax|Tomography, X-Ray Computed|NA",2020-05-15,European journal of radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04577105,0
32328827,NCT04480034,"Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP.","Journal Article|Research Support, Non-U.S. Gov't", ,"Bariatric Surgery|Endoscopy|Europe|Humans|Obesity, Morbid|Practice Guidelines as Topic|Societies, Medical|NA",2021-05-27,Surgical endoscopy,Registry,https://clinicaltrials.gov/ct2/show/NCT04480034,0
32329246,NCT04466670,Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.,Journal Article|Review,Fibrinolytic Agents|Tissue Plasminogen Activator|NA,"Betacoronavirus|COVID-19|Coronavirus Infections|Drug Repositioning|Fibrinolysis|Fibrinolytic Agents|Host-Pathogen Interactions|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|Thrombolytic Therapy|Tissue Plasminogen Activator|Treatment Outcome|NA",2020-07-15,Journal of thrombosis and haemostasis : JTH,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32333494,NCT04368897,Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?,Letter,"Androgen Antagonists|Receptors, Androgen|NA","Alopecia|Androgen Antagonists|COVID-19|Continental Population Groups|Coronavirus Infections|Genetic Variation|Humans|Male|Pandemics|Pneumonia, Viral|Prostatic Neoplasms|Receptors, Androgen|NA",2020-07-02,Journal of cosmetic dermatology,Registry,https://clinicaltrials.gov/ct2/show/NCT04368897,0
32333839,NCT04367896,COVID-19: a need for real-time monitoring of weekly excess deaths.,"Letter|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|Computer Systems|Coronavirus Infections|Data Collection|Humans|Information Dissemination|Mortality|Pandemics|Pneumonia, Viral|Population Surveillance|Public Health|Publishing|SARS-CoV-2|Time Factors|NA",2020-05-05,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04367896,0
32334392,NCT04368351,"Enhancing immunity in viral infections, with special emphasis on COVID-19: A review.",Journal Article|Systematic Review,Micronutrients|Vitamins|NA,"Adolescent|Adult|Aged|Betacoronavirus|COVID-19|Child|Child, Preschool|Controlled Clinical Trials as Topic|Coronavirus Infections|Dietary Supplements|Female|Humans|Immunity|Male|Micronutrients|Middle Aged|Nutrition Therapy|Pandemics|Pneumonia, Viral|Probiotics|PubMed|Respiratory Tract Infections|SARS-CoV-2|Virus Diseases|Vitamins|Young Adult|NA",2020-07-23,Diabetes &amp; metabolic syndrome,Registry,https://clinicaltrials.gov/ct2/show/NCT04368351,0
32334647,NCT04367896,Pitfalls of judgment during the COVID-19 pandemic.,Journal Article|Review, ,"COVID-19|Coronavirus Infections|Humans|Judgment|Pandemics|Pneumonia, Viral|Uncertainty|NA",2020-06-12,The Lancet. Public health,Registry,https://clinicaltrials.gov/ct2/show/NCT04367896,0
32336042,NCT04402853,Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19.,Journal Article, , ,2021-05-07,Acta ophthalmologica,Registry,https://clinicaltrials.gov/ct2/show/NCT04402853,0
32337590,NCT04567979,Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).,"Journal Article|Research Support, Non-U.S. Gov't","Antibodies, Viral|Immunoglobulin G|Immunoglobulin M|NA","Adult|Aged|Antibodies, Viral|COVID-19|COVID-19 Testing|China|Female|Hospitalization|Humans|Immunity, Humoral|Immunoglobulin G|Immunoglobulin M|Male|Middle Aged|SARS-CoV-2|NA",2020-12-04,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Registry,https://clinicaltrials.gov/ct2/show/NCT04567979,0
32338732,NCT04470648,Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston.,Journal Article, ,"Adult|Age Distribution|Betacoronavirus|Boston|COVID-19|Contact Tracing|Continental Population Groups|Coronavirus Infections|Female|Homeless Persons|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prevalence|SARS-CoV-2|Sex Distribution|Symptom Assessment|Young Adult|NA",2020-09-24,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04470648,0
32339082,NCT04577105,CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation.,Journal Article|Multicenter Study|Observational Study, ,"Adult|Aged|Betacoronavirus|COVID-19|Communication|Coronavirus Infections|Female|Humans|Lung|Male|Middle Aged|Netherlands|Observer Variation|Pandemics|Pneumonia, Viral|Radiology Information Systems|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Tomography, X-Ray Computed|NA",2020-07-31,Radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04577105,0
32339487,NCT04515108,"Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.",Journal Article, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|Blood Cell Count|COVID-19|China|Coronavirus Infections|Female|Hospitalization|Humans|Lymphocytes|Male|Middle Aged|Monocytes|Neutrophils|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Young Adult|NA",2020-06-12,Clinica chimica acta; international journal of clinical chemistry,Registry,https://clinicaltrials.gov/ct2/show/NCT04515108,0
32342479,NCT04480034,"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China.",Journal Article|Observational Study, ,"Adult|Betacoronavirus|COVID-19|China|Comorbidity|Coronavirus Infections|Diabetes Complications|Diabetes Mellitus|Electronic Health Records|Female|Humans|Hypertension|Male|Middle Aged|Oxygen Inhalation Therapy|Pandemics|Pneumonia, Viral|Respiration, Artificial|Retrospective Studies|SARS-CoV-2|NA",2020-08-14,Infection,Registry,https://clinicaltrials.gov/ct2/show/NCT04480034,0
32342861,NCT04567979,International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic.,Letter|Comment, , ,2021-01-10,Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04567979,0
32342871,NCT04394182,Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?,Editorial|Comment, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-06-25,Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04394182,1
32350857,NCT04616950,Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services.,Journal Article|Review, ,"COVID-19|Delivery of Health Care|Global Health|Humans|Infection Control|Pandemics|Perioperative Care|Practice Guidelines as Topic|Surgical Procedures, Operative|NA",2020-12-18,The British journal of surgery,Registry,https://clinicaltrials.gov/ct2/show/NCT04616950,0
32356900,NCT04424953,Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adult|Airway Management|Australia|Betacoronavirus|COVID-19|Consensus|Coronavirus Infections|Female|Humans|Infection Control|Intubation, Intratracheal|Male|New Zealand|Pandemics|Pneumonia, Viral|Practice Guidelines as Topic|SARS-CoV-2|NA",2020-06-12,The Medical journal of Australia,Registry,https://clinicaltrials.gov/ct2/show/NCT04424953,0
32356910,NCT04488484,Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.,Journal Article|Systematic Review,"Antibodies, Neutralizing|Antibodies, Viral|Antiviral Agents|NA","Antibodies, Neutralizing|Antibodies, Viral|Antiviral Agents|COVID-19|Humans|Immunization, Passive|NA",2020-12-16,Journal of medical virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04488484,0
32360126,NCT04753762,Myocardial injury and COVID-19: Possible mechanisms.,Journal Article|Review, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Humans|Myocarditis|Myocardium|Myocytes, Cardiac|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-06-08,Life sciences,Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32360300,NCT04480593,Natural product-derived phytochemicals as potential agents against coronaviruses: A review.,Journal Article|Review,Phytochemicals|NA,"Animals|Betacoronavirus|COVID-19|Coronavirus Infections|Coronavirus, Feline|Humans|Infectious bronchitis virus|Middle East Respiratory Syndrome Coronavirus|Pandemics|Phytochemicals|Pneumonia, Viral|Porcine epidemic diarrhea virus|SARS Virus|SARS-CoV-2|NA",2020-06-02,Virus research,Registry,https://clinicaltrials.gov/ct2/show/NCT04480593,0
32361099,NCT04798677,The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19.,Letter, , ,2021-01-19,Medical hypotheses,Registry,https://clinicaltrials.gov/ct2/show/NCT04798677,0
32364011,NCT04485130,"FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication.","Journal Article|Research Support, Non-U.S. Gov't", , ,2021-05-19,Journal of biomolecular structure &amp; dynamics,Registry,https://clinicaltrials.gov/ct2/show/NCT04485130,0
32369666,NCT04466670,Incidence of venous thromboembolism in hospitalized patients with COVID-19.,Comparative Study|Journal Article,Anticoagulants|Biomarkers|Fibrin Fibrinogen Degradation Products|fibrin fragment D|NA,"Aged|Anticoagulants|Betacoronavirus|Biomarkers|COVID-19|Catheterization, Central Venous|Coronavirus Infections|Female|Fibrin Fibrinogen Degradation Products|Humans|Incidence|Intensive Care Units|Male|Middle Aged|Netherlands|Pandemics|Patients' Rooms|Pneumonia, Viral|Pulmonary Embolism|Retrospective Studies|Risk Factors|SARS-CoV-2|Thrombophilia|Thrombophlebitis|Venous Thromboembolism|Venous Thrombosis|NA",2020-08-14,Journal of thrombosis and haemostasis : JTH,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32373721,NCT04394182,Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment.,Journal Article, , ,2020-09-28,Clinical and translational radiation oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04394182,1
32381426,NCT04392323,Nosocomial infection with SARS-Cov-2Â within Departments of Digestive Surgery.,Journal Article, ,"Adult|Aged|COVID-19|Coronavirus Infections|Cross Infection|Digestive System Surgical Procedures|Female|Hospital Departments|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|NA",2020-07-06,Journal of visceral surgery,Registry,https://clinicaltrials.gov/ct2/show/NCT04392323,0
32383778,NCT04468035,A Unique Presentation of Delirium in a Patient with Otherwise Asymptomatic COVID-19.,Case Reports|Journal Article, ,"Aged|Asymptomatic Infections|Betacoronavirus|COVID-19|Coronavirus Infections|Delirium|Humans|Male|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-07-22,Journal of the American Geriatrics Society,Registry,https://clinicaltrials.gov/ct2/show/NCT04468035,0
32387623,NCT04466670,Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.,Letter,Anticoagulants|NA,"Anticoagulants|Betacoronavirus|COVID-19|Cardiovascular Diseases|Comorbidity|Coronavirus Infections|Hemorrhage|Hospitalization|Humans|Length of Stay|Mortality|New York City|Outcome and Process Assessment, Health Care|Pandemics|Pneumonia, Viral|Respiration, Artificial|Risk Assessment|SARS-CoV-2|NA",2020-07-13,Journal of the American College of Cardiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32394480,NCT04526405,Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.,Letter, ,"Acute Chest Syndrome|Anemia, Sickle Cell|Betacoronavirus|COVID-19|Coronavirus Infections|Hemoglobinopathies|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|Thalassemia|NA",2020-07-22,American journal of hematology,Registry,https://clinicaltrials.gov/ct2/show/NCT04526405,0
32395391,NCT04568356,Development of a rapid test kit for SARS-CoV-2: an example of product design.,Journal Article, , ,2020-09-28,Bio-design and manufacturing,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32396163,NCT04577105,Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Validation Study", ,"Adult|Aged|Betacoronavirus|COVID-19|COVID-19 Testing|China|Clinical Laboratory Techniques|Cohort Studies|Coronavirus Infections|Critical Care|Critical Illness|Female|Hospitalization|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Risk Assessment|SARS-CoV-2|NA",2020-10-02,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04577105,0
32396163,NCT04517162,Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.,"Journal Article|Research Support, Non-U.S. Gov't|Validation Study", ,"Adult|Aged|Betacoronavirus|COVID-19|COVID-19 Testing|China|Clinical Laboratory Techniques|Cohort Studies|Coronavirus Infections|Critical Care|Critical Illness|Female|Hospitalization|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Risk Assessment|SARS-CoV-2|NA",2020-10-02,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04517162,0
32399710,NCT04497311,COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia.,Journal Article, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Diagnosis, Differential|Female|Humans|Influenza, Human|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Young Adult|NA",2020-09-14,European radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04497311,0
32399710,NCT04499378,COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia.,Journal Article, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Diagnosis, Differential|Female|Humans|Influenza, Human|Lung|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Tomography, X-Ray Computed|Young Adult|NA",2020-09-14,European radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04499378,0
32401873,NCT04522492,Skin picking treatment with the Rothbaum cognitive behavioral therapy protocol: a randomized clinical trial.,Journal Article|Randomized Controlled Trial, ,Anxiety Disorders|Cognitive Behavioral Therapy|Comorbidity|Humans|Trichotillomania|NA,2020-11-09,"Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",Registry,https://clinicaltrials.gov/ct2/show/NCT04522492,0
32402207,NCT04611269,Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology.,"Editorial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|COVID-19|Clinical Decision-Making|Coronavirus Infections|Humans|Intubation|Pandemics|Pneumonia, Viral|Respiration, Artificial|Risk Factors|SARS-CoV-2|NA",2020-07-14,American journal of respiratory and critical care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04611269,0
32404476,NCT04488484,Estimating the burden of SARS-CoV-2 in France.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Adolescent|Adult|Aged|Aged, 80 and over|COVID-19|Coronavirus Infections|Cost of Illness|Critical Care|Female|France|Hospitalization|Humans|Immunity|Male|Middle Aged|Pandemics|Pneumonia, Viral|Quarantine|SARS Virus|Young Adult|NA",2020-07-16,"Science (New York, N.Y.)",Registry,https://clinicaltrials.gov/ct2/show/NCT04488484,0
32404480,NCT04568356,Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.,Evaluation Study|Letter,"Antigens, Viral|NA","Antigens, Viral|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Humans|Immunoassay|Nasopharynx|Pandemics|Pneumonia, Viral|Point-of-Care Testing|SARS-CoV-2|Sensitivity and Specificity|NA",2020-08-04,Journal of clinical microbiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32406348,NCT04841681,The benefits of meditation and mindfulness practices during times of crisis such as COVID-19.,Journal Article, ,"COVID-19|Humans|Meditation|Mindfulness|Pandemics|Stress, Psychological|NA",2021-01-07,Irish journal of psychological medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04841681,0
32419926,NCT04382768,"Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.",Journal Article,"COVID-19 Vaccines|Receptors, Virus|Spike Glycoprotein, Coronavirus|spike protein, SARS-CoV-2|ACE2 protein, human|Angiotensin-Converting Enzyme 2|NA","Angiotensin-Converting Enzyme 2|COVID-19|COVID-19 Vaccines|China|Humans|Receptors, Virus|SARS-CoV-2|Spike Glycoprotein, Coronavirus|Viral Tropism|NA",2021-01-21,F1000Research,Registry,https://clinicaltrials.gov/ct2/show/NCT04382768,0
32422057,NCT04568356,Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure.,"Journal Article|Research Support, N.I.H., Extramural|Research Support, N.I.H., Intramural|Review", ,"Bayes Theorem|Betacoronavirus|COVID-19|Coronavirus Infections|False Negative Reactions|Humans|Pandemics|Pneumonia, Viral|Reproducibility of Results|Reverse Transcriptase Polymerase Chain Reaction|Risk Factors|SARS-CoV-2|NA",2020-08-27,Annals of internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32437596,NCT04466670,"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.","Comparative Study|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't", ,"Aged|Aged, 80 and over|Autopsy|Betacoronavirus|COVID-19|Coronavirus Infections|Endothelium, Vascular|Female|Humans|Influenza A Virus, H1N1 Subtype|Influenza, Human|Lung|Male|Middle Aged|Neovascularization, Pathologic|Pandemics|Pneumonia, Viral|Respiratory Distress Syndrome|Respiratory Insufficiency|SARS-CoV-2|Thrombosis|NA",2020-07-16,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32444253,NCT04689672,Lung Ultrasound in COVID-19 Pneumonia: Prospects and Limitations.,Letter, , ,2021-01-10,Academic radiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04689672,0
32444460,NCT04611269,Features of 20â€‰133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.,Journal Article|Observational Study, ,"Adolescent|Adult|Age Factors|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Child|Child, Preschool|Comorbidity|Coronavirus Infections|Critical Care|Female|Hospitalization|Humans|Infant|Infant, Newborn|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prospective Studies|Respiration, Artificial|Risk Factors|SARS-CoV-2|Sex Factors|United Kingdom|Young Adult|NA",2020-05-28,BMJ (Clinical research ed.),Registry,https://clinicaltrials.gov/ct2/show/NCT04611269,0
32445064,NCT04466670,Heparin resistance in COVID-19 patients in the intensive care unit.,Journal Article,Anticoagulants|Heparin|NA,"Adult|Aged|Anticoagulants|Betacoronavirus|Blood Coagulation|Blood Coagulation Tests|COVID-19|Coronavirus Infections|Drug Monitoring|Drug Resistance|Female|Heparin|Host-Pathogen Interactions|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Pneumonia, Viral|Retrospective Studies|SARS-CoV-2|Thrombosis|Treatment Outcome|NA",2020-07-22,Journal of thrombosis and thrombolysis,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32445440,NCT04647695,Remdesivir for the Treatment of Covid-19 - Final Report.,"Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Antiviral Agents|remdesivir|Adenosine Monophosphate|Alanine|NA,"Adenosine Monophosphate|Administration, Intravenous|Adult|Aged|Alanine|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Double-Blind Method|Extracorporeal Membrane Oxygenation|Female|Humans|Kaplan-Meier Estimate|Male|Middle Aged|Oxygen Inhalation Therapy|Pandemics|Pneumonia, Viral|Respiration, Artificial|SARS-CoV-2|Time Factors|Young Adult|NA",2020-12-01,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04647695,0
32448749,NCT04632615,Nowhere to hide: The significant impact of coronavirus disease 2019 (COVID-19) measures on elite and semi-elite South African athletes.,Journal Article,Dietary Carbohydrates|NA,"Athletes|Betacoronavirus|COVID-19|Coronavirus Infections|Cross-Sectional Studies|Depression|Dietary Carbohydrates|Exercise|Female|Humans|Male|Pandemics|Pneumonia, Viral|Return to Sport|SARS-CoV-2|Sedentary Behavior|Sleep|Surveys and Questionnaires|NA",2020-06-25,Journal of science and medicine in sport,Registry,https://clinicaltrials.gov/ct2/show/NCT04632615,0
32450344,NCT04466670,"Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.","Clinical Trial, Phase II|Controlled Clinical Trial|Journal Article",Fibrin Fibrinogen Degradation Products|Platelet Aggregation Inhibitors|fibrin fragment D|Clopidogrel|Tirofiban|Aspirin|NA,"Aged|Aspirin|Betacoronavirus|COVID-19|Clopidogrel|Compassionate Use Trials|Coronavirus Infections|Female|Fibrin Fibrinogen Degradation Products|Humans|Hypoxia|Male|Middle Aged|Pandemics|Platelet Aggregation Inhibitors|Pneumonia, Viral|Proof of Concept Study|SARS-CoV-2|Thrombophilia|Tirofiban|NA",2020-07-20,Pharmacological research,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32454138,NCT04631861,"Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK.","Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",C-Reactive Protein|NA,"Adult|Aged|Alcohol Drinking|Betacoronavirus|Body Mass Index|C-Reactive Protein|COVID-19|Cohort Studies|Coronavirus Infections|Exercise|Female|Hospitalization|Humans|Life Style|Male|Middle Aged|Obesity|Pandemics|Pneumonia, Viral|Prospective Studies|Risk Factors|SARS-CoV-2|Smoking|Surveys and Questionnaires|United Kingdom|NA",2020-07-06,"Brain, behavior, and immunity",Registry,https://clinicaltrials.gov/ct2/show/NCT04631861,0
32459672,NCT04466670,Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.,Journal Article|Observational Study,Anticoagulants|Biomarkers|NA,"Adolescent|Adult|Aged|Aged, 80 and over|Anticoagulants|Betacoronavirus|Biomarkers|COVID-19|Comorbidity|Coronavirus Infections|Critical Illness|Female|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|Thrombelastography|Thrombophilia|Venous Thromboembolism|Young Adult|NA",2020-09-02,Critical care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32461699,NCT04454606,Author Correction: Respiratory virus shedding in exhaled breath and efficacy of face masks.,Journal Article|Published Erratum, , ,2021-05-11,Nature medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04454606,0
32462179,NCT04466670,Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.,Letter,Anticoagulants|Platelet Aggregation Inhibitors|Protective Agents|NA,"Adult|Aged|Anticoagulants|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Male|Middle Aged|Pandemics|Platelet Aggregation Inhibitors|Pneumonia, Viral|Propensity Score|Protective Agents|Protective Factors|Retrospective Studies|SARS-CoV-2|Survival Analysis|NA",2020-07-14,Blood,Registry,https://clinicaltrials.gov/ct2/show/NCT04466670,0
32473681,NCT04733729,Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.,"Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Antiviral Agents|Hydroxychloroquine|Azithromycin|NA,"Aged|Antiviral Agents|Azithromycin|Betacoronavirus|COVID-19|Cause of Death|Comorbidity|Coronavirus Infections|Databases, Factual|Female|Humans|Hydroxychloroquine|Male|Middle Aged|Neoplasms|Pandemics|Pneumonia, Viral|Prognosis|Risk Factors|SARS-CoV-2|NA",2020-07-02,"Lancet (London, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04733729,0
32479682,NCT04443140,Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study.,Journal Article|Observational Study,"PGF protein, human|Placenta Growth Factor|L-Lactate Dehydrogenase|Aspartate Aminotransferases|Alanine Transaminase|FLT1 protein, human|Vascular Endothelial Growth Factor Receptor-1|NA","Adult|Alanine Transaminase|Aspartate Aminotransferases|Betacoronavirus|Blood Pressure|COVID-19|Coronavirus Infections|Female|HELLP Syndrome|Humans|L-Lactate Dehydrogenase|Pandemics|Placenta Growth Factor|Pneumonia, Viral|Pre-Eclampsia|Pregnancy|Pregnancy Complications, Infectious|Proteinuria|Pulsatile Flow|SARS-CoV-2|Severity of Illness Index|Tertiary Care Centers|Thrombocytopenia|Uterine Artery|Vascular Endothelial Growth Factor Receptor-1|NA",2020-09-24,BJOG : an international journal of obstetrics and gynaecology,Registry,https://clinicaltrials.gov/ct2/show/NCT04443140,0
32485618,NCT04568356,Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.,Journal Article,"Antigens, Viral|NA","Adolescent|Adult|Aged|Aged, 80 and over|Animals|Antigens, Viral|Betacoronavirus|COVID-19|COVID-19 Testing|Child|Child, Preschool|Clinical Laboratory Techniques|Coronavirus Infections|Female|Humans|Immunoassay|Infant|Infant, Newborn|Male|Middle Aged|Nasopharynx|Pandemics|Pneumonia, Viral|SARS-CoV-2|Sensitivity and Specificity|Young Adult|NA",2020-08-11,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32489804,NCT04475471,World Heart Federation Briefing on Prevention: Coronavirus Disease 2019 (COVID-19) in Low-Income Countries.,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Developing Countries|Humans|Pandemics|Pneumonia, Viral|Poverty|SARS-CoV-2|NA",2020-06-17,Global heart,Registry,https://clinicaltrials.gov/ct2/show/NCT04475471,0
32492293,NCT04308668,A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.,"Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Hydroxychloroquine|NA,"Adult|Betacoronavirus|COVID-19|Canada|Coronavirus Infections|Double-Blind Method|Female|Humans|Hydroxychloroquine|Inhalation Exposure|Male|Middle Aged|Occupational Exposure|Pandemics|Pneumonia, Viral|Post-Exposure Prophylaxis|SARS-CoV-2|Treatment Failure|United States|NA",2020-08-12,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04308668,4
32497809,NCT04568356,Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.,Evaluation Study|Journal Article, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|COVID-19 Testing|COVID-19 Vaccines|Child|Child, Preschool|Clinical Laboratory Techniques|Coronavirus Infections|Female|Humans|Infant|Male|Middle Aged|Nasopharynx|Pandemics|Pneumonia, Viral|SARS-CoV-2|Sensitivity and Specificity|Viral Load|Young Adult|NA",2020-11-02,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32499236,NCT04753762,"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?",Journal Article|Review,"Biomarkers|Troponin|Peptidyl-Dipeptidase A|ACE2 protein, human|Angiotensin-Converting Enzyme 2|NA","Angiotensin-Converting Enzyme 2|Betacoronavirus|Biomarkers|COVID-19|Coronavirus Infections|Humans|Inflammation|Myocarditis|Pandemics|Peptidyl-Dipeptidase A|Pneumonia, Viral|Renin-Angiotensin System|SARS-CoV-2|Troponin|NA",2020-08-10,Heart (British Cardiac Society),Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32504944,NCT04568356,Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital.,Journal Article|Comment, , ,2020-08-04,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32511673,NCT04558996,Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.,Letter, ,"Betacoronavirus|COVID-19|Cesarean Section|Coronavirus Infections|Delivery, Obstetric|Female|Humans|Pandemics|Pneumonia, Viral|Pregnancy|Pregnancy Complications, Infectious|Pregnancy Outcome|SARS-CoV-2|Spain|NA",2020-09-21,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04558996,1
32512122,NCT04753762,Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.,Journal Article|Review, ,"COVID-19|Diagnosis, Differential|Heart|Heart Diseases|Hospitalization|Host-Pathogen Interactions|Humans|Predictive Value of Tests|Prognosis|Risk Factors|SARS-CoV-2|NA",2020-12-04,Progress in cardiovascular diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04753762,0
32513197,NCT04632615,Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey.,Journal Article, ,"Adolescent|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Child|Coronavirus Infections|Diet, Mediterranean|Drinking|Emergencies|Feeding Behavior|Female|Guideline Adherence|Humans|Italy|Life Style|Male|Middle Aged|Pandemics|Pneumonia, Viral|Quarantine|SARS-CoV-2|Sleep|Smoking|Surveys and Questionnaires|Young Adult|NA",2020-06-23,Journal of translational medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04632615,0
32530491,NCT04840940,Presepsin as a predictive biomarker of severity in COVID-19: AÂ case series.,Letter,"Biomarkers|Lipopolysaccharide Receptors|MUC1 protein, human|Mucin-1|Peptide Fragments|presepsin protein, human|C-Reactive Protein|NA",Biomarkers|C-Reactive Protein|COVID-19|Humans|Lipopolysaccharide Receptors|Mucin-1|Peptide Fragments|Retrospective Studies|SARS-CoV-2|NA,2021-03-09,Journal of medical virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04840940,0
32531892,NCT04449731,Changes in Dietary Behaviours during the COVID-19 Outbreak Confinement in the Spanish COVIDiet Study.,Journal Article, ,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Diet Surveys|Diet, Mediterranean|Feeding Behavior|Female|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Quarantine|SARS-CoV-2|Spain|NA",2020-07-02,Nutrients,Registry,https://clinicaltrials.gov/ct2/show/NCT04449731,0
32541583,NCT04627467,"To Protect Health Care Workers Better, To Save More Lives With COVID-19.",Historical Article|Journal Article|Review, ,"COVID-19|China|Coronavirus Infections|Health Personnel|History, 21st Century|Humans|Infectious Disease Transmission, Patient-to-Professional|Pandemics|Pneumonia, Viral|NA",2020-06-25,Anesthesia and analgesia,Registry,https://clinicaltrials.gov/ct2/show/NCT04627467,0
32542934,NCT04568356,"Diagnosing COVID-19 in the Emergency Department: A Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases.","Journal Article|Research Support, Non-U.S. Gov't|Review", ,"Adult|COVID-19|COVID-19 Testing|Diagnostic Tests, Routine|Emergency Service, Hospital|Female|Humans|Pandemics|Physical Examination|SARS-CoV-2|Tomography, X-Ray Computed|NA",2020-12-21,Academic emergency medicine : official journal of the Society for Academic Emergency Medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32557489,NCT04616950,Impact of the COVID-19 pandemic on gastrointestinal endoscopy activity in France.,Journal Article, ,"COVID-19|Endoscopy, Gastrointestinal|Female|France|Gastroenterology|Hospital Departments|Humans|Male|Middle Aged|Occupational Exposure|Pandemics|Personal Protective Equipment|Prevalence|SARS-CoV-2|Surveys and Questionnaires|NA",2020-12-14,Endoscopy,Registry,https://clinicaltrials.gov/ct2/show/NCT04616950,0
32563676,NCT04643522,Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications.,Journal Article,"Peptidyl-Dipeptidase A|ACE2 protein, human|Angiotensin-Converting Enzyme 2|NA","Adult|Aged|Aged, 80 and over|Angiotensin-Converting Enzyme 2|Betacoronavirus|COVID-19|Cell Count|Coronavirus Infections|Humans|Inflammation|Leydig Cells|Male|Microscopy, Electron|Middle Aged|Pandemics|Peptidyl-Dipeptidase A|Pneumonia, Viral|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|Seminiferous Tubules|Sertoli Cells|Spermatogenesis|Testis|NA",2020-08-20,European urology focus,Registry,https://clinicaltrials.gov/ct2/show/NCT04643522,0
32577640,NCT04568356,SARS-CoV2 Testing: The Limit of Detection Matters.,Preprint, , ,2020-09-28,bioRxiv : the preprint server for biology,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32585619,NCT04568356,Evaluation of rapid antigen test for detection of SARS-CoV-2 virus.,Evaluation Study|Journal Article,"Antigens, Viral|NA","Antigens, Viral|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Humans|Immunoassay|Pandemics|Pneumonia, Viral|SARS-CoV-2|Sensitivity and Specificity|NA",2020-08-11,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32595361,NCT04517422,Gut-lung axis and dysbiosis in COVID-19.,Journal Article, , ,2020-09-28,Turkish journal of biology = Turk biyoloji dergisi,Registry,https://clinicaltrials.gov/ct2/show/NCT04517422,0
32602006,NCT04334291,Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.,"Journal Article|Research Support, Non-U.S. Gov't","Peptidyl-Dipeptidase A|ACE2 protein, human|Angiotensin-Converting Enzyme 2|NA","Acute Kidney Injury|Aged|Aged, 80 and over|Angiotensin-Converting Enzyme 2|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Glomerular Filtration Rate|Humans|Male|Middle Aged|Pandemics|Peptidyl-Dipeptidase A|Pneumonia, Viral|Registries|Risk Assessment|SARS-CoV-2|NA",2020-08-10,Journal of nephrology,Registry,https://clinicaltrials.gov/ct2/show/NCT04334291,6
32609874,NCT04343898,ABO phenotype and death in critically ill patients with COVID-19.,"Clinical Trial|Letter|Multicenter Study|Research Support, N.I.H., Extramural",ABO Blood-Group System|NA,ABO Blood-Group System|Aged|COVID-19|Critical Illness|Female|Follow-Up Studies|Humans|Male|Middle Aged|SARS-CoV-2|NA,2020-12-14,British journal of haematology,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
32613682,NCT04476589,Intact Brain Network Function in an Unresponsive Patient with COVID-19.,"Case Reports|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't", ,"Betacoronavirus|Brain|COVID-19|Coma|Coronavirus Infections|Electroencephalography|Functional Neuroimaging|Humans|Magnetic Resonance Imaging|Male|Middle Aged|Neural Pathways|Pandemics|Persistent Vegetative State|Pneumonia, Viral|Prognosis|Recovery of Function|Renal Insufficiency|Respiration, Artificial|Respiratory Distress Syndrome|SARS-CoV-2|Shock|NA",2020-10-22,Annals of neurology,Registry,https://clinicaltrials.gov/ct2/show/NCT04476589,0
32621617,NCT04643522,Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients.,"Journal Article|Research Support, Non-U.S. Gov't",Gonadal Steroid Hormones|Testosterone|NA,Adult|COVID-19|Gonadal Steroid Hormones|Humans|Male|Middle Aged|Semen|Semen Analysis|Testosterone|Young Adult|NA,2021-03-02,Journal of medical virology,Registry,https://clinicaltrials.gov/ct2/show/NCT04643522,0
32627443,NCT04631861,The Correlation of Comorbidities on the Mortality in Patients with COVID-19: an Observational Study Based on the Korean National Health Insurance Big Data.,Journal Article|Observational Study, ,"Adult|Aged|Betacoronavirus|Big Data|COVID-19|Chronic Disease|Comorbidity|Coronavirus Infections|Female|Humans|Male|Middle Aged|National Health Programs|Pandemics|Pneumonia, Viral|Republic of Korea|Risk Factors|SARS-CoV-2|Young Adult|NA",2020-07-13,Journal of Korean medical science,Registry,https://clinicaltrials.gov/ct2/show/NCT04631861,0
32628126,NCT04679168,Environment-Wide Association Study of CKD.,"Journal Article|Research Support, Non-U.S. Gov't", , ,2021-02-08,Clinical journal of the American Society of Nephrology : CJASN,Registry,https://clinicaltrials.gov/ct2/show/NCT04679168,0
32636214,NCT04568356,"Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19.","Journal Article|Research Support, Non-U.S. Gov't","Antigens, Viral|RNA, Viral|NA","Adolescent|Adult|Aged|Aged, 80 and over|Antigens, Viral|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Female|Humans|Immunoassay|Male|Middle Aged|Nucleic Acid Amplification Techniques|Pandemics|Pneumonia, Viral|RNA, Viral|SARS-CoV-2|Saliva|Sensitivity and Specificity|Specimen Handling|Young Adult|NA",2020-09-08,Journal of clinical microbiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32645713,NCT04517422,"Microbiota and Covid-19. Which came first, the chicken or the egg?",Journal Article, , ,2020-09-01,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Registry,https://clinicaltrials.gov/ct2/show/NCT04517422,0
32646750,NCT04568356,How to perform a nasopharyngeal swab in adults and children in the COVID-19 era.,Journal Article,"RNA, Viral|NA","Adult|Betacoronavirus|COVID-19|COVID-19 Testing|Child|Clinical Laboratory Techniques|Coronavirus Infections|Humans|Nasopharynx|Pandemics|Pneumonia, Viral|RNA, Viral|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|NA",2020-09-10,"European annals of otorhinolaryngology, head and neck diseases",Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32650948,NCT04643522,Assessment of SARS-CoV-2 in human semen-a cohort study.,Journal Article,"RNA, Viral|NA","Adult|Betacoronavirus|COVID-19|Cohort Studies|Coronavirus Infections|Humans|Infertility, Male|Male|Middle Aged|Pandemics|Pilot Projects|Pneumonia, Viral|Prospective Studies|RNA, Viral|SARS-CoV-2|Semen|Young Adult|NA",2020-08-11,Fertility and sterility,Registry,https://clinicaltrials.gov/ct2/show/NCT04643522,0
32667668,NCT04343898,Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.,"Journal Article|Multicenter Study|Research Support, N.I.H., Extramural", ,"Adult|Age Factors|Aged|Aged, 80 and over|COVID-19|Critical Illness|Female|Hospital Mortality|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Risk Factors|United States|NA",2021-05-03,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
32670091,NCT04517422,The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?,Journal Article|Review, , ,2020-09-28,Frontiers in physiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04517422,0
32673060,NCT04308668,Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.,Journal Article|Multicenter Study|Randomized Controlled Trial,Antimalarials|Hydroxychloroquine|NA,"Adult|Antimalarials|Betacoronavirus|COVID-19|Coronavirus Infections|Double-Blind Method|Female|Follow-Up Studies|Humans|Hydroxychloroquine|Male|Middle Aged|Outpatients|Pandemics|Pneumonia, Viral|Retrospective Studies|Risk Factors|SARS-CoV-2|Time Factors|NA",2020-10-27,Annals of internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04308668,4
32678530,NCT04381936,Dexamethasone in Hospitalized Patients with Covid-19.,Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial,Anti-Infective Agents|Glucocorticoids|Dexamethasone|NA,"Administration, Oral|Aged|Aged, 80 and over|Anti-Infective Agents|COVID-19|Dexamethasone|Drug Therapy, Combination|Female|Glucocorticoids|Hospitalization|Humans|Injections, Intravenous|Kaplan-Meier Estimate|Length of Stay|Male|Odds Ratio|Oxygen Inhalation Therapy|Respiration, Artificial|United Kingdom|NA",2021-03-01,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04381936,4
32681559,NCT04515108,"Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.",Journal Article|Multicenter Study,Biomarkers|NA,"Adult|Betacoronavirus|Biomarkers|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Cross-Sectional Studies|Female|Humans|Leukocyte Count|Lymphocytes|Male|Middle Aged|Monocytes|Neutrophils|Pandemics|Pneumonia, Viral|Predictive Value of Tests|SARS-CoV-2|NA",2020-11-20,Journal of clinical laboratory analysis,Registry,https://clinicaltrials.gov/ct2/show/NCT04515108,0
32692012,NCT04334291,"The COVID-19 curve, health system overload, and mortality.",Journal Article|Multicenter Study, ,"Adolescent|Adult|Age Distribution|Age Factors|Aged|Betacoronavirus|COVID-19|Cardiovascular Diseases|Child|China|Cohort Studies|Comorbidity|Coronavirus Infections|Female|Health Services Accessibility|Hospital Mortality|Humans|Male|Middle Aged|Pandemics|Patient Discharge|Pneumonia, Viral|SARS-CoV-2|Sex Distribution|Spain|Symptom Assessment|United States|Young Adult|NA",2020-07-29,Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias,Registry,https://clinicaltrials.gov/ct2/show/NCT04334291,6
32692185,NCT04685512,"Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19.","Journal Article|Research Support, N.I.H., Extramural",Antiviral Agents|Dideoxynucleosides|Viral Nonstructural Proteins|RNA-Dependent RNA Polymerase|Sofosbuvir|NA,"Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Dideoxynucleosides|Humans|Pandemics|Pneumonia, Viral|RNA-Dependent RNA Polymerase|SARS-CoV-2|Sofosbuvir|Viral Nonstructural Proteins|NA",2020-11-30,Journal of proteome research,Registry,https://clinicaltrials.gov/ct2/show/NCT04685512,0
32723665,NCT04514705,Recovery after COVID-19: The potential role of pulmonary rehabilitation.,Editorial, ,COVID-19|Humans|Recovery of Function|Respiratory Therapy|SARS-CoV-2|NA,2021-01-13,Brazilian journal of physical therapy,Registry,https://clinicaltrials.gov/ct2/show/NCT04514705,0
32728349,NCT04517422,Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients.,Journal Article, , ,2020-09-28,Biological procedures online,Registry,https://clinicaltrials.gov/ct2/show/NCT04517422,0
32728654,NCT04662437,The Impact of SARS-Cov-2 Virus Infection on the Endocrine System.,Journal Article|Review, , ,2020-09-28,Journal of the Endocrine Society,Registry,https://clinicaltrials.gov/ct2/show/NCT04662437,0
32728965,NCT04611269,"Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.","Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't", ,"Adult|Analysis of Variance|COVID-19|Correlation of Data|Female|Humans|Male|Middle Aged|Proportional Hazards Models|Prospective Studies|Respiration, Artificial|Respiratory Distress Syndrome|Severity of Illness Index|Spain|Statistics, Nonparametric|NA",2020-12-23,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04611269,0
32732744,NCT04514705,Rehabilitation Therapy for a COVID-19 Patient Who Received Mechanical Ventilation in Japan.,Case Reports|Journal Article, ,"Aged|Betacoronavirus|COVID-19|Coronavirus Infections|Drainage, Postural|Exercise Therapy|Humans|Japan|Male|Pandemics|Pneumonia, Viral|Respiration, Artificial|Respiratory Therapy|SARS-CoV-2|Treatment Outcome|NA",2020-09-29,American journal of physical medicine &amp; rehabilitation,Registry,https://clinicaltrials.gov/ct2/show/NCT04514705,0
32733907,NCT04517422,Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19.,Journal Article, , ,2020-09-28,Frontiers in medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04517422,0
32737507,NCT04514705,Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome-Related Coronavirus Infection: Implications for COVID-19 Rehabilitation.,"Journal Article|Research Support, Non-U.S. Gov't|Systematic Review", ,"Betacoronavirus|COVID-19|Coronavirus Infections|Exercise|Health Status|Humans|Pandemics|Pneumonia, Viral|Recovery of Function|SARS-CoV-2|NA",2020-10-07,Physical therapy,Registry,https://clinicaltrials.gov/ct2/show/NCT04514705,0
32745548,NCT04578158,Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.,Journal Article,Antiviral Agents|Protease Inhibitors|Viral Nonstructural Proteins|Quercetin|Cysteine Endopeptidases|Coronavirus 3C Proteases|NA,"Antiviral Agents|Betacoronavirus|COVID-19|Catalytic Domain|Coronavirus 3C Proteases|Coronavirus Infections|Cysteine Endopeptidases|Drug Discovery|Humans|Molecular Docking Simulation|Pandemics|Pneumonia, Viral|Protease Inhibitors|Protein Conformation|Protein Unfolding|Quercetin|SARS-CoV-2|Viral Nonstructural Proteins|NA",2020-11-23,International journal of biological macromolecules,Registry,https://clinicaltrials.gov/ct2/show/NCT04578158,0
32747157,NCT04753476,A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.,Journal Article|Review,Antiviral Agents|BCG Vaccine|Cytokines|NA,"Antiviral Agents|BCG Vaccine|Betacoronavirus|COVID-19|Cardiovascular Diseases|Coronavirus Infections|Cytokine Release Syndrome|Cytokines|Diabetes Mellitus|Humans|Hypertension|Middle East Respiratory Syndrome Coronavirus|Mycobacterium bovis|Pandemics|Pneumonia, Viral|Pulmonary Disease, Chronic Obstructive|Risk Factors|SARS-CoV-2|Severe Acute Respiratory Syndrome|Vaccination|NA",2020-09-28,Cytokine &amp; growth factor reviews,Registry,https://clinicaltrials.gov/ct2/show/NCT04753476,0
32759457,NCT04514705,An interdisciplinary approach to the management of critically ill patients during covid-19 pandemic; an experience of a university hospital in England.,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Critical Illness|England|Humans|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-11,"Wiadomosci lekarskie (Warsaw, Poland : 1960)",Registry,https://clinicaltrials.gov/ct2/show/NCT04514705,0
32760752,NCT04515108,"Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China.",Journal Article, , ,2020-09-28,Open forum infectious diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04515108,0
32766458,NCT04514705,Occupational therapy: The key to unlocking locked-up occupations during the COVID-19 pandemic.,Journal Article, , ,2020-09-28,Wellcome open research,Registry,https://clinicaltrials.gov/ct2/show/NCT04514705,0
32772205,NCT04841681,A Mindfulness Mobile App for Traumatized COVID-19 Healthcare Workers and Recovered Patients: A Response to &quot;The Use of Digital Applications and COVID-19&quot;.,Journal Article|Comment, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Health Personnel|Humans|Mindfulness|Mobile Applications|Pandemics|Pneumonia, Viral|SARS-CoV-2|NA",2020-08-24,Community mental health journal,Registry,https://clinicaltrials.gov/ct2/show/NCT04841681,0
32780788,NCT04517422,Gut microbiota and COVID-19: A superfluous diagnostic biomarker or therapeutic target?,Journal Article, , ,2020-09-01,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Registry,https://clinicaltrials.gov/ct2/show/NCT04517422,0
32787470,NCT04517422,Probiotics and Covid-19.,Journal Article|Review, ,COVID-19|Dysbiosis|Gastrointestinal Microbiome|Humans|Probiotics|NA,2021-04-08,International journal of food sciences and nutrition,Registry,https://clinicaltrials.gov/ct2/show/NCT04517422,0
32794128,NCT04841681,"Effectiveness of mindfulness by smartphone, for patients with chronic migraine and medication overuse during the Covid-19 emergency.",Journal Article, ,"COVID-19|Headache Disorders, Secondary|Humans|Migraine Disorders|Mindfulness|Pilot Projects|SARS-CoV-2|Smartphone|Treatment Outcome|NA",2020-12-09,Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04841681,0
32798473,NCT04733729,"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.",Journal Article|Multicenter Study|Observational Study, ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Female|Follow-Up Studies|Hematologic Neoplasms|Humans|Inpatients|Italy|Leukemia|Lymphoma, Non-Hodgkin|Male|Middle Aged|Myeloproliferative Disorders|Neoplasms, Plasma Cell|Pandemics|Pneumonia, Viral|Retrospective Studies|Risk Factors|SARS-CoV-2|Young Adult|NA",2020-10-02,The Lancet. Haematology,Registry,https://clinicaltrials.gov/ct2/show/NCT04733729,0
32800855,NCT04568356,"Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients.",Comparative Study|Journal Article|Validation Study, ,"Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|Humans|Immunoenzyme Techniques|Luminescent Measurements|Nasal Cavity|Pandemics|Pneumonia, Viral|Real-Time Polymerase Chain Reaction|SARS-CoV-2|Sensitivity and Specificity|Viral Load|NA",2020-10-28,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32803989,NCT04604249,<i>Letter to the Editor:</i> Influence of Altitude on the Prevalence and Case Fatality Rate of COVID-19 in Peru.,Letter|Comment, ,Altitude|COVID-19|Humans|Peru|Prevalence|SARS-CoV-2|NA,2021-01-01,High altitude medicine &amp; biology,Registry,https://clinicaltrials.gov/ct2/show/NCT04604249,0
32815745,NCT04604249,Mortality Attributed to COVID-19 in High-Altitude Populations.,Journal Article, ,"Adult|Age Factors|Aged|Altitude|COVID-19|Female|Humans|Intubation, Intratracheal|Male|Mexico|Middle Aged|Prevalence|Retrospective Studies|SARS-CoV-2|Sex Factors|United States|NA",2021-01-11,High altitude medicine &amp; biology,Registry,https://clinicaltrials.gov/ct2/show/NCT04604249,0
32821939,NCT04292730,Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.,"Clinical Trial, Phase III|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|remdesivir|Adenosine Monophosphate|Alanine|NA,"Adenosine Monophosphate|Administration, Intravenous|Aged|Alanine|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Drug Administration Schedule|Female|Hospitalization|Humans|Male|Middle Aged|Odds Ratio|Pandemics|Patient Acuity|Pneumonia, Viral|SARS-CoV-2|Treatment Outcome|NA",2020-09-29,JAMA,Registry,https://clinicaltrials.gov/ct2/show/NCT04292730,1
32823866,NCT04568356,Proposal of De Novo Antigen Test for COVID-19: Ultrasensitive Detection of Spike Proteins of SARS-CoV-2.,Journal Article, , ,2020-09-28,"Diagnostics (Basel, Switzerland)",Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32844546,NCT04343898,Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States.,Journal Article|Multicenter Study, ,Aged|COVID-19|Comorbidity|Critical Illness|Female|Follow-Up Studies|Hospital Mortality|Hospitalization|Humans|Intensive Care Units|Male|Middle Aged|Organ Transplantation|Pandemics|Risk Factors|SARS-CoV-2|Survival Rate|United States|NA,2020-12-23,American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
32845525,NCT04568356,"Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.","Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review","Antigens, Viral|NA","Antigens, Viral|Betacoronavirus|COVID-19|COVID-19 Testing|Clinical Laboratory Techniques|Coronavirus Infections|False Negative Reactions|False Positive Reactions|Humans|Pandemics|Pneumonia, Viral|Point-of-Care Systems|SARS-CoV-2|Sensitivity and Specificity|NA",2020-09-16,The Cochrane database of systematic reviews,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32880381,NCT04885478,[Descriptive study of the health service workers of a Primary Care Department confined by Covid-19.],Journal Article|Observational Study, ,"Adult|Betacoronavirus|COVID-19|Coronavirus Infections|Cross-Sectional Studies|Female|Health Personnel|Humans|Male|Middle Aged|Occupational Diseases|Pandemics|Pneumonia, Viral|Primary Health Care|Quarantine|SARS-CoV-2|Spain|NA",2020-09-09,Revista espanola de salud publica,Registry,https://clinicaltrials.gov/ct2/show/NCT04885478,0
32883593,NCT04343261,SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma.,"Clinical Trial, Phase II|Journal Article","Antibodies, Viral|Immunoglobulin G|Immunoglobulin M|NA","Adult|Aged|Antibodies, Viral|COVID-19|Female|Humans|Immunization, Passive|Immunoglobulin G|Immunoglobulin M|Male|Middle Aged|SARS-CoV-2|NA",2020-12-21,Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,Registry,https://clinicaltrials.gov/ct2/show/NCT04343261,4
32937978,NCT04632615,Psychological Distress and Problem Gambling in Elite Athletes during COVID-19 Restrictions-A Web Survey in Top Leagues of Three Sports during the Pandemic.,"Journal Article|Research Support, Non-U.S. Gov't", ,"Athletes|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Gambling|Humans|Male|Pandemics|Pneumonia, Viral|Psychological Distress|SARS-CoV-2|Surveys and Questionnaires|Sweden|NA",2020-09-22,International journal of environmental research and public health,Registry,https://clinicaltrials.gov/ct2/show/NCT04632615,0
32943637,NCT04885478,"A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.","Journal Article|Research Support, N.I.H., Extramural|Research Support, N.I.H., Intramural|Research Support, Non-U.S. Gov't|Systematic Review","Antibodies, Viral|Immunoglobulin Isotypes|NA","Antibodies, Viral|Betacoronavirus|COVID-19|Coronavirus Infections|Cross Reactions|Databases, Factual|Humans|Immunization, Passive|Immunoglobulin Isotypes|Middle East Respiratory Syndrome Coronavirus|Pandemics|Pneumonia, Viral|SARS-CoV-2|Seroepidemiologic Studies|NA",2020-09-30,Nature communications,Registry,https://clinicaltrials.gov/ct2/show/NCT04885478,0
32951151,NCT04343261,Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective PhaseÂ II Clinical Trial.,Journal Article, , ,2021-04-28,Infectious diseases and therapy,Registry,https://clinicaltrials.gov/ct2/show/NCT04343261,4
32960881,NCT04568356,Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.,"Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't|Systematic Review", ,"Asymptomatic Diseases|Asymptomatic Infections|Betacoronavirus|COVID-19|Coronavirus Infections|Disease Progression|Humans|Mass Screening|Pandemics|Pneumonia, Viral|Reverse Transcriptase Polymerase Chain Reaction|SARS-CoV-2|NA",2020-10-01,PLoS medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04568356,0
32961244,NCT04343898,Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States.,"Journal Article|Research Support, N.I.H., Extramural", ,"Aged|COVID-19|Comorbidity|Critical Illness|Female|Hospital Mortality|Humans|Intensive Care Units|Kidney Function Tests|Male|Renal Dialysis|Renal Insufficiency, Chronic|Retrospective Studies|Risk Factors|SARS-CoV-2|Treatment Outcome|United States|NA",2021-02-01,American journal of kidney diseases : the official journal of the National Kidney Foundation,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
32963090,NCT04818866,Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.,"Journal Article|Multicenter Study|Observational Study|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't","PLAUR protein, human|Receptors, Urokinase Plasminogen Activator|NA","Acute Kidney Injury|Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Humans|Incidence|Male|Middle Aged|Pandemics|Pneumonia, Viral|Receptors, Urokinase Plasminogen Activator|SARS-CoV-2|NA",2020-11-16,Journal of the American Society of Nephrology : JASN,Registry,https://clinicaltrials.gov/ct2/show/NCT04818866,0
32971150,NCT04604249,"Incidence of COVID-19 infection and prevalence of diabetes, obesity and hypertension according to altitude in Peruvian population.",Journal Article, ,Adolescent|Adult|Altitude|COVID-19|Diabetes Mellitus|Female|Humans|Hypertension|Hypoxia|Incidence|Male|Middle Aged|Obesity|Peru|Prevalence|SARS-CoV-2|Young Adult|NA,2020-12-29,Diabetes research and clinical practice,Registry,https://clinicaltrials.gov/ct2/show/NCT04604249,0
32986516,NCT04712292,Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study.,Journal Article, ,"Betacoronavirus|COVID-19|Cancer Care Facilities|Coronavirus Infections|Cross-Sectional Studies|Global Burden of Disease|Health Services Accessibility|Humans|Infection Control|International Cooperation|Medical Oncology|Neoplasms|Pandemics|Pneumonia, Viral|SARS-CoV-2|Surveys and Questionnaires|NA",2020-10-14,JCO global oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04712292,0
32987040,NCT04700254,Type 1 diabetes and COVID-19: The &quot;lockdown effect&quot;.,Journal Article, ,"Adult|COVID-19|Diabetes Mellitus, Type 1|Female|Humans|Male|Retrospective Studies|SARS-CoV-2|NA",2021-01-04,Diabetes research and clinical practice,Registry,https://clinicaltrials.gov/ct2/show/NCT04700254,0
32992075,NCT04486508,Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.,Clinical Trial Protocol|Journal Article,Anticoagulants|Enoxaparin|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Atorvastatin|NA,Anticoagulants|Atorvastatin|COVID-19|Critical Illness|Double-Blind Method|Enoxaparin|Humans|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Iran|Multicenter Studies as Topic|Randomized Controlled Trials as Topic|Thrombosis|Time Factors|Treatment Outcome|Venous Thromboembolism|NA,2020-12-10,Thrombosis research,Registry,https://clinicaltrials.gov/ct2/show/NCT04486508,1
32998872,NCT04343898,In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study.,"Journal Article|Multicenter Study|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't", ,"Adult|Aged|Aged, 80 and over|Betacoronavirus|COVID-19|Cohort Studies|Coronavirus Infections|Female|Heart Arrest|Hospital Mortality|Humans|Intensive Care Units|Male|Middle Aged|Pandemics|Pneumonia, Viral|SARS-CoV-2|United States|NA",2020-10-21,BMJ (Clinical research ed.),Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33001138,NCT04329923,Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.,Journal Article|Multicenter Study|Randomized Controlled Trial,Hydroxychloroquine|NA,"Adult|COVID-19|Cross Infection|Double-Blind Method|Female|Hospitals, Urban|Humans|Hydroxychloroquine|Incidence|Male|Pennsylvania|Personnel, Hospital|Pre-Exposure Prophylaxis|SARS-CoV-2|NA",2021-02-05,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04329923,1
33009668,NCT04715477,"The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis.",Journal Article|Meta-Analysis|Systematic Review, ,Anxiety|COVID-19|Depression|Female|Humans|Male|Mental Health|Pandemics|Prevalence|SARS-CoV-2|Sleep Wake Disorders|NA,2021-02-25,Annals of the New York Academy of Sciences,Registry,https://clinicaltrials.gov/ct2/show/NCT04715477,0
33013503,NCT04841681,"Mindfulness, Age and Gender as Protective Factors Against Psychological Distress During COVID-19 Pandemic.",Journal Article, , ,2020-10-06,Frontiers in psychology,Registry,https://clinicaltrials.gov/ct2/show/NCT04841681,0
33013686,NCT04659200,Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study.,Journal Article,Thyroid Hormones|NA,"Adult|Aged|Aged, 80 and over|COVID-19|Cohort Studies|Coronavirus Infections|Female|Hospitalization|Humans|Hypothyroidism|Male|Middle Aged|New York City|Pandemics|Pneumonia, Viral|Respiration, Artificial|Retrospective Studies|Risk|Thyroid Hormones|Treatment Outcome|NA",2020-10-15,Frontiers in endocrinology,Registry,https://clinicaltrials.gov/ct2/show/NCT04659200,0
33017138,NCT04824664,Set up of a dedicated COVID-19 surgical pathway and operating room for surgical emergencies.,Journal Article, ,"Betacoronavirus|COVID-19|Coronavirus Infections|Critical Pathways|Emergency Treatment|Humans|Infection Control|Infectious Disease Transmission, Patient-to-Professional|Italy|Operating Rooms|Pandemics|Personal Protective Equipment|Pneumonia, Viral|SARS-CoV-2|Surgical Procedures, Operative|Workflow|NA",2020-10-13,The journal of trauma and acute care surgery,Registry,https://clinicaltrials.gov/ct2/show/NCT04824664,0
33026829,NCT04343898,Outcomes of Critically Ill Pregnant Women with COVID-19 in the United States.,"Letter|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't", ,COVID-19|Comorbidity|Critical Illness|Female|Humans|Intensive Care Units|Pregnancy|Pregnancy Complications|Risk Factors|SARS-CoV-2|United States|NA,2021-01-12,American journal of respiratory and critical care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33031652,NCT04381936,Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.,Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial,Antiviral Agents|Hydroxychloroquine|NA,"Aged|Aged, 80 and over|Antiviral Agents|Betacoronavirus|COVID-19|Coronavirus Infections|Female|Hospitalization|Humans|Hydroxychloroquine|Male|Middle Aged|Pandemics|Pneumonia, Viral|Respiration, Artificial|SARS-CoV-2|Treatment Failure|NA",2020-12-01,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04381936,4
33032660,NCT04733729,Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.,"Journal Article|Multicenter Study|Observational Study|Research Support, Non-U.S. Gov't",Antineoplastic Agents|Antiviral Agents|NA,"Adolescent|Adult|Age Factors|Aged|Aged, 80 and over|Antineoplastic Agents|Antiviral Agents|Betacoronavirus|COVID-19|Comorbidity|Coronavirus Infections|Female|Hematologic Neoplasms|Humans|Male|Middle Aged|Pandemics|Pneumonia, Viral|Prospective Studies|Registries|Risk Factors|SARS-CoV-2|Severity of Illness Index|Spain|Treatment Outcome|Young Adult|NA",2020-10-27,Journal of hematology &amp; oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04733729,0
33054403,NCT04604249,"<i>Letter to the Editor:</i> COVID-19 Infections Do Not Change with Increasing Altitudes from 1,000 to 4,700â€‰m.",Letter|Comment, ,Altitude|COVID-19|Humans|SARS-CoV-2|NA,2021-01-01,High altitude medicine &amp; biology,Registry,https://clinicaltrials.gov/ct2/show/NCT04604249,0
33065991,NCT04449731,Associations between Changes in Health Behaviours and Body Weight during the COVID-19 Quarantine in Lithuania: The Lithuanian COVIDiet Study.,Journal Article, ,"Adolescent|Adult|Betacoronavirus|Body Mass Index|Body Weight|COVID-19|Coronavirus Infections|Cross-Sectional Studies|Energy Intake|Fast Foods|Feeding Behavior|Female|Health Behavior|Humans|Life Style|Lithuania|Male|Middle Aged|Obesity|Pandemics|Pneumonia, Viral|Quarantine|SARS-CoV-2|Snacks|Social Isolation|Weight Gain|Young Adult|NA",2020-10-22,Nutrients,Registry,https://clinicaltrials.gov/ct2/show/NCT04449731,0
33067383,NCT04343898,AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.,Journal Article|Multicenter Study, ,"Acute Kidney Injury|Adolescent|Adult|Aged|Aged, 80 and over|COVID-19|Cohort Studies|Critical Care|Female|Hospital Mortality|Hospitalization|Humans|Incidence|Logistic Models|Male|Middle Aged|Renal Replacement Therapy|Risk Factors|Survival Rate|United States|Young Adult|NA",2021-03-17,Journal of the American Society of Nephrology : JASN,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33072682,NCT04798677,Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality-Perspectives.,Journal Article, ,"Adult|COVID-19|Humans|Influenza A Virus, H1N1 Subtype|Influenza, Human|Morbidity|SARS-CoV-2|NA",2021-05-14,Frontiers in public health,Registry,https://clinicaltrials.gov/ct2/show/NCT04798677,0
33080002,NCT04343898,Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.,"Journal Article|Research Support, N.I.H., Extramural","Adrenal Cortex Hormones|Antibodies, Monoclonal, Humanized|Anticoagulants|Receptors, Interleukin-6|tocilizumab|NA","Adolescent|Adrenal Cortex Hormones|Adult|Aged|Antibodies, Monoclonal, Humanized|Anticoagulants|COVID-19|Cohort Studies|Critical Illness|Early Medical Intervention|Female|Hospital Mortality|Hospitalization|Humans|Intensive Care Units|Male|Middle Aged|Mortality|Organ Dysfunction Scores|Patient Positioning|Prone Position|Proportional Hazards Models|Receptors, Interleukin-6|Respiration, Artificial|Respiratory Insufficiency|SARS-CoV-2|Young Adult|NA",2021-01-15,JAMA internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33080051,NCT04334291,Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.,Journal Article,"Anticoagulants|Factor Xa Inhibitors|Heparin, Low-Molecular-Weight|Heparin|NA","Aged|Aged, 80 and over|Anticoagulants|Atrial Fibrillation|COVID-19|Comorbidity|Factor Xa Inhibitors|Female|Heart Failure|Heart Valve Prosthesis|Heart Valve Prosthesis Implantation|Heparin|Heparin, Low-Molecular-Weight|Hospital Mortality|Humans|Intensive Care Units|Male|Multivariate Analysis|Prognosis|Propensity Score|Proportional Hazards Models|Renal Insufficiency|Respiration, Artificial|Respiratory Insufficiency|Risk Factors|SARS-CoV-2|Sepsis|Systemic Inflammatory Response Syndrome|Thromboembolism|Venous Thromboembolism|NA",2021-01-01,European journal of clinical investigation,Registry,https://clinicaltrials.gov/ct2/show/NCT04334291,6
33085966,NCT04763213,The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.,Journal Article,Platelet Aggregation Inhibitors|NA,"Acute Coronary Syndrome|Arrhythmias, Cardiac|Humans|Non-ST Elevated Myocardial Infarction|Platelet Aggregation Inhibitors|NA",2021-05-14,European heart journal,Registry,https://clinicaltrials.gov/ct2/show/NCT04763213,0
33094320,NCT04348214,Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers.,Journal Article, ,"Adult|Asymptomatic Diseases|COVID-19|COVID-19 Nucleic Acid Testing|COVID-19 Testing|Egypt|Female|Fever|Health Personnel|Hospitals, University|Humans|Infection Control|Male|Mass Screening|Middle Aged|Pandemics|Reverse Transcriptase Polymerase Chain Reaction|Risk Factors|SARS-CoV-2|Tertiary Healthcare|NA",2021-03-11,International journal of epidemiology,Registry,https://clinicaltrials.gov/ct2/show/NCT04348214,0
33095752,NCT04840940,Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection.,Journal Article, , ,2021-01-20,Clinical chemistry and laboratory medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04840940,0
33097915,NCT04712292,Consequences of COVID-19 for cancer care - a CRUK perspective.,Journal Article, ,Biomedical Research|COVID-19|Epidemics|Humans|Medical Oncology|Neoplasms|SARS-CoV-2|United Kingdom|NA,2021-01-25,Nature reviews. Clinical oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04712292,0
33135047,NCT04407273,EFFECT oF STATIN THERAPY oN SARS-CoV-2 INFECTION-RELATED.,Journal Article, , ,2020-11-17,European heart journal. Cardiovascular pharmacotherapy,Registry,https://clinicaltrials.gov/ct2/show/NCT04407273,0
33140181,NCT04885517,Clinical strategies for implementing lung and diaphragm-protective ventilation: avoiding insufficient and excessive effort.,Journal Article|Review, ,"Diaphragm|Humans|Lung|Respiration|Respiration, Artificial|Ventilators, Mechanical|NA",2021-05-21,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04885517,0
33151050,NCT04643522,Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections on Testis.,Journal Article, , ,2021-01-06,The world journal of men's health,Registry,https://clinicaltrials.gov/ct2/show/NCT04643522,0
33165755,NCT04334291,"Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry.",Journal Article, , ,2020-11-13,Internal and emergency medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04334291,6
33165763,NCT04662437,Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients.,Letter,Biomarkers|Calcium|NA,"Acute Disease|Aged|Aged, 80 and over|Biomarkers|COVID-19|Calcium|Case-Control Studies|Cohort Studies|Female|Hospitalization|Humans|Hypocalcemia|Italy|Male|Prognosis|Respiratory Tract Infections|Retrospective Studies|SARS-CoV-2|NA",2021-02-16,Endocrine,Registry,https://clinicaltrials.gov/ct2/show/NCT04662437,0
33179911,NCT04578158,Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity.,Journal Article,"Angiotensin-Converting Enzyme Inhibitors|Polyphenols|Recombinant Proteins|Quercetin|Peptidyl-Dipeptidase A|ACE2 protein, human|Angiotensin-Converting Enzyme 2|NA",Angiotensin-Converting Enzyme 2|Angiotensin-Converting Enzyme Inhibitors|Enzyme Assays|Humans|Kinetics|Peptidyl-Dipeptidase A|Polyphenols|Quercetin|Recombinant Proteins|Temperature|NA,2020-12-01,Journal of agricultural and food chemistry,Registry,https://clinicaltrials.gov/ct2/show/NCT04578158,0
33181332,NCT04799600,Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting.,Journal Article, ,"Aged|COVID-19|Female|Hospital Mortality|Hospitalization|Hospitals, Community|Humans|Intensive Care Units|Male|Middle Aged|Prognosis|ROC Curve|Retrospective Studies|SARS-CoV-2|Severity of Illness Index|NA",2021-01-18,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04799600,0
33190397,NCT04834102,Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.,Case Reports|Journal Article, ,Aged|Alopecia|Alopecia Areata|COVID-19|Communicable Disease Control|Female|Humans|Middle Aged|SARS-CoV-2|NA,2021-02-26,Dermatologic therapy,Registry,https://clinicaltrials.gov/ct2/show/NCT04834102,0
33201181,NCT04334291,Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19.,Journal Article|Multicenter Study, ,"Aged|Aged, 80 and over|COVID-19|Female|Geriatric Assessment|Hospital Mortality|Hospitalization|Humans|Intensive Care Units|International Cooperation|Male|Mortality|Multimorbidity|Prognosis|Registries|Risk Assessment|Risk Factors|SARS-CoV-2|NA",2021-03-17,Age and ageing,Registry,https://clinicaltrials.gov/ct2/show/NCT04334291,6
33204764,NCT04308668,Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.,Journal Article, , ,2021-04-28,Open forum infectious diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04308668,4
33210302,NCT04331795,COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.,"Clinical Trial, Phase II|Journal Article|Research Support, Non-U.S. Gov't","Anti-Inflammatory Agents|Antibodies, Monoclonal, Humanized|Receptors, Interleukin-6|C-Reactive Protein|tocilizumab|NA","Aged|Anti-Inflammatory Agents|Antibodies, Monoclonal, Humanized|C-Reactive Protein|COVID-19|Dose-Response Relationship, Drug|Drug Monitoring|Female|Fever|Humans|Male|Pneumonia, Viral|Receptors, Interleukin-6|SARS-CoV-2|Severity of Illness Index|Time Factors|Treatment Outcome|NA",2021-03-01,Clinical pharmacology and therapeutics,Registry,https://clinicaltrials.gov/ct2/show/NCT04331795,0
33215159,NCT04721457,Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection.,Journal Article, , ,2021-04-28,"Function (Oxford, England)",Registry,https://clinicaltrials.gov/ct2/show/NCT04721457,0
33223114,NCT04819165,Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.,Journal Article, ,Aged|COVID-19|Cohort Studies|Coinfection|Female|Hospitalization|Humans|Incidence|Italy|Male|Middle Aged|Respiratory Tract Infections|Risk Factors|SARS-CoV-2|Sepsis|NA,2021-03-11,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04819165,0
33226117,NCT04834102,Telogen effluvium: a sequela of COVID-19.,Letter, ,Adult|Aged|Alopecia Areata|COVID-19|Female|Humans|Middle Aged|NA,2021-02-08,International journal of dermatology,Registry,https://clinicaltrials.gov/ct2/show/NCT04834102,0
33230249,NCT04728828,The seroprevalence of SARS-CoV-2 in patients on haemodialysis.,Journal Article|Comment, ,COVID-19|Cross-Sectional Studies|Humans|Prevalence|Renal Dialysis|SARS-CoV-2|Seroepidemiologic Studies|United States|NA,2021-03-26,Nature reviews. Nephrology,Registry,https://clinicaltrials.gov/ct2/show/NCT04728828,0
33264556,NCT04315948,Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.,"Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't",Antiviral Agents|Lopinavir|remdesivir|Adenosine Monophosphate|Hydroxychloroquine|Alanine|Interferon beta-1a|NA,"Adenosine Monophosphate|Aged|Alanine|Antiviral Agents|COVID-19|Drug Therapy, Combination|Female|Hospital Mortality|Hospitalization|Humans|Hydroxychloroquine|Intention to Treat Analysis|Interferon beta-1a|Kaplan-Meier Estimate|Length of Stay|Lopinavir|Male|Middle Aged|Respiration, Artificial|Treatment Failure|NA",2021-02-12,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04315948,3
33274176,NCT04753476,Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.,Journal Article|Review, ,COVID-19|Coronavirus Infections|Humans|Mesenchymal Stem Cells|Pandemics|Respiratory Distress Syndrome|SARS-CoV-2|NA,2020-12-14,Analytical cellular pathology (Amsterdam),Registry,https://clinicaltrials.gov/ct2/show/NCT04753476,0
33274360,NCT04308668,Reply to author.,Journal Article, , ,2020-12-04,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,Registry,https://clinicaltrials.gov/ct2/show/NCT04308668,4
33290293,NCT04404244,COVID-19 in Children With Cancer: A Single Low-Middle Income Center Experience.,Journal Article, , ,2020-12-08,Journal of pediatric hematology/oncology,Registry,https://clinicaltrials.gov/ct2/show/NCT04404244,0
33301246,NCT04798677,Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.,"Clinical Trial, Phase II|Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","COVID-19 Vaccines|Vaccines, Synthetic|mRNA Vaccine|BNT162 vaccine|NA","Adolescent|Adult|Aged|COVID-19|COVID-19 Vaccines|Fatigue|Female|Headache|Humans|Immunization, Secondary|Male|Middle Aged|SARS-CoV-2|Single-Blind Method|Treatment Outcome|Vaccines, Synthetic|Young Adult|NA",2021-01-12,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04798677,0
33310111,NCT04834102,A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19.,Journal Article|Multicenter Study, ,"Adult|Alopecia|COVID-19|European Continental Ancestry Group|Female|Hispanic Americans|Hospitals, Urban|Humans|Incidence|Male|Middle Aged|New York City|Poverty Areas|Retrospective Studies|SARS-CoV-2|Stress, Psychological|Young Adult|NA",2021-03-01,Journal of the American Academy of Dermatology,Registry,https://clinicaltrials.gov/ct2/show/NCT04834102,0
33339569,NCT04712292,Declines in Cancer Screening During COVID-19 Pandemic.,Editorial, ,COVID-19|Early Detection of Cancer|Global Health|Health Care Rationing|Health Services Accessibility|Humans|Pandemics|Patient Acceptance of Health Care|NA,2021-01-04,Journal of the National Medical Association,Registry,https://clinicaltrials.gov/ct2/show/NCT04712292,0
33346365,NCT04334291,Underlying heart diseases and acute COVID-19 outcomes.,Journal Article|Multicenter Study, ,Aged|COVID-19|Comorbidity|Female|Global Health|Heart Diseases|Humans|Male|Middle Aged|Pandemics|Prognosis|Registries|Retrospective Studies|Risk Factors|SARS-CoV-2|NA,2021-05-06,Cardiology journal,Registry,https://clinicaltrials.gov/ct2/show/NCT04334291,6
33364250,NCT04449731,Reported Changes in Dietary Habits During the COVID-19 Lockdown in the Danish Population: The Danish COVIDiet Study.,Journal Article, , ,2020-12-29,Frontiers in nutrition,Registry,https://clinicaltrials.gov/ct2/show/NCT04449731,0
33388794,NCT04819165,Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study.,"Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't", ,"Aged|COVID-19|Europe|Female|Humans|Incidence|Influenza, Human|Male|Middle Aged|Pneumonia, Ventilator-Associated|Respiratory Tract Infections|Retrospective Studies|Ventilators, Mechanical|NA",2021-02-25,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04819165,0
33390932,NCT04705753,"The Therapeutic Potential of the Essential Oil of <i>Thymbra capitata</i> (L.) Cav., <i>Origanum dictamnus</i> L. and <i>Salvia fruticosa</i> Mill. And a Case of Plant-Based Pharmaceutical Development.",Journal Article|Review, , ,2021-01-05,Frontiers in pharmacology,Registry,https://clinicaltrials.gov/ct2/show/NCT04705753,0
33440088,NCT04843917,Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.,"Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't","Antibodies, Neutralizing|Antibodies, Viral|COVID-19 Vaccines|Ad26.COV2.S vaccine|NA","Adolescent|Adult|Antibodies, Neutralizing|Antibodies, Viral|CD4 Lymphocyte Count|CD4-Positive T-Lymphocytes|CD8-Positive T-Lymphocytes|COVID-19|COVID-19 Vaccines|Cohort Studies|Double-Blind Method|Humans|Immunogenicity, Vaccine|Male|Middle Aged|SARS-CoV-2|Young Adult|NA",2021-05-17,The New England journal of medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04843917,0
33484863,NCT04348214,SARS-CoV-2 seroconversion among 4040 Egyptian healthcare workers in 12 resource-limited healthcare facilities: A prospective cohort study.,Journal Article, ,Academic Medical Centers|Adult|COVID-19|COVID-19 Testing|Cohort Studies|Egypt|Female|Health Personnel|Humans|Incidence|Male|Middle Aged|Prospective Studies|Risk Factors|SARS-CoV-2|Seroconversion|Serologic Tests|Young Adult|NA,2021-04-23,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,Registry,https://clinicaltrials.gov/ct2/show/NCT04348214,0
33493012,NCT04343898,"Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.",Journal Article|Multicenter Study|Observational Study,Anticoagulants|NA,Aged|Anticoagulants|Blood Coagulation Disorders|COVID-19|Critical Illness|Female|Hemorrhage|Humans|Intensive Care Units|Male|Middle Aged|SARS-CoV-2|Survival Rate|United States|Venous Thromboembolism|NA,2021-05-28,Annals of internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33519466,NCT04340349,Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method.,Journal Article, , ,2021-02-02,Frontiers in pharmacology,Registry,https://clinicaltrials.gov/ct2/show/NCT04340349,0
33528595,NCT04343898,Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19.,"Journal Article|Multicenter Study|Research Support, N.I.H., Extramural", ,Adult|COVID-19|Cohort Studies|Extracorporeal Membrane Oxygenation|Female|Humans|Male|Middle Aged|Respiratory Distress Syndrome|Treatment Outcome|NA,2021-02-25,Intensive care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33558079,NCT04340349,Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19.,Journal Article, , ,2021-02-22,Therapie,Registry,https://clinicaltrials.gov/ct2/show/NCT04340349,0
33591017,NCT04343898,d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019.,Journal Article|Multicenter Study,Biomarkers|Fibrin Fibrinogen Degradation Products|fibrin fragment D|NA,Aged|Biomarkers|COVID-19|Cohort Studies|Critical Illness|Female|Fibrin Fibrinogen Degradation Products|Hospital Mortality|Humans|Intensive Care Units|Male|Middle Aged|SARS-CoV-2|Severity of Illness Index|Thrombophilia|United States|NA,2021-04-28,Critical care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33595960,NCT04343898,Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure.,Journal Article, , ,2021-05-31,Critical care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33597143,NCT04798677,Impact of temperature and relative humidity on the transmission of COVID-19: a modelling study in China and the United States.,"Journal Article|Research Support, Non-U.S. Gov't", ,"COVID-19|China|Cities|Cross-Sectional Studies|Humans|Humidity|Models, Theoretical|Retrospective Studies|SARS-CoV-2|Temperature|United States|NA",2021-02-25,BMJ open,Registry,https://clinicaltrials.gov/ct2/show/NCT04798677,0
33677049,NCT04598581,Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study.,Journal Article, , ,2021-04-04,"International journal of radiation oncology, biology, physics",Registry,https://clinicaltrials.gov/ct2/show/NCT04598581,0
33721539,NCT04308668,Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.,Journal Article|Comment,Hydroxychloroquine|NA,Adult|COVID-19|Coronavirus Infections|Humans|Hydroxychloroquine|SARS-CoV-2|NA,2021-03-18,Annals of internal medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04308668,4
33785743,NCT04331899,Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial.,"Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't",Antiviral Agents|Interleukins|peginterferon lambda-1a|Polyethylene Glycols|NA,"Adult|Aged|Antiviral Agents|COVID-19|Female|Humans|Injections, Subcutaneous|Interleukins|Male|Middle Aged|Outpatients|Polyethylene Glycols|SARS-CoV-2|Single-Blind Method|Treatment Failure|Virus Shedding|Young Adult|NA",2021-04-12,Nature communications,Registry,https://clinicaltrials.gov/ct2/show/NCT04331899,1
33872546,NCT04343898,Tissue Plasminogen Activator in Critically Ill Adults with COVID-19.,Journal Article, , ,2021-04-19,Annals of the American Thoracic Society,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33891529,NCT04343898,Hospital-Level Variation in Death for Critically Ill Patients with COVID-19.,Journal Article, , ,2021-04-23,American journal of respiratory and critical care medicine,Registry,https://clinicaltrials.gov/ct2/show/NCT04343898,0
33891615,NCT04467931,Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.,"Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, Non-P.H.S.",Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|NA,Aged|Angiotensin Receptor Antagonists|Angiotensin-Converting Enzyme Inhibitors|COVID-19|Female|Hospitalization|Humans|Hypertension|Male|Middle Aged|Propensity Score|Proportional Hazards Models|Retrospective Studies|Risk Factors|SARS-CoV-2|Survival Rate|Veterans|NA,2021-05-07,PloS one,Registry,https://clinicaltrials.gov/ct2/show/NCT04467931,0
